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Abstract 
 
In the current clinical environment, treatment options for nerve and spinal cord injuries remain 
limited.  To develop novel therapies, we require a better understanding of axonal repair and its 
underlying molecular mechanisms.  The response of an axon to a transection injury is complex: the 
axon still attached to the cell body begins a process of regenerative regrowth, whereas a concurrent 
process of degeneration is activated in the severed axonal fragment.  Characterizing ways in which 
the axon can achieve repair, involving both regeneration and degeneration, is crucial to making 
progress in a clinical setting. 
We have studied a means of axonal repair called axonal fusion, which occurs spontaneously in 
the mechanosensory neurons of the nematode C. elegans.  Following axotomy with a UV laser, the 
regrowing axonal fragment is able to directly fuse with its own severed fragment, re-establishing 
continuity.  When axonal fusion was first described in C. elegans, the molecular pathways involved 
were unknown, and the only protein associated with the process was the fusogen Epithelial Fusion 
Failure-1 (EFF-1).  EFF-1 is a nematode-specific transmembrane glycoprotein that acts to fuse 
plasma membranes.  It has been studied extensively in other C. elegans tissues, but its function and 
regulation in neurons have been largely uncharacterized.   
In this context, we aimed to further understand the role of EFF-1 in axonal repair, focusing on 
its potential contribution to both regeneration and degeneration, and the mechanisms that regulate 
its fusogenic activity.  We approached these biological questions using a combination of genetic 
and molecular biology techniques available in the C. elegans model system.  
The following chapters characterize EFF-1 function and regulation in the C. elegans 
mechanosensory neuron PLM.  Firstly, we demonstrate a cell-autonomous role for EFF-1 in axonal 
fusion, and show that it has a dynamic localization pattern in the regenerating axon, whereby it is 
mobilized to the membrane of the regenerating growth cone.  We also place it downstream in a 
pathway of apoptotic clearance molecules that allow recognition of the distal axonal fragment.  
Secondly, we find that neuronal EFF-1 is regulated by the endocytic GTPase RAB-5, with 
alterations in RAB-5 activity affecting both EFF-1 localization and its function in axonal fusion.  
Thirdly, we characterize the genes involved in the degeneration of the distal PLM axon following 
axotomy, and find a remarkable overlap with the molecules involved in regenerative fusion, 
possibly including EFF-1.  Finally, we discuss an intriguing potential role for EFF-1 in mediating 
neuronal repair through cell-cell fusion.  The research detailed here represents significant progress 
in understanding how a fusogen mediates axonal repair in vivo.  It will potentially contribute to the 
application of axonal fusion as a novel therapy for patients with nerve injuries.    
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Chapter 1: Review of regenerative neurite fusion and EFF-1 
 
(Review in preparation) 
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1.1 Introduction 
 
Axonal repair is an important field of research with clear clinical applications.  The free-living 
nematode Caenorhabditis elegans (C. elegans) is an ideal animal model system in which to study 
this process, as individual neurons can be visualized in vivo using genetically-encoded fluorophores.  
Our laboratory investigates axonal repair in the two posterior lateral microtubule cells of C. elegans 
(PLM neurons left and right).  Following UV laser axotomy, the anterior axon of PLM can undergo 
spontaneous self-repair via axonal fusion, a mechanism by which the proximal axon (still attached 
to the cell body) regrows, reconnects, and fuses with its own separated distal fragment, re-
establishing the original axonal tract1,2.  
Understanding this spontaneous neurite fusion is of great interest, as it presents an efficient and 
novel approach to nerve repair.  To date, it has been observed only in C. elegans and a select 
number of other invertebrates3-7.  
Central to understanding neurite fusion is a characterization of the molecules involved.  The 
key effector of axonal fusion in PLM is known to be the molecule Epithelial Fusion Failure-1 
(EFF-1)1,8.  How EFF-1 functions in the repair of this axon is the central question underpinning this 
thesis.  Previous characterization of EFF-1 has been largely performed in other C. elegans tissues 
and heterologous cell systems (see below).  This information has provided the basis for hypotheses 
in this thesis regarding EFF-1 function in neurons.  
This first chapter consists of an unpublished manuscript (Section 1.2) that is a mini-review of 
regenerative neurite fusion.  It focuses on processes of both axonal regeneration and degeneration 
relevant to this mechanism of repair.  It should be noted that this review includes some results from 
subsequent thesis chapters that are now published; these will be discussed in more detail in the 
relevant chapter.  
Following the manuscript is an additional section providing more detailed information on 
EFF-1 (Section 1.3), as background knowledge on this molecule is key to this thesis.  Details are 
provided of EFF-1 function as well as its regulation in different cellular contexts.  The chapter then 
concludes with a summary of the thesis aims (Section 1.4).   
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1.2 Review in preparation 
 
Repairing injured neurites through spontaneous fusion   
 
Linton, C., Neumann, B., Giordano-Santini, R. & Hilliard, M. A. Repairing injured neurites 
through spontaneous fusion.  In preparation.  
 
Please note that this manuscript has been reformatted for inclusion in the thesis; references are 
included in a combined reference list at the end of the chapter. 
 
 
  
	 4	
1.2.1 Introduction  
Understanding and achieving repair of the nervous system is an enduring clinical problem.  
Traumatic spinal cord and nerve injuries are notoriously difficult to treat and rely on poor 
endogenous regenerative responses.  Following transection of a nerve, the key to restoring its 
function is re-establishing connection with its synaptic target.  While peripheral nerves can achieve 
some regrowth towards their targets, the spinal cord appears incapable, due to a complex 
combination of intrinsic and extrinsic inhibitory factors9,10.  As such, novel means of reconnecting 
these neurites to their targets must be developed.  
In some invertebrate species, neurites can spontaneously repair a transection injury by fusing 
the two separated fragments.  This has been reported to occur in both axons and dendrites.  How is 
this fusion achieved?  Does it effectively repair the neurite?  Is it a specific process, and, if so, how 
might it be regulated?  Such fusion of neurites relies upon correct recognition of the severed neurite, 
and must overcome barriers such as self-avoidance mechanisms that act during development.  
Dedicated molecular machinery must also exist to mediate merging of the axonal membranes. 
This review will explore what is currently known about neurite fusion.  Fusion events observed 
in both axons and dendrites will be discussed, as well as the molecular effectors of this fusion 
process, called fusogens.  The role of neurite degeneration, and how this concurrent process could 
affect the process of fusion, will also be examined.  
 
1.2.2 Axonal fusion 
After a transection injury, an axon is separated into a proximal fragment that is still attached to the 
cell body, and a distal, severed fragment (Figure 1.1a).  In the classical model of axonal 
regeneration (Figure 1.1b), the proximal fragment initiates regrowth that must extend the entire 
length of the severed fragment in order to re-establish connection with its synaptic target.  In this 
scenario, the distal fragment is left to degenerate and undergo clearance.  In an alternative model of 
axonal regeneration, some axons can instead undergo direct fusion between the proximal and distal 
fragments, restoring the original axonal tract (Figure 1.1c).  
To date, this seemingly efficient pattern of regeneration has only been observed in a number of 
invertebrate species.  Neurons in the crayfish, leech, earthworm, sea slug (Aplysia) and nematode C. 
elegans are all capable of fusing their axons1-7.  
! &!
 
Figure 1.1.  Models of axonal regeneration.  Following transection injury to an axon (a), repair 
can be achieved via different mechanisms.  In the classical model of regeneration (b), the axonal 
fragment still attached to the cell body regrows past the distal severed fragment to make a new 
connection to the synaptic target; the severed axonal fragment undergoes degeneration and 
clearance.  In axonal fusion (c), the regrowing axon instead fuses directly with the severed 
fragment, re-establishing the original axonal tract and preventing degeneration of the severed 
fragment.  
 
Axonal fusion has been most recently characterized in the mechanosensory neurons of C. 
elegans1,2,8.  This animal has a total of six mechanosensory neurons that respond to light touch11.  
The best characterized of these neurons are the two posterior lateral microtubule cells (PLM left and 
right).  Each has a cell body located in the tail of the animal, and extends a long anterior process 
towards the midbody.  This axon exhibits a robust rate of regrowth following UV laser 
axotomy1,2,8,12-14 and a high rate of subsequent fusion with its severed axonal fragment1,2,8.  It has 
been demonstrated that this fusion re-creates both membrane and cytoplasmic continuity with the 
distal axon2 and prevents its degeneration for up to 10 days (Dr. B. Neumann, personal 
communication).  This fusion is also a remarkably specific event, as the regrowing PLM axon will 
fuse with its own distal axon even in the presence of other transected axonal fragments2. 
Perhaps the most crucial question regarding axonal fusion is whether it restores function to the 
axon.  Excitingly, some form of functional recovery has been demonstrated in crayfish, earthworm 
and Aplysia models of the process3,4,6, despite differences in neuronal class and mechanism of 
injury.  In the C. elegans PLM neuron, very recent work has now demonstrated that, in addition to 
morphological recovery, fusion does restore full function to the neuron15,16. 
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1.2.3 Dendritic fusion  
Regenerative neurite fusion has also been observed in dendrites.  Maintaining the integrity of 
dendrites is crucial for allowing correct sensory input to a neuron.  Studies of the C. elegans neuron 
PVD have revealed that its dendrites can undergo fusion similar to that observed in axons.   
PVD is a nociceptive neuron that responds to harsh touch stimuli17.  It is highly arborized and 
elaborates multiple dendritic branches in a stereotypical pattern resembling menorahs.  The 
development of these branches is complex, and has been shown to involve dynamic processes of 
branch growth, pruning, and retraction18,19, in addition to mechanisms of self-avoidance that prevent 
overlap of branches19,20.  Curiously, this developmental remodeling may also involve fusion 
between particular dendritic branches.  Electron microscopy of wild-type PVD neurons 
demonstrated that the terminal PVD branches can form loop-like structures, which are likely 
achieved through self-fusion18.  The function of the loops is currently unclear; one possibility is that 
they restrict further growth of the dendrites, and act in conjunction with mechanisms of self-
avoidance to ensure that the dendritic tree achieves its correct final morphology.  
More recently, the PVD dendrites were shown to undergo fusion instead as a means of repair21.  
Following UV laser dendrotomy, the PVD dendrites exhibited regrowth and formed reconnections 
between branches to bypass the injury site.  Crucially, this was shown to restore cytoplasmic 
continuity and hence morphological recovery.  In this context, fusion events represent loss of the 
self-avoidance process exhibited during development, as contact was required between dendritic 
branches that normally undergo mutual repulsion as part of their formation.   
Functional recovery following regenerative fusion in PVD has not been specifically tested.  
However, the morphology of the PVD neuron has been closely linked with its function, as genetic 
mutants that exhibit aberrant branching patterns display a corresponding reduction in their response 
to harsh touch stimuli18.  It is thus likely that fusion which restores PVD morphology will 
contribute to the functional outcome.  
It has therefore been established that both dendrites and axons undergo fusion following injury 
to potentially achieve morphological and functional recovery.  In this context, it becomes intriguing 
to consider what molecular machinery is activated to mediate this regenerative fusion in neurites.  
 
1.2.4 Neurite fusion is mediated by fusogens   
Neurite fusion is an example of fusion between plasma membranes, which occurs in many 
biological contexts.  The processes of viral infection and syncytial tissue formation, as well as 
neurite fusion, all involve merging of two apposed membranes to create continuity between 
compartments.  
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Membrane fusion is not a spontaneous process, but requires energy generated by 
transmembrane proteins specialized in membrane merging22.  Well-characterized examples of these 
proteins include viral fusogens, which allow entry of a virus into a host cell23 and the SNARE 
intracellular fusion machinery, which mediates fusion of synaptic vesicles for the release of their 
contents24.   
For many other membrane fusion events, the proteins responsible are yet to be identified.  
However, the search has uncovered an important class of these molecules in the nematode C. 
elegans.  Epithelial Fusion Failure-1 (EFF-1) and Anchor cell Fusion Failure-1 (AFF-1) are the two 
founding members of the C. elegans Fusion Family (CeFF).  Together, they mediate the majority of 
membrane fusion events in C. elegans, including neurite fusion. 
EFF-1 is a nematode type I transmembrane glycoprotein.  It has a crucial role in fusing a 
variety of C. elegans cells during normal development to generate syncytia25.  This molecule is also 
able to mediate membrane fusion in vitro in other cellular contexts26-31.  EFF-1 must be inserted into 
both membranes to mediate fusion; current models suggest that its mechanism of action involves 
the formation of trimers in trans across apposing membranes28,31.  Its activity is known to be 
precisely regulated in development, ensuring it mediates fusion at the correct place and time23,32-28.   
AFF-1 functions similarly to EFF-1 by mediating specific membrane fusion events during C. 
elegans development39-42.  The mechanism through which it mediates fusion has not yet been 
determined, but similarly to EFF-1, it requires insertion into both membranes26.  
Both EFF-1 and AFF-1 are expressed in a subset of C. elegans neurons, and in cells closely 
associated with neurons25,41.  These two molecules have now been shown to mediate important roles 
in the fusion of C. elegans axons and dendrites (see below).  It is noted that these molecules are also 
able to mediate fusion between different neurons; this has been discussed elsewhere43.  It is not 
currently known whether all EFF-1- or AFF-1-expressing neurons may undergo fusion, or 
conversely, whether neurons that don’t express these two fusogens can instead undergo fusion 
through as-yet-undiscovered fusogens.    
 
1.2.5 Molecular mediators of axonal fusion  
To achieve repair via axonal fusion, an axon must undergo sequential processes of regrowth, 
reconnection and fusion.  That is, the proximal axon must first regrow towards its distal fragment 
(regrowth); it must then make contact with the distal fragment (reconnection); finally, it must merge 
the apposing axonal membranes and create continuity between the two axonal fragments (fusion).   
These three processes are distinct and are mediated by different molecular mechanisms.  The 
molecular pathways allowing for regrowth of C. elegans axons following injury have been studied 
extensively and are becoming well established44-46.  In contrast, relatively few studies have focused 
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on the mechanisms of reconnection and fusion.  The ability of the proximal axon to reconnect with 
its distal fragment is influenced by neuronal class, genetic background, larval stage, and method of 
axotomy12,47.  Additionally, the caspase ced-3 has been shown to affect reconnection rates in some 
mechanosensory neurons in a time-dependent manner48.  The process of fusion is promoted by 
elevated calcium and cAMP levels, which are also required for axonal regrowth1,48,49.   
Until recently, the molecular machinery specific to the process of fusion remained a mystery.  
However, it has now been revealed that the fusogen EFF-1 mediates axonal fusion in the C. elegans
PLM neuron, and acts together with components of the apoptotic clearance machinery (Figure 1.2; 
also see Chapter 2). 
 
Figure 1.2.  Model of EFF-1 and the apoptotic recognition molecules that mediate regenerative 
axonal fusion in PLM neurons.  This schematic depicts the site of fusion between the regrowing 
PLM axon and the distal fragment (dotted box).  The phosphatidylserine (PS) receptor PSR-1 
recognizes PS (red) that becomes externalized on the distal axonal fragment following injury.  It 
acts in a cell corpse engulfment pathway that includes the secreted PS-binding protein TTR-52, the 
transmembrane receptor CED-1 and intracellular adapter CED-6.  PS recognition is also 
facilitated by the ABC transporter CED-7 and the lipid-binding protein NRF-5.  EFF-1 (green, 
three molecules are shown in a trimer configuration) acts as the final downstream effector, present 
on both membranes to mediate fusion and restore membrane and cytoplasmic continuity.  
Schematic courtesy of Dr. R. Giordano-Santini. 
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Mutations in eff-1 caused strong defects in axonal fusion in the PLM neuron1,8, which could be 
rescued cell-autonomously8.  In addition, EFF-1 within the PLM neuron localized to the membrane 
of the regenerating axon, consistent with its role in fusing the two axonal membranes.  Upstream of 
EFF-1, signaling via molecules involved in recognition of apoptotic cells allowed the regrowing 
axon to recognize its distal fragment.  Axonal injury triggered exposure of the phospholipid 
phosphatidylserine (PS) on the surface of the severed axon.  This acted as a ‘save me signal’ by 
recruiting both the PS receptor PSR-1 and the secreted PS-binding protein TTR-52; these acted in a 
pathway with the intracellular adaptor CED-6, the ABC transporter CED-7 and the lipid-binding 
protein NRF-5 to improve the efficiency of axonal fusion.  This signaling pathway was first 
described as a mechanism for apoptotic cell corpse engulfment50-54; strikingly, it appears to have 
been repurposed for neurite fusion8.  
 
1.2.6 Molecular mediators of dendritic fusion  
In the C. elegans PVD neuron, the sculpting of dendrites, both during development and repair, is 
also mediated by fusogens.  In the context of development, EFF-1 was found to be required for 
dendritic branch remodeling18.  Specifically, it mediated simplification of the dendritic arbor 
through controlled branch retraction and autofusion.  Loss of eff-1 led to a hyperbranching 
phenotype, whereas cell-autonomous overexpression of eff-1 led to a reduction in branching.  
Conditional expression of EFF-1 resulted in fusion of terminal branches to form loops at the end of 
menorahs, similar to those observed in wild-type PVD neurons (see Section 1.2.3).   
In the context of regeneration, dendritic remodeling is instead achieved through the combined 
activities of EFF-1 and AFF-121.  Following dendrotomy, AFF-1 was responsible for fusion 
between dendritic branches to bypass the injury site.  Curiously, this AFF-1 was derived non-cell-
autonomously and produced as extracellular vesicles by the neighbouring lateral seam cells.  
Dendrotomy was also associated with growth of ectopic branches; these were simplified via the 
activity of EFF-1, which acted cell-autonomously for branch retraction and simplification.  The 
authors proposed a stepwise process in which vesicle-derived AFF-1 acts in the earlier steps of 
regenerative dendrite fusion, and EFF-1 expressed within the neuron acts later for pruning of any 
excessive regrowth.  Additionally, EFF-1 and AFF-1 can promote dendritic repair in ageing 
neurons55.  The ageing PVD neuron demonstrates a decline in rates of fusion post-dendrotomy, and 
an increase in ectopic branching, but these can be improved with ectopic expression of AFF-1 or 
EFF-1 respectively.  Such concurrent activity of AFF-1 and EFF-1 has been described in other C. 
elegans tissues40, and potentially represents a very elegant way of controlling fusogen activity to 
achieve different forms of membrane remodeling.  
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These studies on the PVD neuron raise interesting questions regarding how fusogens are 
regulated in different contexts of neurite fusion.  In the case of EFF-1, it appears that this molecule 
is programmed to function during development, but can be repurposed later in life to optimise 
dendritic repair.  How EFF-1 is regulated, such that it mediates dendritic fusion during development 
but not following injury, is unclear, but may involve context-specific regulation.  Just as the growth 
of an axon has different molecular regulators during development compared with regeneration 
13,44,56-59, there may also be distinct mechanisms for regulating fusogens in these two contexts.  In 
contrast, AFF-1 has not been reported to function during neuronal development, and may instead be 
activated by cellular responses unique to regeneration. 
 
1.2.7 Neurite degeneration  
When examining the molecular mechanisms of neurite fusion, it is also important to consider 
processes activated within the severed neurite fragment.  Following neurite transection, this 
fragment that is detached from the cell body will undergo an active process of degeneration, unless 
it fuses with its regrowing proximal fragment as described above.  The associated thinning and 
fragmentation of the axon, followed by clearance, is known collectively as Wallerian degeneration, 
and requires distinct molecular machinery.  Curiously, some of the same molecules that mediate 
Wallerian degeneration also promote regrowth of the proximal axonal fragment.  The DLK-1 
mitogen-activated protein kinase signaling pathway, for example, has been shown to regulate both 
of these processes in several species60-63.  
For vertebrate axons, in which repair is attempted via regrowth of the full axonal tract instead 
of fusion, this overlapping function is clearly beneficial.  Clearance of the distal axon is in fact 
required for nerve regrowth in some vertebrates64 and delaying this clearance can delay functional 
recovery65.  In contrast, neurons that undergo regeneration via fusion presumably require minimal 
Wallerian degeneration, such that the detached axon has not irreversibly degenerated before fusion 
can occur.  It is clear that regeneration and degeneration are intrinsically linked, and a balance must 
be achieved depending on the mechanism of repair attempted by the neurite66.   
Currently, the C. elegans PLMs are the only fusion-competent neurons in which axonal 
degeneration has been characterized.  Degeneration was studied in the severed PLM axon when 
repair via axonal fusion failed to occur following axotomy67 (see Chapter 4).  This degeneration 
occurred similarly to Wallerian degeneration in other species, although the processes of 
fragmentation and clearance appeared to happen simultaneously rather than as distinct steps.  
Curiously, it was found that many of the canonical mediators of Wallerian degeneration in 
vertebrate species, including DLK-160,62, WLDS (ref. 68), Sarm169 and the Nmnat pathway70,71 had 
no effect in C. elegans neurons.  On the contrary, it was instead determined that some of the C. 
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elegans axonal fusion machinery, including CED-6, CED-7 and NRF-5, exhibited an overlap and 
also promoted axonal degeneration.  It is currently a mystery as to how these same molecules 
achieve neuronal repair when they promote two conflicting steps in the process.  This molecular 
‘tug-of-war’66 may be resolved by differences in the timing and location of protein expression, or 
other layers of regulation that are yet to be discovered.  Overall, it appears that neurite repair in C. 
elegans utilizes different molecular machinery to vertebrate systems, and repair is achieved through 
a distinct mechanism that coordinates axonal degeneration and regeneration.  
To our knowledge, Wallerian degeneration in PVD dendrites has not been specifically 
characterized.  However, ectopic branches formed during PVD development were removed through 
EFF-1-mediated fission events18.  It is possible that fission-based activity of EFF-1 also contributes 
to fragmentation of separated dendritic fragments.  Following dendrotomy, eff-1 mutants did not 
show a change in the rate of degeneration of separated dendritic fragments; this indicated that EFF-
1 had no role in regenerative dendrite fusion21, but the degeneration phenotype of the distal 
dendritic fragment was not specifically characterized.  Given the ability of EFF-1 to sculpt neurites 
and mediate fission events, is tempting to speculate that EFF-1 may function in the degeneration of 
separated neurites, either axons or dendrites.  It is clearly an integral component of the machinery 
for C. elegans neurite fusion, machinery that is exquisitely regulated to ensure fusion occurs 
correctly, rescuing degeneration of the severed axonal fragment and enabling functional recovery.  
 
1.2.8 Discussion and conclusions  
The study of spontaneous neurite fusion is clearly a field in its infancy, with many unanswered 
questions regarding the scope and regulation of these fusion events.  What has been established is 
the remarkable ability of some neurites to spontaneously repair transection injuries through fusion.  
These fusion events restore the morphology of the neurite, and in some cases its function.  They are 
mediated by dedicated fusogenic machinery that is regulated to ensure efficient and specific fusion.   
Of particular interest is the molecular machinery that acts upstream of fusogens for neurite 
fusion.  In the PLM axon, this includes the apoptotic clearance machinery.  However, the molecules 
directly regulating EFF-1 in the neuron remain undiscovered.  It is also unknown whether the fusion 
machinery is activated in concert with other cascades of regenerative signaling.  Currently, calcium 
signaling is the only mechanism known to be required for both regenerative regrowth and neurite 
fusion1,48,49. 
The degeneration occurring concurrently in the severed neurite fragment is an important 
consideration.  Active signaling from this fragment has been shown to be important for the 
efficiency of axonal fusion8.  Molecules acting on the distal fragment are also likely to play a 
crucial role in determining whether fusion occurs, or regeneration is instead attempted through 
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regrowth of the axon towards its original target.  There is evidence for overlapping suites of 
molecules mediating regeneration and degeneration in the same neuron, highlighting that they are 
intrinsically linked processes.  Maintaining the distal fragment appears crucial for axonal fusion, 
and the molecules allowing for this are beginning to be identified.  
Finally, replication of axonal fusion in vertebrate neurons using synthetic materials is currently 
in development.  Thus far, approaches have been based on surgical reconnection of transected 
mammalian nerve fibres, combined with the application of polymers such as polyethylene glycol 
(PEG)72-77.  The mechanism through which PEG acts is not clear, but it is proposed to work like a 
fusogen by facilitating membrane merging72.  It has had very promising results in vivo, with 
evidence of both morphological and functional recovery.  These studies were predominantly 
performed in rat sciatic nerves, but also more recently have included a small clinical trial directed at 
repairing damaged human digital nerves78.  Development of these techniques has been directly 
attributed to observations of endogenous fusion mechanisms in invertebrates72.  One could 
speculate that EFF-1 or AFF-1 would also be promising candidates for inducing fusion at these 
injury sites, provided we gain a better understanding of their fusogenic activity and regulation in 
neurons.  It is tempting to speculate that either translation of the endogenous neurite fusion 
machinery, or synthetic fusion approaches, will eventually lead to a breakthrough in how we 
manage nerve injuries in the clinical setting.  
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1.3 Further review of EFF-1  
 
1.3.1 Functions of EFF-1  
The eff-1 gene was identified in genetic screens for a cell-cell fusion failure phenotype in C. 
elegans, and was found to play a role in almost all developmental cell-cell fusion events25.  It is 
required for correct formation of the C. elegans hypodermis, pharynx, uterus, and vulva25.  It is not 
only essential for these fusion events25, but it is also sufficient to promote fusion in non-fusion-fated 
cells.  Ectopic expression of EFF-1 induces fusion in C. elegans cells that would not normally 
undergo fusion79 and causes heterochronic fusion of undifferentiated cells34.  Heterologous 
expression of EFF-1 mediates cell-cell fusion in both insect cells27-30 and mammalian cells26.  It can 
also mediate viral entry into mammalian cells when expressed both on a viral particle and the target 
cell26.  These findings all provide evidence that EFF-1 is a genuine fusogen that is necessary and 
sufficient to mediate membrane fusion. 
EFF-1 not only fuses different cells, but it also mediates ‘self-fusion’ in which fusion occurs 
between different membrane regions of the same cell.  This type of fusion was first described in C. 
elegans80.  EFF-1-mediated self-fusion has been documented in the C. elegans pharynx and 
excretory duct cell, transforming cellular shape as part of their development40,42; this is in addition 
to the self-fusion of the PLM and PVD neurons described in Section 1.2.  
 
1.3.2 Mechanism of EFF-1-mediated fusion  
EFF-1 is a type 1 transmembrane glycoprotein.  It has minimal sequence homology with other 
known proteins, and putative orthologs have been identified only in select species, including 
arthropods, ctenophores, chordates and protists26,81.  Curiously, however, its tertiary structure has 
striking homology to class II viral fusogens, including the same key domains and hairpin 
conformation28.  While this would appear to be a clue as to how EFF-1 mediates fusion, current 
evidence suggests that EFF-1 acts through its own distinct fusion mechanism (Figure 1.3).  Unlike 
viral fusogens, EFF-1 is required on both cell membranes to mediate fusion, both in vitro and in 
vivo26,27,29,30.  The current working model is that, prior to fusion, EFF-1 exists as a monomer in an 
upright position on the membrane31.  Fusion then involves trimerisation of EFF-1 molecules in 
trans across apposing membranes28.  Subsequent conformational changes in the trimer, with 
zippering of the transmembrane segments at the tip of the trimer, allow for the merging of the two 
apposing membranes and opening of the fusion pore31.  While this model requires further 
experimental work to be confirmed, it presents a unique fusion mechanism for EFF-1, one which 
has implications for how EFF-1 is regulated.   	
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Figure 1.3.  Model for homotypic EFF-1-mediated fusion (adapted from Perez-Vargas et al., 
2014).  Prior to fusion, single EFF-1 molecules are present on the surface of the two cells (yellow, 
blue and red represent the ectodomain of one molecule).  Fusion involves formation of a trimer 
between EFF-1 molecules on the two apposing cells.  Relocation and zippering of the 
transmembrane segments at the tip of the trimer allows for formation of the fusion pore. This figure 
has been reprinted and minimally adapted from Perez-Vargas et al., 2014, with permission from 
Elsevier.   
 
1.3.3 Transcriptional regulation of eff-1  
EFF-1 is precisely regulated during C. elegans development.  EFF-1-mediated fusions occur in 
precise spatiotemporal and sex-specific patterns32.  A hypodermal cell will specifically fuse with a 
particular neighbor out of up to 10 possible cell contacts25.  Uncontrolled, ectopic fusions induced 
by EFF-1 misexpression invariably result in lethality34,79, highlighting the importance of this fusion 
specificity.  However, the molecular mechanisms that define correct cell partners in EFF-1-
mediated fusion were not originally clear35.  
The first identified regulation of EFF-1 was at the transcriptional level.  Cascades of 
transcription factors have been shown to control hypodermal cell fusion patterns through negative 
regulation of EFF-1.  These factors include zinc-finger-containing genes, homeobox genes, Wnt 
pathway members and heterochronic genes23,32,33,36,38.  Thus, it is clear that the spatial and temporal 
regulation of eff-1 is achieved through a complex network of genetic pathways23. 
Another potential level of EFF-1 regulation is through the generation of alternative splicing 
variants.  There are four known isoforms of EFF-1, designated A, B, C and D.  Isoforms A and B 
have identical extracellular and transmembrane domains but differ in the composition of their C-
terminal cytoplasmic tails.  The shorter C and D isoforms completely lack transmembrane domains.  
Consistent with their predicted domains, isoforms A and B have been visualized on cell surfaces 
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and in intracellular organelles, whereas isoform C was found in secreted media29.  Work in cell 
culture has revealed that only the transmembrane isoforms A and B were capable of mediating cell-
cell fusion29, and only isoform A has been found to rescue morphological defects in vivo34.  
However, the role of these different isoforms is yet to be elucidated.  
Another means of regulation may be through alternate expression with aff-1.  It has been noted 
that EFF-1 and AFF-1 are sometimes expressed simultaneously in adjacent cells, and that this 
alternate expression could help to specify fusion partners40,41.  In the pharynx, two neighboring cells 
undergo developmental self-fusion to form unicellular tubes.  One expresses EFF-1 for this purpose, 
whereas the other expresses AFF-1, potentially preventing cross-fusion between the two cells40.  In 
contrast, as mentioned in Section 1.2, EFF-1 and AFF-1 appear to be co-expressed during PVD 
dendritic repair and act cooperatively, albeit for mediating different forms of membrane sculpting.  
Ultimately, alternate expression with aff-1 is unlikely to be the only key determinant of fusion 
specificity, as heterotypic fusion between EFF-1 and AFF-1 is possible and has been observed in 
vitro26.   
 
1.3.4 Post-translational regulation of EFF-1  
Post-translational control of EFF-1 must exist, as EFF-1 expression persists in many cells after they 
have undergone developmental fusion25.  One important means of regulating protein activity is 
through subcellular localization.  EFF-1 can only function in membrane fusion once it has been 
inserted into the membrane, whereas sequestering it into intracellular compartments should render it 
inactive and prevent fusion events.  There is now significant evidence that such dynamic 
localization of EFF-1 occurs, and plays a role in controlling its fusogenic activity.  EFF-1 
localization has been characterized in multiple tissue and cell types, albeit with somewhat varied 
results.  In some cells, EFF-1 has been observed accumulating at cell-cell borders prior to 
fusion29,30,34,82.  However, another study using immunostaining demonstrated that endogenous EFF-
1 instead localized predominantly to intracellular compartments, and was present only transiently at 
the membrane.  These authors suggested that accumulation might only be seen in models that 
involve ectopic expression of EFF-137.  They also noted that one of these studies34 utilized an EFF-
1::GFP reporter that was subsequently found to contain two mutations in its coding sequence37.  
However, several findings illustrate that EFF-1 localization probably varies depending on both 
temporal and spatial context.  Firstly, even within the hypodermis of the animal, the localization 
pattern appears to differ between the embryonic and larval stages of development.  Localization 
studies in the embryo suggested only transient localization of EFF-1 to the membrane37, whereas in 
larvae, there was clear accumulation of EFF-1 at the site prior to fusion82.  It has been postulated 
that this discrepancy may be due to differences in the extent of cellular apposition at these different 
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developmental time points82.  Secondly, there is some evidence that EFF-1 is regulated by distinct 
mechanisms in different cell types.  For example, loss of vacuolar H+-ATPase complex subunits 
increased EFF-1-mediated cell-cell fusion in the hypodermis, but not in other epithelial tissues such 
as the pharynx35.  Similarly, loss of EFF-1 has different effects on fusion pore formation in the 
hypodermis compared to the pharynx79.  These discrepancies highlight the need for cell-specific 
exploration of EFF-1 function and regulation, and a neuron-specific characterization.  
To date, two key mechanisms have been demonstrated to influence EFF-1 protein activity, at 
least in part through its localization.  The first is rearrangements of the actin cytoskeleton.  Actin 
regulators can promote cell-cell fusion events in mammalian cells83 and changes in the actin 
cytoskeleton have been shown to promote EFF-1-mediated fusion, both in Drosophila cell culture30, 
and in vivo in larval hypodermal cells82.  In Drosophila cells, ectopically-expressed EFF-1 
accumulates at the end of membranous actin-rich protrusions; in the larval hypodermis, alterations 
in actin regulators were associated with changes in EFF-1 localization.  Additionally, EFF-1 puncta 
in the embryonic hypodermis have a linear arrangement that may be enforced by the cytoskeleton, 
although this better corresponds to the distribution of microtubules than that of actin37. 
The second regulatory mechanism, endocytosis, has conversely been found to inhibit EFF-1 
activity.  The endosomal GTPases RAB-5 and DYN-1 inhibit EFF-1-mediated hypodermal fusion.  
In rab-5 mutants, or when rab-5 is knocked down by RNAi, hypodermal cells undergo excessive 
fusion and have mis-localization of EFF-1 to cell junctions37.  This study was the first to identify 
specific molecular regulators of EFF-1 localization in vivo.  
A number of other genes have been investigated as potential EFF-1 regulators but returned 
negative results.  The vha-17 gene, which encodes a subunit of a vacuolar H+-ATPase, has been 
found to repress EFF-1-mediated hypodermal fusion but not by affecting eff-1 expression patterns 
or levels35.  However, while the v-ATPase complex localizes to the apical membrane of hypodermal 
cells, it co-localizes poorly with EFF-1 and does not appear to influence EFF-1 membrane 
localization37.  Another group of candidate regulators was the family of 14-3-3 proteins.  The 
cytoplasmic tail of EFF-1A contains motifs for binding of these proteins84, but neither mutation in 
the 14-3-3 binding sites, nor mutations in the two known C. elegans 14-3-3 protein orthologs, were 
found to affect EFF-1 function or localization in vivo85.  Overall, it is clear that additional regulators 
of EFF-1 must exist, and remain to be discovered.  
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1.4 Aims and approach  
 
Prior to commencing this thesis, almost nothing was known about the role of EFF-1 in axonal 
repair.  It had been reported only that eff-1 mutants displayed significant defects in axonal fusion1.  
Significant literature existed about EFF-1 but largely in the setting of C. elegans development in 
vivo or in heterologous cell models.  The discovery of EFF-1’s role in neurons, and in a 
regenerative context, warranted more specific investigation.  The aims of this thesis were twofold: 
 
Aim 1: Characterize how EFF-1 functions in axonal repair in the C. elegans PLM neurons. 
Hypothesis: EFF-1 functions cell-autonomously in the PLM neuron to achieve regenerative axonal 
fusion; this function is likely to be regulated via dynamic localization involving controlled 
movement of EFF-1 between intracellular compartments and the membrane.    
 
Aim 2: Discover and characterize neuronal regulators of EFF-1 that control the above functions. 
Hypothesis: Molecular regulators exist which regulate EFF-1 localization and function in neurons.  
 
One of our key approaches was to determine whether EFF-1 functioned within PLM and exhibited 
dynamic subcellular localization, as demonstrated in other models.  To study this process, we 
developed a transgenic C. elegans strain that allowed visualization of EFF-1 in PLM in vivo.  We 
have used this model to describe EFF-1 localization in different neuronal compartments undergoing 
regeneration and degeneration, as well as in the uninjured condition.  We have also used it as a 
platform to identify potential regulators of EFF-1 (chosen using a candidate gene approach).  
To determine EFF-1 activity, we used an experimental paradigm developed in our lab to study 
axonal regeneration and degeneration2,8,67.  UV laser axotomy is performed on the PLM neuron 
(Figure 1.4) and, after regrowth, the visual reconnection of the two separated axonal fragments is 
determined.  If reconnection has occurred, the success of fusion is then assessed based on the 
integrity of the distal fragment.  If reconnection does not occur, axonal degeneration can be studied 
via analysis of the distal fragment.  
 
 
Figure 1.4.  Axotomy of the PLM mechanosensory neuron.  A UV laser is used to transect the 
PLM axon.  Two PLMs are present in each animal, but just one is represented.  D = dorsal, V = 
ventral, A = anterior, P = posterior. 
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2.1 Introduction 
 
As discussed in Chapter 1, the C. elegans mechanosensory neuron PLM can undergo spontaneous 
self-repair via axonal fusion following UV laser axotomy.  When axonal fusion was first described 
in C. elegans, the molecular pathways involved were unknown.  EFF-1 was the only protein 
associated with the process, with loss-of-function in eff-1 leading to a strong defect in the rate of 
axonal fusion1.  
In this context, we aimed to further understand EFF-1 function in axonal fusion, focusing on its 
subcellular localization, as there was evidence at the time that dynamic localization of EFF-1 played 
a key role in its function in other tissues2.  We also aimed to identify other molecules required for 
axonal fusion.    
In this chapter, a manuscript is presented in Section 2.2 that was published in the journal 
Nature.  It represents a collaboration with Ding Xue’s laboratory at the University of Colorado.  In 
this work, we established a cell-autonomous role for EFF-1 in axonal fusion.  Using a transgenic C. 
elegans strain developed to visualize EFF-1 in PLM, we characterized a dynamic in vivo 
localization pattern for this fusogen during axonal regeneration.  We also placed EFF-1 downstream 
in a genetic pathway of conserved apoptotic clearance genes that promote axonal fusion.  We 
showed that EFF-1 acts as the final downstream effector of this pathway, mediating the fusion of 
the two separated axonal membranes.  
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2.2 Published manuscript 
 
EFF-1-mediated regenerative axonal fusion requires components of the apoptotic pathway 
 
Neumann, B., Coakley, S.*, Giordano-Santini, R.*, Linton, C., Lee, E. S., Nakagawa, A., Xue, D., 
& Hilliard, M.A. EFF-1-mediated regenerative axonal fusion requires components of the apoptotic 
pathway. Nature 517, 219-222 (2015) (Cover image).   
*These authors contributed equally to this work 
 
Please note that this manuscript has been reformatted for inclusion in the thesis; references are 
included in a combined reference list at the end of the chapter.  For original format of the published 
manuscript, see the online version of the paper: https://dx.doi.org/10.1038/nature14102    
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ABSTRACT  
Functional regeneration after nervous system injury requires transected axons to reconnect with 
their original target tissue.  Axonal fusion, a spontaneous regenerative mechanism identified in 
several species, provides an efficient means of achieving target reconnection as a regrowing axon is 
able to contact and fuse with its own separated axon fragment, thereby re-establishing the original 
axonal tract1,3-8.  Here we report a molecular characterization of this process in Caenorhabditis 
elegans, revealing dynamic changes in the subcellular localization of the EFF-1 fusogen after 
axotomy, and establishing phosphatidylserine (PS) and the PS receptor (PSR-1) as critical 
components for axonal fusion.  PSR-1 functions cell-autonomously in the regrowing neuron and, 
instead of acting in its canonical signaling pathway9, acts in a parallel phagocytic pathway that 
includes the transthyretin protein TTR-52, as well as CED-7, NRF-5 and CED-6 (ref. 10-13).  We 
show that TTR-52 binds to PS exposed on the injured axon, and can restore fusion several hours 
after injury.  We propose that PS functions as a ‘save-me’ signal for the distal fragment, allowing 
conserved apoptotic cell clearance molecules to function in reestablishing axonal integrity during 
regeneration of the nervous system. 
 
Introduction and results  
Axonal fusion, which occurs spontaneously in several invertebrate species1,3-8, is a highly efficient 
means to re-establish the connection between an injured neuron and its target tissue; the proximal 
axon which is still attached to the cell body regrows towards, reconnects, and fuses with its 
separated distal fragment.  We and others have shown that axonal fusion occurs in C. elegans 
mechanosensory neurons1,8.  However, the genetic components of this process remain largely 
unidentified, with the nematode-specific fusogen, Epithelial Fusion Failure-1 (EFF-1), the only 
protein known to be involved1. 
We expressed green fluorescent protein (GFP) specifically within the six mechanosensory 
neurons of C. elegans (Figure 2.1) and performed laser axotomy of the posterior lateral 
mechanosensory (PLM) neurons.  We then analysed severed axons that re-established a contact 
between the regrowing proximal axon and its separated distal fragment (Supplementary Figure 2.1); 
maintenance, or inhibition of degeneration of the distal axonal fragment, was used as evidence of 
successful fusion, whereas degeneration indicated unsuccessful fusion8.  In wild-type animals, 80% 
of axons that displayed proximal-distal reconnection underwent successful fusion (Figure 2.1b,d).  
EFF-1, a trimeric fusogen similar to class-II viral fusion proteins14,15, mediates a wide range of 
fusion events in C. elegans16,17,  including the sculpting of dendritic arbors through self-fusion of 
excessive branches18.  Animals lacking EFF-1 displayed a strong defect in axonal fusion1 (Figure 
2.1c,d).  To determine where EFF-1 is required, we expressed a GFP-tagged version of this protein  
! "'!
 
Figure 2.1.  EFF-1 mediates axonal fusion cell autonomously and localizes to the membrane of 
growth cones.  (a) A wild-type (WT) zdIs5(Pmec-4::GFP) animal with fluorescent mechanosensory 
neurons.  Anterior is left and ventral is down in this and all following images.  Out of focus neurons 
are shown in grey in the schematic.  Scale bar 25 µm.  Image representative of 242 animals.  (b) 
Successful axonal fusion in a WT animal, 24 hr post-axotomy.  Filled arrowhead points to the cut 
site; open arrowheads point to the fusion site.  Scale bar 25 µm.  Image representative of 75 
animals.  (c) Defective axonal fusion in an eff-1(ok1021) mutant animal 48 hr post-axotomy.  Filled 
arrowhead points to the cut site.  Scale bar 25 !m.  Image representative of 54 animals.  (d) 
Quantification of axonal fusion in eff-1(ok1021) animals compared to WT, and cell-autonomous 
rescue with expression of Pmec-4::EFF-1::GFP in independent transgenic lines.  Error bars 
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indicate standard error of proportion.  n values listed adjacent to each bar.  P values from t-test: 
**P<0.01, ***P<0.001 compared to WT, unless marked on graph.  (e) Single-plane structured 
illumination microscopy image of an intact axon carrying the transgene vdEx662(Pmec-4::EFF-
1::GFP; Pmec-4::mCherry) in an eff-1(ok1021) mutant background.  Fluorescence profiles from 
line scan 1 illustrate the presence of EFF-1::GFP on a section of the axonal membrane.  Scale bar 
10 µm.  au = arbitrary units.  Images representative of 15 animals.  (f) Single-plane structured 
illumination microscopy image 18 hr post-axotomy (left and middle panels).  Right panels, 
fluorescence profiles from line scans 2 and 3 (taken from middle panels) illustrate the presence of 
EFF-1::GFP on the membrane of the growth cone.  Asterisks show out of focus sections.  Scale 
bars 10 µm (left panel), 1 µm (middle panels).  Images representative of 3 animals.  
 
specifically in the mechanosensory neurons.  This transgene could rescue the axonal fusion defect 
of eff-1 null animals, indicating a cell-autonomous function of EFF-1 in PLM (Figure 2.1d).  Prior 
to axotomy, we observed EFF-1::GFP in an indiscriminate punctate pattern throughout the PLM 
cell body and axon (Figure 2.1e and Supplementary Figure 2.2a).  Soon after axotomy, a ‘cap’ of 
EFF-1::GFP appeared on the membrane at the tips of both the proximal and distal segments by the 
cut site (Supplementary Figures 2.2b,c).  Following regenerative growth, we consistently observed 
EFF-1::GFP on the membrane of the growth cone (Figure 2.1f and Supplementary Figures 2.2d and 
2.3a,b), suggesting rapid re-localization of EFF-1 to mediate fusion once contact is re-established. 
We speculated that axonal fusion might share similarities with apoptotic cell corpse clearance, 
in which plasma membrane phospholipid asymmetry is lost.  PS, normally restricted to the 
cytoplasmic leaflet, becomes externalized to the exoplasmic leaflet of the apoptotic cell, which 
enables its recognition by phagocytic cells19.  Two different loss-of-function deletions in the PS 
receptor gene psr-1 (ref. 9,20) caused a strong reduction in axonal fusion (Figure 2.2a,b).  
Furthermore, double mutants between eff-1 and psr-1 were no more defective than eff-1 mutants 
(Figure 2.2b), indicating that psr-1 and eff-1 are in the same genetic pathway.  PSR-1 contains two 
highly conserved functional domains, an extracellular lysine-rich PS binding domain21, and an 
intracellular JmjC domain with multiple enzymatic activities22-24.  We expressed different versions 
of full-length psr-1 cDNA selectively in the mechanosensory neurons of psr-1 mutant animals. 
Expression of wild-type cDNA rescued axonal fusion (Figure 2.2c), demonstrating that PSR-1 
functions cell-autonomously within PLM.  Next, we expressed psr-1 cDNA carrying mutations that 
disrupt either its PS binding activity (K308E/K315E)21 or its Fe(II) binding site (H192A/D194A) in 
the JmjC domain21 and found that they no longer rescued the axonal fusion defect (Figure 2.2c).  
Thus, PSR-1 requires both the extracellular PS binding domain and the intracellular JmjC domain 
for its cell-autonomous activity in axonal fusion. 
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Figure 2.2.  PSR-1 functions cell-autonomously in 
regulating axonal fusion.  (a) Unsuccessful fusion in a 
psr-1(ok714) mutant animal 24 hr after axotomy.  
Bracket highlights the region of reconnection.  Scale bar 
25 µm.  Image representative of 14 animals.  (b) 
Quantification of successful fusion events in wild-type 
(WT, black bar), and single (white bars) and double (grey 
bar) mutant animals.  (c) Cell-autonomous rescue in psr-
1(ok714) animals with expression of WT psr-1 cDNA 
(untagged or tagged with mCherry) in the 
mechanosensory neurons.  Expression of psr-1 cDNA-
carrying mutations in the PS binding (K308E/K315E), or 
in the JmjC domain (H192A/D194A), fails to rescue the 
defect; representative results from the six independent 
lines tested.  For (b) and (c), error bars indicate standard 
error of proportion. n values within each bar.  P values 
from t-test: *P<0.05, **P<0.01, ***P<0.001 compared 
to WT unless marked on graph.  ns = not significant.  (d) 
Single plane confocal images showing the localization of 
PSR-1::mCherry in PLM in a psr-1(ok714) mutant 
animal before axotomy (top two panels), and 4 hr post-
axotomy (middle two panels).  Bottom panels show 
magnified images of boxed regions to highlight 
accumulation of PSR-1 at the end of the regrowing 
proximal axon.  Arrowheads point to cut site.  Scale bar 
25 µm.  Image representative of 21 animals. 
 
 
To determine where PSR-1 functions within PLM, we analysed the localization of a functional 
mCherry-tagged version of PSR-1 in this neuron (Figure 2.2c).  PSR-1 localized to the nucleus and 
mitochondria of PLM (Figure 2.2d and Supplementary Figures 2.4a,b).  However, following 
axotomy, we observed an accumulation of PSR-1::mCherry towards the end of the regrowing 
proximal axon (Figure 2.2d and Supplementary Figure 2.4b).  Thus, PSR-1 is normally confined to 
the nucleus and mitochondria of PLM, but may be re-localized following injury.  
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Figure 2.3.  PSR-1 functions 
in the TTR-52 pathway 
during axonal fusion.  (a) 
Schematic of two partially 
redundant parallel pathways 
that mediate recognition and 
engulfment of apoptotic cells.  
(b) TTR-52 is required for 
successful axonal fusion.  
Expression of TTR-
52::mCherry rescues the 
defect when induced from a 
heat-shock (HS) promoter 
immediately after axotomy (0 
hr) and up to 6 hr post-
axotomy.  (c) Mutations in 
genes acting in the ttr-52 
pathway reduce axonal 
fusion, and double mutants 
with psr-1 are not more defective than single mutants.  For (b) and (c), error bars indicate standard 
error of proportion.  n values within each bar; P values from t-test: *P<0.05, **P<0.01, 
***P<0.001.  (d) Single plane confocal images showing the localization of TTR-52::mCherry in ttr-
52(sm211) mutants to the PLM axon before axotomy and at several time points after transection.  
Filled arrowheads point to cut sites, asterisk highlights accumulation of TTR-52::mCherry at the 
injury site.  Scale bar 25 µm.  Image representative of 22 animals.  (e,f) Quantification of the 
relative fluorescence levels of TTR-52::mCherry (e) and sAnxV::mRFP (f) on the distal and 
proximal PLM axonal segments after transection compared to mock surgery conditions.  Error bars 
indicate standard error.  n values for distal and proximal n = 22 (e) and n = 26 (f), for mock 
surgery n = 23 (e) and n = 21 (f).  P values from Kolmogorov-Smirnov test: **P<0.01, 
***P<0.001.  
 
PSR-1 functions in a signaling pathway that includes CED-2/CrkII, CED-5/Dock180, 
CED-12/ELMO and CED-10/RAC1 to mediate the recognition and removal of apoptotic cells9,25-27 
(Figure 2.3a).  We found that other components of this engulfment pathway are not required for 
axonal fusion, as animals carrying mutations in ced-2, ced-5, ced-12, or ced-10 were not defective 
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(Supplementary Figure 2.5a).  Similarly, the core apoptotic pathway is not required, as mutations in 
CED-9/BCL-2, CED-4/APAF-1, or cell-killing caspase ced-3 did not significantly alter axonal 
fusion (Supplementary Table 2.1).  Next, we analysed components of another, partly redundant cell 
corpse engulfment pathway, which includes the secreted PS binding protein TTR-52/transthyretin11, 
the lipid-binding protein NRF-5 (ref. 13), the membrane-bound CED-7/ABC transporter12, the 
transmembrane receptor CED-1/LRP1/MEGF10 (ref. 28), and the intracellular adaptor 
CED-6/GULP9 (Figure 2.3a).   
We found that TTR-52 was critical for successful axonal fusion (Figure 2.3b and 
Supplementary Figure 2.5b).  As TTR-52 is normally secreted from intestinal cells to bind PS 
exposed by apoptotic cells11, we asked whether TTR-52 binding to PS also occurred after axonal 
injury.  TTR-52 tagged with mCherry and expressed from a heat-shock promoter rescued the axonal 
fusion defect when induced either at the time of injury, or up to 6 hr after injury (Figure 2.3b and 
Supplementary Figures 2.5c-g).  We then used the same functional transgene to visualize TTR-52 
before and after PLM axotomy.  Following axotomy, TTR-52 rapidly localized to both the distal 
and proximal axon segments, with slightly stronger mCherry signals observed on the distal segment 
(Figures 2.3d,e).  These results suggest that TTR-52 functions as a secreted molecule that binds 
injured axonal fragments to mediate their regenerative fusion.  To further confirm that TTR-52 was 
binding PS, we analysed the localization of a secreted version of AnnexinV (sAnxV), a highly 
efficient and specific calcium-dependent PS binding protein29.  PS was rapidly exposed on the 
proximal and distal PLM axon segments following axotomy, with the sAnxV::mRFP signal 
strongest on the distal segment (Figure 2.3f and Supplementary Figure 2.5h).  This localization 
pattern closely matched that of TTR-52::mCherry (Figures 2.3d,e), supporting a model in which PS 
is exposed on the axonal membrane after injury and acts as a ‘save-me’ signal for TTR-52 binding, 
thereby triggering reconnection and fusion. 
Next we examined the involvement of the other components of the TTR-52 engulfment 
pathway.  Inactivation of ced-1 caused a modest defect, whereas animals lacking NRF-5, CED-7, or 
CED-6 displayed strong fusion defects (Figure 2.3c and Supplementary Table 1).  Double mutants 
between psr-1 and either ttr-52, ced-1, nrf-5, ced-7 or ced-6 were no more defective than single 
mutant animals (Figure 2.3c and Supplementary Table 1), indicating that PSR-1 functions within 
this TTR-52-mediated pathway during axonal fusion.  Similar to psr-1; eff-1 double mutant animals 
(Figure 2.2b), double mutants between eff-1 and either ttr-52, ced-1, ced-6 or ced-7 were no more 
defective than single eff-1 mutants (Supplementary Figure 2.3c), indicating that these genes act in 
the same genetic pathway.  Importantly, overexpression of EFF-1 specifically in the 
mechanosensory neurons could overcome the axonal fusion defects caused by mutation of either 
psr-1 or ttr-52 (Supplementary Figure 2.3d), demonstrating that EFF-1 functions genetically 
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downstream of these molecules.  Notably, although mutations in some axonal fusion genes caused 
defective PLM regrowth, we found no correlation between regrowth and axonal fusion 
(Supplementary Figure 2.6 and Supplementary Table 2.2).  
Similar to the localization pattern of PSR-1, we observed that a functional tagged version of 
CED-6 (mRFP::CED-6) predominantly localized to mitochondria in PLM, and accumulated in the 
regrowing proximal segment after axotomy (Supplementary Figures 2.7a-c).  Next, we analysed 
localization of a tagged version of the ABC transporter, CED-7 (CED-7::mRFP), which could cell-
autonomously rescue the axonal fusion defect (Supplementary Figure 2.7a), and found a diffuse 
localization pattern throughout the PLM axon before, and at several time points after axotomy 
(Supplementary Figure 2.7d).  Finally, we analysed the localization of NRF-5, a lipid-binding 
molecule that is normally secreted from the body wall muscle cells during apoptotic clearance13.  
Using a mCherry-tagged version of NRF-5 expressed from a heat-shock promoter, we found that 
NRF-5 binds to the PLM axon after axotomy (Supplementary Figures 2.7e,f).  This suggests that, 
similarly to TTR-52, NRF-5 may recognize and bind to the exposed PS signal following injury. 
We have previously shown that, although axonal fusion is a highly specific process, non-
specific fusion can occur when a second axon in close proximity to PLM is also severed8.  The PLN 
axon fasciculates with that of PLM (Figure 2.4a), and when both axons are simultaneously 
transected approximately 10% of animals undergo non-specific fusion between these two neurons8.  
We observed a similar phenotype in animals deficient in UNC-70/β-spectrin, a genetic background 
in which the axons of C. elegans motor neurons undergo spontaneous cycles of breaks followed by 
regeneration30.  We observed that unc-70 mutant animals display aberrant PLM axonal morphology 
comprising breaks, loop structures, and branching (Supplementary Figures 2.8a,b), as well as 
transfer of fluorophores between PLM and PLN (Figure 2.4b,c).  Time lapse imaging and a 
tethered-fluorophore assay demonstrated that this transfer of fluorophores occurred through fusion 
events, and was not due to aberrant promoter activity (Supplementary Figures 2.8c,d).  These fusion 
events were dependent on the EFF-1 fusogen and required DLK-1, a mitogen-activated triple kinase 
essential for regeneration31 (Figure 2.4c and Supplementary Figure 2.8e).  Remarkably, we found 
that loss of psr-1, ttr-52, or ced-6 caused a strong reduction in unc-70-induced PLM-PLN fusion 
(Figure 2.4c).  Analogous to our finding post-axotomy, we observed TTR-52::mCherry and 
sAnxV::mRFP binding to the PLM axon in unc-70 mutants (Supplementary Figure 2.9), suggesting 
that axonal damage induced by this genetic insult could also trigger the flipping of PS to the 
external surface of the membrane.  Thus, recognition of separated distal segments by a regrowing 
axon is achieved by changes in lipid membrane composition, and is mediated by apoptotic 
clearance molecules with the fusogen EFF-1 acting downstream to restore membrane and 
cytoplasmic continuity (Supplementary Figure 2.10).  
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Figure 2.4.  Apoptotic molecules mediate non-specific axonal fusion caused by mutation of 
unc-70.  (a) Schematic showing fasciculation between the axons of PLN (brown) and PLM (green).  
(b) Loss of unc-70 causes spontaneous fusion between PLM (asterisk) and PLN (arrowhead) 
(appearance of GFP in PLN); single plane confocal image is shown.  Scale bar 10 µm.  Image 
representative of 31 animals.  (c) The frequency of non-specific fusion events is strongly reduced in 
animals with mutations in eff-1, psr-1, ttr-52 and ced-6.  Error bars indicate standard error of 
proportion.  n values shown adjacent to each bar.  P values from t-test: ***P<0.001 compared to 
unc-70(s1502). 
 
Methods  
Strains and genetics 
Standard techniques were used for C. elegans maintenance, crosses and other genetic 
manipulations32.  All experiments were performed on hermaphrodites grown at room temperature 
(~22 °C) unless otherwise stated, and all strains were grown on OP50 bacteria, except for animals 
carrying the unc-70(s1502) mutation, which were grown on HB101 bacteria.  The following 
mutations were used: LGI: ced-1(e1735), ced-12(bz187), dlk-1(ju476), sem-4(n1971); 
LGII: eff-1(ok1021), eff-1(hy21); LGIII: ced-4(n1162), ced-6(n1813), ced-7(n2690), ced-9(n1950), 
ttr-52(sm211), ttr-52(tm2078); LGIV: ced-2(e1752), ced-3(n717), ced-5(n1812), ced-10(n3246), 
psr-1(ok714), psr-1(tm469); LGV: nrf-5(sa513), unc-70(s1502).  Transgenes used: 
smIs119[Phsp16-2::ttr-52::mCherry]11, smIs95[Phsp16-2::sAnxV::mRFP]33, oxIs95[Ppdi-2::unc-
70; Pmyo2::GFP]30, qxIs92[Phsp::nrf-5::mCherry] (a gift from X. Wang), vdEx575[Pmec-4::psr-
1(c) (10 ng/"l), Podr-1::DsRed (30 ng/"l)], vdEx661/vdEx662/vdEx663[Pmec-4::EFF-
1::GFP (5 ng/"l); Pmec-4::mCherry (20 ng/"l); Podr-1::DsRed (60 ng/"l)], vdEx705[Pmec-
4::psr-1(c)(H192A/D194A) (10 ng/"l); Podr-1::DsRed (30 ng/"l)], vdEx709[Pmec-4::psr-
1(c)(K308E/K315E) (10 ng/"l); Podr-1::DsRed (30 ng/"l)], vdEx851[Pmec-4::eff-1 (5 ng/"l); 
Podr-1::DsRed (60 ng/"l)], vdEx862[Pmec-4::psr-1(c)::mCherry (2.5 ng/"l); Podr-
1::DsRed (25 ng/"l)], vdEx876[Pmec-4::tomm-20::GFP (0.5 ng/"l); Podr-1::GFP (50 
ng/"l)], vdEx895[Pmec-4::mRFP::ced-6 (5 ng/"l); Podr-1::DsRed (30 ng/"l)], vdEx998[Pmec-
4::ced-7::mRFP (2.5 ng/"l); Podr-1::DsRed (30 ng/"l)], zdIs5[Pmec-4::GFP]. 
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Molecular biology 
Standard molecular biology techniques were used.  The Pmec-4::EFF-1 plasmid was created by 
excising EFF-1 from a Podr-1::EFF-1 plasmid using Kpn I and Apa I restriction enzymes, and 
cloning it in front of the Pmec-4 promoter in a Pmec-4::unc-54_3′ UTR plasmid.  To build 
the Pmec-4::EFF-1::GFP plasmid, eff-1 genomic DNA was amplified (fwd primer 5′-
ctagctagcatggaaccgccgtttgagtg-3′; rev primer 5′-gaaccggtttaatgtactggctactgctatag-3′) and cloned into 
the pSM-mCherry plasmid using Nhe I and Age I restriction enzymes, to obtain pSM::EFF-
1::mCherry.  The mec-4 promoter was then cloned from plasmid pSM::Pmec-4::EFF-
1 into pSM::EFF-1::mCherry using Sal I and Sph I restriction enzymes, to obtain Pmec-4::EFF-
1::mCherry.  Finally, an Age I/Apa I fragment from plasmid pCP.179 (ref. 34) (a gift from Shai 
Shaham) was cloned into Pmec-4::EFF-1::mCherry to obtain Pmec-4::EFF-1::GFP.  The Pmec-
4::psr-1(c) plasmid was generated through insertion of a Bam HI/Age I psr-1 cDNA amplicon 
between the mec-4 promoter and the unc-54 3′UTR.  The following primers were used: fwd primer 
5′-tcagtgggatccatgtcattagggcgagatag-3′; rev primer 5′-tcagtgaccggtttaaactagcgagttctgaaaat-3′.  
The Pmec-4::psr-1(c)::mCherry plasmid was created in similar fashion, except a different reverse 
primer was used (rev primer 5′-tcagtgaccggtcgaactagcgagttctgaaaataag-3′) and the cDNA was 
cloned into a Pmec-4::mCherry::unc-54_3′UTR plasmid.  QuikChange mutagenesis (Agilent 
Technologies, Santa Clara, CA) was used to introduce the K308/K315E and H192A/D194A 
mutations, with the Pmec-4::psr-1(c) plasmid used as the template.  The ced-6 gene was amplified 
from genomic DNA and inserted downstream of mRFP into a Pmec-4::mRFP::unc-
54_3′UTR plasmid using Xma I and Age I restriction enzymes.  The following primers were used: 
fwd primer 5′-tcagtccccgggaatggcaaaagacatttacaagacc-3′; rev primer 5′-
tcagtcaccggtttattgcttcaaattcatcattttcg-3′.  The Pmec-4::tomm-20::GFP plasmid was created by 
switching the mRFP fluorophore from a Pmec-4::tomm-20::mRFP35	plasmid using Age I and Eco 
RI restriction enzymes.  Pmec-4::ced-7::mRFP was created through insertion of full-length ced-
7 cDNA upstream of the mRFP sequence in a Pmec-4::mRFP::unc-54_3′UTR plasmid using Xma I 
and Nhe I restriction enzymes and the following primers: fwd primer 5′-
tcagtgcccgggatgaatagattgcgacaattctc-3′, and rev primer 5′-tcagtggctagcgacatgtgtggaatgggaaatc-3′. 
 
Laser axotomy and microscopy 
Animals were immobilized in 0.05% tetramisole hydrochloride on 4% agar pads.  Axotomies were 
performed as previously described8, using a MicroPoint Laser System Basic Unit attached to a Zeiss 
Axio Imager A1 (Objective EC Plan-Neofluar 100X/1.30 Oil M27).  Axons were severed in L4 or 
one-day-old adult (for localization of TTR-52, sAnxV, and NRF-5) animals approximately 50 µm 
anterior to the PLM cell body, visualized on a Zeiss Axio Imager Z1 microscope equipped with a 
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Photometrics camera (Cool Snap HQ2; Tucson, AZ) and analysed with MetaMorph software 
(Molecular Devices, Sunnyvale, CA) or ImageJ 1.48s.  Animals were analysed 24 hr post-axotomy 
for regrowth, reconnection and fusion.  Regrowth was recorded as the length of regenerative growth 
from the proximal side of the cut site: the proximal axon was traced from the start of regrowth to 
the tip of the longest regenerative branch using Metamorph software; neurons that underwent 
axonal fusion were excluded from these quantifications.  Axons were deemed to be reconnected 
when the proximal and distal axons were visually connected and within the same focal plane when 
observed with a 63X objective (Supplementary Figure 2.1).  Axonal fusion was defined as 
proximal-distal reconnection that prevented the onset of degeneration in the distal axon8.  For 
clarification of successful fusion, animals were re-analysed at 48 hr and/or 72 hr post-axotomy as 
necessary. 
To analyse a selection of reconnection events with greater resolution, three-dimensional 
structured illumination microscopy (3D-SIM) was performed with an Elyra PS.1 SIM/STORM 
microscope, using a 63X 1.4 NA oil objective.  To visualize reconnection sites, z-stacks (3D-SIM) 
were acquired and SIM processing performed.  Green fluorescence was visualized with a 488 nm 
laser (10% power, 50 ms exposure time, 28 µm grating, 3 rotations).  Processing was completed 
with a sectioning of 100/83/83.  Wild-type and eff-1(ok1021) mutant animals were analysed 24 hr 
post-axotomy and scored for proximal-distal reconnection with both standard compound imaging 
and 3D-SIM.  Reconnection was scored separately and double blinded with respect to each 
technique before comparisons were made to determine the accuracy between the two techniques.  In 
cases where the distal fragment had become too faint, SIM processing could not be completed. 
 
Visualization of EFF-1 
To study the localization of EFF-1::GFP in regrowing axons, laser axotomies were performed in 
animals carrying the vdEx662 transgene in 0.05% tetramisole.  Acquisitions were performed on 
animals mounted on 10% agarose pads in M9, in 25 mM sodium azide.  Individual animals were 
then imaged 30 min, 3 hr, 8 hr and 18-24 hr after axotomy using a LSM 710 META confocal 
microscope, equipped with a GaAsP detector and Zen 2012 software.  Green fluorescence was 
visualized with a 488 nm laser (10% power, with a gain of 600 and 4x averaging) and red 
fluorescence was visualized with a 543 nm laser (1.4% power, with a gain of 500 and 4x 
averaging).  Image analysis was performed using ImageJ 1.48s.  To score for the presence of EFF-
1::GFP on the membrane of regrowing axons, fluorescence profiles of line scans at different 
sections of the regrowing axon tip were obtained using the ‘Plot Profile’ tool in ImageJ.  EFF-
1::GFP was scored as localizing to the membrane if the peak of green intensity (EFF-1::GFP) and 
the peak of red intensity (cytoplasmic mCherry) were not overlapping. 
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To visualize EFF-1::GFP by SIM, axotomized animals were mounted in 10% agarose pads in 
M9, in 25 mM sodium azide.  Single plane acquisitions (2D-SIM) were performed with an Elyra 
PS.1 SIM/STORM microscope, using a 63X 1.4 NA oil objective, and SIM processing was 
performed using the ZEN software 2012, Black edition.  Green fluorescence was visualized with a 
488 nm laser (20% power, 200-400 ms exposure time, 28 µm grating, 3 rotations) and red 
fluorescence was visualized with a 561 nm laser (10% power, 200 ms exposure time, 34 µm 
grating, 3 rotations).  Processing was completed with a sectioning of 100/83/83.  Fluorescence 
profiles of line scans were obtained as described above. 
 
Visualization of other tagged proteins 
The subcellular localization of PSR-1::mCherry, mRFP::CED-6, CED-7::mRFP, and NRF-
5::mCherry was analysed in animals immobilized with 0.05% tetramisole with a LSM 710 META 
confocal microscope, equipped with a GaAsP detector and Zen 2012 software.  Green cytoplasmic 
fluorescence was visualized with a 488 nm laser (0.15% power, with a gain of 650 and 4x 
averaging) and red fluorescence was visualized with a 561 nm laser (1.5% power, with a gain of 
700 and 4x averaging for PSR-1 and CED-6; 0.7% power, with a gain of 600 and 4x averaging for 
CED-7; 2.4% power, with a gain of 700 and 8x averaging for NRF-5).  TTR-52::mCherry and 
sAnxV::mRFP were visualized in one-day-old adult animals (unless stated otherwise) with a LSM 
510 META confocal microscope and Zen 2008 software.  Green fluorescence was analysed with a 
488 nm laser (2.4% power, with a gain of 601 and 8x averaging) and red fluorescence with a 
543 nm laser (100% power, with a gain of 1012 and 8x averaging). 
 
Quantification of the binding of TTR-52, Annexin V, and NRF-5 to the PLM axon 
Expression of transgenes was induced 4 hr before analysis with incubation at 30 °C for 30 min.  
Changes in fluorescence intensity were calculated with line scans performed using ImageJ 1.46s 
software.  To avoid bright fluorescence associated with collateral laser damage, line scans were 
recorded ~5 µm from the damage site on both the proximal and distal axon segments for a length of 
~15 µm.  Line scans were recorded along the same region for the 488 nm and 543 nm channels for 
each image.  To control for changes in focus and intensity, mCherry/mRFP expression was 
normalized to GFP for each image and recorded relative to pre-axotomy levels.  For the unc-
70 mutant background, analyses were performed as above, except that for TTR-52::mCherry line 
scans were recorded along the PLM axon for a length of ~15 µm, whereas for sAnxV::mRFP three 
separate line scans were recorded along the PLM axon for a length of ~5 µm, with the mean values 
used for each axon.  Background fluorescence of the 488 nm and 543 nm channels was also 
subtracted from the corresponding axonal line scans. 
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Analysis of cell-cell fusion events in unc-70 mutants 
For time lapse microscopy, one-day-old adult unc-70(s1502) animals were immobilized in 0.05% 
tetramisole hydrochloride on 10% agar pads sealed with Vaseline and visualized using a Zeiss 
inverted spinning disk confocal microscope equipped with a Yokogawa W1 disk head and a 
Piezo z-drive.  Images were acquired every 30 min for 15 hr with a Hamamatsu Flash 4.0 scientific 
CMOS camera using Slidebook 5.0 software.  Adult animals were used for the tethered fluorophore 
experiments, and the presence and location of TOMM-20::mRFP were scored in the PLM neuron, 
and GFP-positive PLN and additional neurons.  For unc-70(s1502) animals, only those displaying 
PLM-PLN fusion were analysed. 
 
Statistical analysis 
Statistical analysis was performed using Primer of Biostatistics 3.01, GraphPad Prism and 
Microsoft Excel.  Error of proportions was used to assess variation across a single population, two-
way comparison was performed using the t-test, and ANOVA was used for more than two groups.  
For those data sets that did not follow a Normal distribution we used the Kolmogorov-Smirnov test 
(Figures 2.3e,f and Supplementary Figures 2.5d-f, 2.6a, 7f, and 2.9c,f).  No statistical method was 
used to predetermine sample size. 
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Above: Supplementary Figure 2.1.  Analysis of proximal-distal reconnection using compound 
microscopy and 3D-SIM imaging.  Typical examples of how reconnection was scored with 
compound microscopy (a,b).  (a) Image and schematic of a wild-type (WT) animal 24 hr post-
axotomy captured with a 20X objective (top panel) and two different z planes captured with a 63X 
objective.  Despite visually appearing reconnected at 20X, the proximal regrowing axon has not 
made contact with the distal axon (63X); image representative of 150 animals.  (b) Representative 
images from a total of 90 animals taken with a 20X objective (top panels) and a 63X objective 
(bottom panels) of a WT animal 24 hr post-axotomy in which reconnection has occurred between 
the proximal and distal axon segments.  Three dimensional structured illumination microscopy 
(3D-SIM) was used to confirm contact regions between regrowing and distal axon fragments in WT 
(c) and eff-1(ok1021) mutant (d) animals.  In each case that reconnection was observed with 
compound microscopy (63X), it was also evident with 3D-SIM imaging; n = 14 for each genotype. 
(c) Successful reconnection in a WT animal, 24 hr post-axotomy.  Top panel: single-plane image 
acquired with a 20X objective on a compound microscope.  Bottom panels: single-plane images 
acquired with a 63X objective on a compound microscope (left, 63X) and a SIM image of the same 
region (right, 63X SIM); images representative of 18 animals.  (d) Proximal-distal reconnection in 
an eff-1(ok1021) mutant animal, 24 hr post-axotomy.  Top panel: single-plane image acquired with 
a 20X objective on a compound microscope.  Middle panel: single-plane images acquired with a 
63X objective on a compound microscope (63X), showing two different z-planes where the regions 
indicated by brackets as ‘contact’ zones are in focus.  Bottom panel: a SIM image of the same 
regions highlighting the points of contact; images representative of 14 animals.  Arrowheads point 
to the site of axotomy, and brackets highlight zones of either potential (a) or actual reconnection (b-
d).  Dashed boxes represent regions magnified in the 63X images.  Scale bars 25 µm (a,b and 20X 
images in c,d) or 5 µm (63X images in c,d).  Estimated resolution of SIM images (as per Zeiss 
software ZEN Black 2012): 120 nm in (c) and 110 nm in (d). 
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Above: Supplementary Figure 2.2.  EFF-1 localization in PLM neurons before and after 
axotomy.  Maximum projections of z-stack confocal images of an uncut axon and regrowing axons 
carrying the transgene Pmec-4::EFF-1::GFP; Pmec-4::mCherry in an eff-1(ok1021) mutant 
background.  Representative images are shown for an intact axon (a), and axotomized axons 30 min 
post-axotomy (b), 3 hr post-axotomy (c), and 8 hr post-axotomy (d).  (a) In uncut axons, EFF-1 is 
present in the cell body (excluding the nucleus), posterior process and all along the axon in an 
irregular pattern.  (b) Thirty minutes after axotomy, EFF-1 forms a ‘cap’ on both the proximal 
(arrow) and distal (arrowhead) fragments   (c) After 3 hr, the proximal stump begins to swell.  
‘Capping’ of the proximal (arrow) and distal (arrowhead) fragments by EFF-1 is still present.  (d) 
After 8 hr, a growth cone with filopodia-like protrusions forms from the proximal stump.  EFF-1 is 
present on the membrane of the growth cone (arrow) and filopodia-like structures (arrowheads).  
Scale bars 10 µm.  Asterisks highlight intestinal autofluorescence.  Images representative of 15 (a), 
12 (b), 9 (c), and 7 (d) animals. 
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Above: Supplementary Figure 2.3.  EFF-1 localizes to the membrane of growth cones, and 
functions genetically downstream from the apoptotic genes.  (a) Maximum projection of z-stack 
confocal images of a regrowing axon carrying the transgene Pmec-4::EFF-1::GFP; Pmec-
4::mCherry in eff-1(ok1021) mutant background, 24 hr post-axotomy.  EFF-1 is present on the 
membrane of the growth cone (line scans 1, 2 and 3) and forms a ‘cap’ at the proximal tip of the 
distal fragment (arrowhead).  Asterisk shows the scar at the cut site.  Scale bars 10 µm.  Images 
representative of 8 animals.  (b) Fluorescence profiles from the line scans shown in the left panels 
of panel (a) illustrate the presence of EFF-1::GFP on the membrane of the growth cone (1 to 3) but 
not on the membrane of a putative fusion site (line scan 4).  au = arbitrary units.  (c) Successful 
axonal fusion in single mutant animals (white bars) compared to double mutants with eff-1(ok1021) 
(grey bars).  Double mutants do not show a worsening of the defect compared to eff-1 single 
mutants.  (d) Cell-autonomous overexpression of EFF-1 (white bars) in wild-type (WT) animals, or 
in those carrying mutations in psr-1 or ttr-52, rescuing their defect.  For (c) and (d), error bars 
represent standard error of proportion.  n values shown adjacent to each bar.  P values from t-test: 
*P<0.05, **P<0.01, ***P<0.001 compared to WT unless otherwise indicated.  ns = not 
significant. 
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Supplementary Figure 2.4.  Analysis of the localization of functional fluorophore-tagged PSR-1.  
(a) Maximum projection confocal images showing the co-localization of PSR-1::mCherry (top 
panel) with a mitochondrial marker (TOMM-20::GFP, middle panel) in a psr-1(ok714) mutant 
animal.  PSR-1 displays strong co-localization with the mitochondria; however, there are regions 
where co-localization is not present, and these are highlighted by the arrow and arrowheads in the 
overlay image (bottom panel).  Images are representative of 35 animals.  Animals of the same 
genotype were analysed before and after axotomy (b) to determine the localization of PSR-1 
compared to the mitochondrial marker during regrowth.  PSR-1 accumulates to the end of the 
regrowing proximal axon, whereas the TOMM-20::GFP remains restricted to the mitochondria; 
images representative of 27 animals.  Panels to the right show magnified views of the boxed 
regions; arrowheads point to the site of axotomy.  Scale bars 25 µm. 
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Above: Supplementary Figure 2.5.  Analysis of axonal fusion and regeneration after heat-shock 
treatment in wild-type and ttr-52 mutant animals, and analysis of sAnxV localization after 
axotomy.  (a) Animals mutant in ced-2, ced-5, ced-12, or ced-10 have normal axonal fusion similar 
to that of wild-type (WT) animals.  (b) Unsuccessful fusion in a ttr-52(sm211) animal.  Regrowth 
has extended from the cut site (arrowhead) and contacted the distal fragment (bracketed region), 
but degeneration of the distal fragment has begun.  Scale bar 25 µm.  Image representative of 16 
animals.  (c) Rate of successful axonal fusion in ttr-52(sm211) animals without or with heat-shock 
(HS) treatment.  (d) The average length of regrowth in ttr-52(sm211) animals given HS after 
axotomy compared to those without HS treatment.  (e) Quantification of regrowth in ttr-52(sm211); 
Phsp::TTR-52::mCherry animals without HS treatment compared to those that received HS 
immediately after axotomy (0 hr), or at 6 or 9 hr post-axotomy.  (f) Comparison of the average 
length of regrowth in zdIs5 animals without HS or with HS given at different times after axotomy.  
(g) Successful axonal fusion in zdIs5 animals without HS compared to animals given HS at different 
times post-axotomy.  Error bars represent standard error of proportion (a, c, g) and standard error 
(d-f).  n values shown adjacent to each bar.  P values (from t-test for a, c, g; from Kolmogorov-
Smirnov test for d-f): **P<0.01, ***P<0.001 compared to WT or no HS (black bars), unless 
marked otherwise on the graph.  ns, not significant.  h) Single plane confocal images showing the 
localization of the PS sensor, sAnxV::mRFP, to the axon of PLM before axotomy and at several 
time points after transection.  The overlay image shows the 60 min time point; filled arrowhead 
points to the site of axotomy, and asterisks highlight the accumulation of sAnxV::mRFP at the 
injury site.  Scale bar 25 µm.  Images representative of 26 animals. 
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Above: Supplementary Figure 2.6.  Quantification of regeneration.  (a) To determine if the loss of 
any of the genes analysed caused a reduction in the regenerative potential of PLM, we calculated 
the average length of regrowth over the first 24 hr post-axotomy.  Mutations in several genes that 
reduced axonal fusion, including psr-1, ttr-52, nrf-5 and ced-7, caused defective regrowth in PLM.  
However, we found no correlation between the average length of regrowth and the rate of axonal 
fusion.  For instance, ced-10 and ced-12 mutants displayed reduced regrowth (Supplementary 
Table 2.2), but presented no defect in axonal fusion (Supplementary Figure 2.5a), whereas animals 
that lacked eff-1 had the strongest defect in axonal fusion, but their regenerative growth was not 
different from that of wild-type (WT) animals.  Moreover, there was no correlation between axonal 
fusion and the percentage of animals able to initiate any regrowth from the proximal axon after 
transection (b), the average number of axons that were able to regrow across the cut site at 
different time points after axotomy (c), or the percentage of axons presenting a growth cone at 
different stages of regeneration (d).  Error bars represent standard error (a) or standard error of 
proportion (b-d).  n values are displayed in Supplementary Table 2.  P values (from Kolmogorov-
Smirnov test for (a); from t-test for b-d): *P<0.05, **P<0.01, ***P<0.001. 
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Above: Supplementary Figure 2.7.  Localization of CED-6, CED-7, and NRF-5 in PLM before 
and after axotomy.  (a) Cell-autonomous rescue of the axonal fusion defect in ced-6(n1813) and 
ced-7(n2690) animals with expression in the mechanosensory neurons of either wild-type ced-6 
genomic DNA, or ced-7 cDNA, tagged with mRFP.  Error bars represent standard error of 
proportion; n values displayed in graph.  P values from t-test: *P<0.05.  (b) Maximum projection 
confocal images highlighting co-localization between mRFP::CED-6 and a mitochondrial marker 
(TOMM-20::GFP) in a ced-6(n1813) mutant background.  Arrowheads point to regions where this 
co-localization is absent.  Scale bar 25 µm.  Images representative of 12 animals.  (c) Single plane 
confocal images showing the localization of mRFP::CED-6 in PLM in a ced-6(n1813) mutant 
animal before axotomy (top two panels), and 4 hr post-axotomy (bottom three panels).  Panels to 
the right show magnified images of the boxed regions to highlight accumulation of CED-6 at the 
end of the regrowing proximal axon.  Arrowheads point to the site of axotomy.  Scale bars 25 µm; 
images representative of 9 animals.  (d) CED-7::mRFP localization in single plane confocal images 
of PLM in ced-7(n2690) mutant animals without axotomy (top panels) and at several time points 
after axotomy.  Different animals are shown for each time point.  Filled arrowheads point to the 
site of axotomy; open arrowhead points to site of fusion.  Scale bars 25 µm.  Images representative 
of 10 animals.  (e) Single plane confocal images of the localization of NRF-5::mCherry (expressed 
from a heat-shock promoter) in nrf-5 mutants to the PLM axon before axotomy and at several time 
points after transection in animals with genotype nrf-5(sa513); qxIs92; zdIs5.  Overlay image is 
shown for the 60 min time point; arrowheads point to the site of axotomy.  Scale bar 25 µm.  Images 
representative of 29 animals.  (f) Quantification of the relative fluorescence levels of NRF-
5::mCherry on the PLM distal (blue line) and proximal (red line) axons after axotomy compared to 
mock surgery conditions (black line).  Error bars represent standard error; n = 29 for distal and 
proximal axon, n = 13 for mock surgery.  P values from Kolmogorov-Smirnov test: *P<0.05 
compared to mock surgery. 
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Above: Supplementary Figure 2.8.  Mutation of unc-70 causes axonal defects and PLM-PLN 
fusion events that are dependent on eff-1 and dlk-1.  (a) In the absence of UNC-70 the PLM 
mechanosensory neurons develop abnormal morphology with breaks, loop structures (arrowhead) 
and branching.  Scale bar 25 µm; image representative of 21 animals.  (b) Quantification of the 
penetrance of abnormal loop structures as well as axonal breakages; n value within the bar.  (c) To 
determine whether the fluorescence observed in PLN was a result of fusion with PLM, or due to a 
promoter-switching event, time lapse imaging was undertaken in vivo, in unc-70(s1502) mutant 
animals.  Single plane images captured on a spinning disk confocal are shown.  Asterisk denotes 
PLM cell body (i); filled arrowhead indicates the site of initial GFP transfer first visible at 0 hr (i); 
open arrowhead indicates site of eventual PLN cell body appearance, which occurs after GFP is 
visible in the axonal process (ii-ix).  Scale bar 50 µm.  Image representative of one fusion event 
captured from 23 animals imaged.  (d) To further confirm the fusion events in unc-70(s1502) 
mutants, a tethered fluorophore assay was used to analyze cytoplasmic movement between PLM 
and PLN.  Cytoplasmic GFP was expressed together with mRFP targeted to the mitochondria 
(TOMM-20::mRFP), both expressed under the control of the Pmec-4 promoter in the same extra-
chromosomal array.  In wild-type (WT) animals, both GFP and TOMM-20::mRFP are only visible 
in the soma and axon of the PLM neuron (no extra cell was visible).  In those unc-70(s1502) mutant 
animals that presented PLM and PLN spontaneous neuronal fusion visible as GFP in both cells, 
PLM appeared as per wild-type with TOMM-20::mRFP in the soma and axon (left bar), whereas in 
PLN (designated ‘Extra’ in the bar) mitochondria were never observed.  Animals with mutations in 
sem-4(n1971) and ced-3(n717) contain extra cells due to cell fate defects36; as a result, both GFP 
andTOMM-20::mRFP are visible in the axon and soma of both PLM and the extra cells.  Error 
bars represent standard error of proportion; n values for cells analysed in each bar.  (e) 
Spontaneous fusion between PLM and PLN is completely abolished in dlk-1 mutants, and shows a 
large reduction in an eff-1 mutant background.  Overexpression of EFF-1 in the PLM neuron 
causes a large enhancement in spontaneous fusion events, but in animals lacking DLK-1, 
overexpression of EFF-1 in PLM is not sufficient to induce neuronal fusion between PLM and PLN.  
For (d) and (e), error bars represent standard error of proportion.  n values are shown adjacent to 
each bar.  P values from t-test: ***P<0.001. 
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Supplementary Figure 2.9.  TTR-52 and sAnxV bind to the PLM axon in unc-70 mutants.  
Localization of TTR-52::mCherry to the PLM axon at the L4 stage (a) or one-day-old adult (1DOA) 
animal (b) of unc-70 mutant animals (genotype: unc-70(s1502); oxIs95; smIs119; zdIs5).  Scale 
bars 20 µm.  Images representative of 16 (a) and 17 (b) animals.  (c) Quantification of the relative 
fluorescence levels of TTR-52::mCherry on the PLM axons in L4 and 1DOA wild-type (WT) 
animals compared to unc-70(s1502) mutants.  The intensity of TTR-52::mCherry on the axon shows 
a small but significant increase in unc-70(s1502) mutants compared to WT animals at the L4 stage 
and a more pronounced enhancement in 1DOA animals; n = 15 for WT L4, n = 16 for unc-70 L4, 
and n = 17 for both genotypes at 1DOA stage.  (d) Localization of the PS sensor, sAnxV::mRFP, to 
the PLMaxon in an unc-70(s1502) mutant animal at the L4 stage.  (e) Localization of 
sAnxV::mRFP to the PLM axon in a 1DOA unc-70(s1502) mutant animal. Scale bars 20 µm.  
Images representative of 14 (d) and 15 (e) animals.  (f) Quantification of the relative fluorescence 
levels of sAnxV::mRFP on the PLM axons in L4 and 1DOA WT animals compared to unc-
70(s1502) mutants.  In 1DOA animals there is a large increase in the relative fluorescence in unc-
70(s1502) mutants compared to WT animals; n = 15 for WT L4, n = 14 for unc-70 L4, n = 14 for 
WT 1DOA, and 15 for unc-70 1DOA.  For (c) and (f), error bars indicate standard error.  P values 
from Kolmogorov-Smirnov test: *P<0.05, ***P<0.001.  ns = not significant.  au = arbitrary units. 
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Supplementary Figure 2.10.  Proposed model for how the apoptotic recognition molecules and 
the fusogen EFF-1 mediate axonal fusion during regeneration of PLM. 
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Supplementary Table 2.1.  Quantification of regeneration in single and double mutant animals. 
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Supplementary Table 2.2.  Average length of regrowth in single and double mutant animals.  
Underlining indicates values that are significantly different from zdIs5 animals (measured with the 
Kolmogorov-Smirnov test).   
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2.3 Discussion  
 
This study provided the first characterization of EFF-1 localization in a regenerating axon.  Based 
on studies of EFF-1 localization in other tissues2,37, we had hypothesized that this fusogen would 
localize dynamically during regeneration.  We observed that EFF-1 was present in an indiscriminate 
punctate pattern in the intact axon, but was mobilized to the membrane of the regenerating axon.  
This pattern suggests that, in a steady state, EFF-1 is retained within intracellular compartments, but 
during regeneration is trafficked to the membrane, allowing it to be present at the site of contact 
with the distal fragment.  
One limitation of this study is that it characterized the localization of one isoform of EFF-1, but 
did not confirm that this is the isoform responsible for axonal fusion.  The transgene used to 
visualize EFF-1 in PLM expresses the genomic sequence of eff-1 but places the GFP tag in the 
reading frame of isoform A (see Section 2.2 Methods); it thus allows for expression of all isoforms 
of EFF-1, but only visualization of isoform A.  As mentioned previously (Section 1.3), isoform A is 
a strong candidate for mediating axonal fusion, as it has been shown to generate fusion in other 
cells both in vitro and in vivo2,38.  Our lab has now performed additional experiments to determine 
whether EFF-1A is the isoform responsible for the rescue of axonal fusion seen with genomic eff-1 
DNA (Figure 2.5).  
 
 
Figure 2.5.  EFF-1A mediates axonal fusion.  Quantification of axonal fusion in eff-1(ok1021) 
animals expressing EFF-1A in PLM demonstrates rescue of the eff-1 axonal fusion defect.  Rescue 
is demonstrated for three independent transgenic lines comparing animals expressing EFF-1A 
(grey bars) with non-transgenic siblings (white bars).  Error bars indicate standard error of 
proportion; n values listed above or within each bar.  P values from t-test: *P<0.05.  Data courtesy 
of Dr. R. Giordano-Santini.  
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 We found that selective expression of EFF-1A in PLM was indeed able to rescue the eff-1 
axonal fusion defect, whereas rescue with selective expression of EFF-1B was only obtained for 
one transgenic line (Figure 2.5).  This data suggests that EFF-1A mediates axonal fusion, and that 
the localization changes we observed during regeneration are likely to be of functional significance.   
Curiously, accumulation of EFF-1 at the site of fusion has been observed in some, but not all, 
models of EFF-1 localization.  Concentration of EFF-1 to cell borders prior to and during fusion has 
been observed in vivo in C. elegans as well as in heterologous systems2,38-40.  In contrast, a study of 
endogenous EFF-1 in the embryonic hypodermis has suggested only transient localization of EFF-1 
to the membrane for fusion37.  Some authors have postulated that this discrepancy may be related to 
how closely two fusing cells are apposed40.  Following this hypothesis, it is logical that a neuron 
must target EFF-1 to the membrane, as it has to undergo processes of regrowth and reconnection to 
achieve apposition.  Accumulation of EFF-1 might also promote engagement of the membranes and 
therefore improve chances of fusion.  Importantly, while close apposition of membranes can be 
mediated by various molecular complexes, such as integrins and cadherins, the complete reduction 
of this gap to achieve fusion can only be achieved by bone fide fusogens41. 
Interestingly, we found that overexpression of EFF-1 could suppress the axonal fusion defect 
caused by mutations in upstream molecules.  In particular, EFF-1 overexpression in a wild-type 
background did not further increase the axonal fusion rate, but it could overcome the axonal fusion 
defect in animals carrying mutations in psr-1 or ttr-52, molecules necessary for the recognition of 
the separated distal fragment.  This supports our genetic data indicating that EFF-1 acts genetically 
downstream of these molecules.  Importantly, it also suggests that changes in EFF-1 levels in the 
axon, and perhaps changes in localization, can have functional consequences for axonal fusion.  We 
have now used this information in a subsequent study that investigated the molecular machinery 
responsible for EFF-1 localization (see Chapter 3).  We have been able to identify a crucial gene for 
controlling EFF-1 localization, and dissect its functional importance.  
We have shown that a pathway of conserved apoptotic molecules provide an active mechanism 
through which the distal fragment is recognized (Figure 2.6).  Similar machinery is likely to exist in 
other organisms that undergo axonal fusion, such as leech neurons, in which a breakdown of self-
avoidance must occur to enable axonal fusion42.  This is in stark contrast to vertebrate systems, such 
as zebrafish, in which self-avoidance is maintained following axotomy and hence prevents regrowth 
towards the distal fragment43.  
While the apoptotic clearance molecules were found to act upstream of EFF-1, they did not 
have a clear role in controlling EFF-1 localization.  There was no change in the localization pattern 
of EFF-1 in psr-1 or ttr-52 mutant backgrounds, with EFF-1 still mobilized to the membrane during 
regeneration (Dr. R. Giordano-Santini, personal communication, not shown).  It is therefore likely 
! %*!
that other molecular machinery exists for this intracellular control of EFF-1, allowing it to be 
present at the membrane following recognition of the distal fragment. 
 
 
Figure 2.6.  EFF-1 acts downstream of the apoptotic clearance machinery for regenerative 
axonal fusion in PLM.  This schematic depicts the site of fusion between the regrowing PLM axon 
and the distal fragment (dotted box).  The pathway of apoptotic molecules mediating recognition of 
the distal fragment is shown in grey (for details, see Figure 1.2).  EFF-1 (green) acts as the final 
downstream effector, present on both membranes to mediate fusion and restore membrane and 
cytoplasmic continuity.  Schematic courtesy of Dr. R. Giordano-Santini. 
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2.4 Statement of contribution   
 
In this study, I contributed to characterizing EFF-1 localization in the PLM axon pre- and post-
axotomy.  This was achieved using a transgenic C. elegans strain previously developed in the lab.  
In a collaborative effort with Dr. R. Giordano-Santini, a post-doctoral fellow in the lab, I used a 
combination of standard and super-resolution microscopy techniques to characterize EFF-1 
distribution in PLM before injury and at different time points during axonal regeneration and 
fusion.  
As part of the response to reviewers, I also performed experiments to confirm that the axonal 
fusion failure in eff-1 mutant animals is not merely due to insufficient proximity of two axonal 
fragments, but rather to their inability to merge plasma membranes.  To address this, I developed a 
transgenic strain of C. elegans expressing a membrane-bound mCherry fluorophore in PLM, as well 
as cytoplasmic GFP.  This strain improved our capacity to identify how closely two axonal 
fragments were apposed.  Using Structured Illumination Microscopy (SIM), I confirmed that 
membrane contact is not sufficient for axonal fusion, indicating that the axonal fusion defects are 
related to loss of specific molecular machinery (EFF-1).  An image of this strain was also selected 
for the cover of the 8th January 2015 issue of Nature.  Finally, I also contributed to axotomies for 
screening of candidate genes (unpublished), a process that was essential to the final published 
manuscript.   
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Chapter 3: RAB-5 regulates EFF-1 localization  
and function in C. elegans neurons  
 
(Manuscript in preparation) 
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3.1 Introduction 
 
Our findings from the previous chapter demonstrate that EFF-1 localization during the process of 
axonal fusion is dynamic.  This localization seems to be directly linked to EFF-1 function, as EFF-1 
accumulation at the membrane of the regenerating axon should maximise the chances of successful 
fusion following reconnection with the distal axonal fragment.  We next sought to understand how 
EFF-1 localization is controlled, such that EFF-1 activity is suppressed in the steady state but 
promoted during regeneration.  Our approach was to identify and characterize candidate neuronal 
regulators of EFF-1.  
Our primary candidate was the endocytic regulator RAB-5, which has been shown in work 
from the Podbilewicz lab to regulate EFF-1-mediated cell-cell fusion in the C. elegans hypodermis1.  
RAB-5 was found to negatively regulate EFF-1 activity.  Depletion or loss-of-function of RAB-5 
resulted in mis-localization of EFF-1 to the plasma membrane, which was in turn associated with 
excessive, uncontrolled hypodermal cell-cell fusion.  We wondered whether a similar function is 
performed by RAB-5 in PLM, perhaps controlling EFF-1 activity prior to and during axonal 
regeneration.  
This chapter consists of a first-author manuscript (Section 3.2) prepared for publication.  It 
details original research on the role of RAB-5 activity in EFF-1 localization and function in the 
PLM neuron.  It is followed by a discussion of these results in the context of the thesis as a whole 
(Section 3.3) and a statement of personal contribution (Section 3.4).  
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3.2 Manuscript in preparation  
 
RAB-5 regulates EFF-1 localization and function in C. elegans neurons  
 
Linton, C., Neumann, B., Giordano-Santini, R. & Hilliard, M. A. RAB-5 regulates EFF-1 
localization and function in C. elegans neurons.  In preparation.  
 
Please note that this manuscript has been reformatted for inclusion in the thesis; references are 
included in a combined reference list at the end of the chapter. 
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ABSTRACT  
Following a transection injury to the axon, some C. elegans neurons undergo spontaneous repair via 
fusion of the two separated axonal fragments.  This regenerative axonal fusion is mediated by the 
nematode fusogen Epithelial Fusion Failure-1 (EFF-1), which acts as the effector that directly fuses 
the axonal membranes.  Identifying the molecular regulators of EFF-1 in neurons is critical to our 
further understanding of this process.  Here, we show that neuronal EFF-1 is regulated by the 
endocytic GTPase RAB-5.  We find that perturbing RAB-5 activity increases the capacity of the 
neuron to undergo EFF-1-mediated regenerative axonal fusion.  This change in EFF-1 function is 
associated with membranous localization of EFF-1, and the production of extracellular EFF-1-
containing vesicles.  Conversely, enhanced RAB-5 activity leads to accumulation of EFF-1 in 
enlarged endosomes.  These findings identify the first neuronal regulator of EFF-1, and a potential 
therapeutic target for translating axonal fusion into the clinical setting.  
 
Introduction 
Treating nerve injuries is of great interest in the clinical setting.  Significant research efforts have 
focussed on developing new methods to repair an axon following transection, as current outcomes 
are less than optimal.  A novel approach to this problem has come from work in invertebrate 
systems, demonstrating that some neurons are capable of spontaneously rejoining the two axonal 
fragments.  This regenerative mechanism, called axonal fusion, has been observed in a number of 
species2-6, and best characterized in the mechanosensory neurons of the nematode C. elegans7-11.  
To undergo axonal fusion, the proximal axon (still attached to the cell body), regrows, 
reconnects, and then fuses with its separated axonal fragment.  It has been demonstrated in C. 
elegans that this fusion not only restores continuity of the axon following UV laser axotomy8, but 
also restores neuronal function10,11.   
To date, the molecules implicated in C. elegans axonal fusion include the membrane fusogen 
Epithelial Fusion Failure-1 (EFF-1) and components of the apoptotic clearance machinery7,9.  
EFF-1 is the key molecular effector that directly fuses the axonal membranes, acting downstream of 
a conserved pathway of apoptotic molecules.  These molecules, which include the 
phosphatidylserine (PS) receptor PSR-1 and the transthyretin protein TTR-52, allow for recognition 
of the distal axonal fragment following exposure of PS on its outer surface9.  
EFF-1 activity in the injured neuron is crucial for successful axonal fusion.  eff-1 mutants 
exhibit strong defects in axonal fusion7,9 and these defects can be rescued by expression of wild-
type EFF-1 cell-autonomously9.  Overexpression of EFF-1 does not increase the rate of fusion 
beyond wild-type levels, but it is able to enhance fusion in mutant backgrounds defective for this 
process.  In particular, mutants in psr-1 or ttr-52 exhibit defects in axonal fusion that can be rescued 
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with EFF-1 overexpression9.  This indicates that higher levels of EFF-1 in the neuron, and perhaps 
at the membrane, are sufficient to improve axonal fusion when a defect exists.  
How EFF-1 activity is regulated within the neuron is currently unknown.  However, there is 
now strong evidence that EFF-1 activity can be controlled via dynamic subcellular localization.  To 
mediate fusion, EFF-1 must be inserted into the membrane, and it is inactive when sequestered in 
intracellular compartments.  This was first demonstrated in other cell types in C. elegans, including 
the hypodermis, where EFF-1 generates syncytia during development12.  EFF-1 in these 
hypodermal cells is mobilized from intracellular compartments to the plasma membrane where it 
mediates fusion1,13.  In the mechanosensory neuron PLM, we have observed that EFF-1 exhibits 
similar dynamics following axonal injury.  In the uninjured axon, EFF-1 exists largely in puncta, 
but is then mobilized to the regenerating axonal membrane9.  
To date, two molecules have been identified to regulate EFF-1 localization to the membrane: 
the GTPases RAB-5 (a small GTPase) and dynamin (DYN-1)1.  RAB-5 and its mammalian 
ortholog Rab5 localize to early endosomes and play important roles in endocytosis.  They facilitate 
transport of clathrin-coated vesicles to early endosomes, fusion between endosomes, and cargo 
trafficking from endosomes into lysosomes for degradation14-18.  Depletion phenotypes of RAB-5 
largely involve defects in protein internalization from the membrane.  Similarly, in the C. elegans 
hypodermis, depletion or loss-of-function of RAB-5 resulted in mis-localization of EFF-1 to the 
plasma membrane; this was in turn associated with excessive hypodermal cell-cell fusion1.  These 
authors have thus proposed that RAB-5 negatively regulates EFF-1 activity through endocytosis.  
As a GTPase, RAB-5 exists in either an active or inactive state, and can switch between these 
two states depending on endogenous regulation.  Expressing versions of RAB-5 that are locked in 
an active or inactive state has been shown to produce specific cellular phenotypes.  Inactive, GDP-
locked RAB-5 acts in a dominant negative fashion (RAB-5(DN)) and perturbs the function of 
endogenous RAB-5, inhibiting RAB-5-mediated endocytosis19. GTP-locked RAB-5 is 
constitutively active (RAB-5(CA)); its presence leads to excessive early endosome fusion, and a 
phenotype of enlarged endosomes both in C. elegans and other systems19,20.  Expression of these 
activity-locked forms of RAB-5 can be used to interrogate the role of RAB-5 activity in a particular 
process.  
Here, we demonstrate that RAB-5 regulates EFF-1 in the C. elegans mechanosensory neuron 
PLM.  We show that altering RAB-5 activity in the neuron leads to changes in both EFF-1 function 
and localization.  These findings are consistent with a model in which RAB-5 controls neuronal 
EFF-1 via endocytosis.   
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Results  
 
RAB-5 regulates EFF-1 activity during regenerative axonal fusion  
To determine whether RAB-5 controls the function of neuronal EFF-1, we investigated the effect of 
altering RAB-5 activity on axonal fusion.  Firstly, we perturbed RAB-5 activity by expressing a 
dominant negative RAB-5 (RAB-5(DN)) selectively in the mechanosensory neurons.  We 
anticipated that RAB-5(DN) would prevent endocytosis of EFF-1, increasing the amount of EFF-1 
at the membrane and potentially mimicking overexpression of EFF-1.  We have previously 
demonstrated that EFF-1 overexpression cannot increase the endogenous rate of axonal fusion, but 
is sufficient to rescue the defects observed in psr-1 mutant animals9.  Thus, we tested whether 
RAB-5(DN) could similarly rescue the defect in animals lacking psr-1. 
Axotomies were performed on the PLM neuron approximately 50 µm anterior to the cell body 
as previously described8.  The rate of axonal fusion was calculated from axons that regrew and 
visibly reconnected to their distal fragment.  Successful axonal fusion occurred if the distal 
fragment was maintained 48 hr post-axotomy (Figure 3.1a); fusion was unsuccessful if the distal 
fragment instead underwent degeneration (Figure 3.1b).  
As previously shown, we found that psr-1 mutant animals had a defective rate of axonal fusion 
compared to wild-type animals9.  Most importantly, expression of RAB-5(DN) in the PLM neuron 
was sufficient to rescue the rate of fusion to wild-type levels (Figure 3.1c).  To confirm that this 
effect was eff-1-dependent, we next performed axotomies on eff-1; psr-1 double mutant animals 
expressing RAB-5(DN).  We found that loss of eff-1 suppressed the increase in axonal fusion 
mediated by RAB-5(DN) (Figure 3.1c), indicating that RAB-5(DN) increases the axonal fusion rate 
in an eff-1-dependent manner.  
We also performed axotomies on wild-type animals expressing constitutively active RAB-5 
(RAB-5(CA)) in the mechanosensory neurons.  We hypothesized that this increased RAB-5 activity 
might cause the opposite phenotype and reduce the rate of axonal fusion.  However, we instead 
found no significant change in axonal fusion rates in these animals (Figure 3.1d).  This may indicate 
that, while RAB-5 activity removes EFF-1 from the membrane, an independent signal initially 
mobilizes EFF-1 to the membrane, explaining why fusion still occurs at wild-type levels in the 
setting of RAB-5 overactivity.  
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Figure 3.1.  Perturbing RAB-5 increases EFF-1-dependent axonal fusion rates.  (a) Successful 
PLM axonal fusion in a psr-1(ok714) animal expressing RAB-5(DN), 48 hr post-axotomy.  Filled 
arrowhead indicates the cut site; open arrowhead indicates the site of fusion.  Another neuron 
(PVM, grey in schematic) can be seen but is out of focus.  (b) Defective PLM axonal fusion in a psr-
1(ok714) animal, 48 hr post-axotomy.  Filled arrowhead indicates the cut site; open arrowhead 
indicates the site of reconnection (which did not result in fusion).  (c, d) Quantification of axonal 
fusion in psr-1(ok714) animals expressing RAB-5(DN) in the PLM neuron (c) demonstrates rescue 
of the psr-1(ok714) axonal fusion defect.  This rescue is suppressed in psr-1(ok714); eff-1(ok1021) 
mutant animals, indicating the effect of RAB-5(DN) is eff-1-dependent.  Quantification of axonal 
fusion in animals expressing RAB-5(CA) in the PLM neuron (d) shows no significant effect on the 
level of axonal fusion compared to controls.  Error bars indicate the standard error of proportions.  
n values are listed below each bar.  P values from t-test: *P<0.05.  D = dorsal, V = ventral, A = 
anterior, P = posterior for all images.  Scale bars 25 µm.   
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RAB-5 controls EFF-1 localization to the plasma membrane  
We hypothesized that the enhanced axonal fusion with RAB-5(DN) was associated with increased 
EFF-1 localization to the plasma membrane.  To investigate this, we visualized EFF-1 using a 
transgenic strain in which eff-1 null mutant animals express cytoplasmic mCherry in the PLM 
mechanosensory neurons, as well as GFP-tagged EFF-1.  This EFF-1::GFP transgene has been 
demonstrated to be functional and sufficient to rescue axonal fusion in eff-1 mutants9.  Using 
confocal microscopy, we characterized EFF-1 localization in the cell body and proximal axon of 
PLM (Figure 3.2a-d).  In the uninjured axon, EFF-1 formed an indiscriminate punctate pattern as 
previously reported9 (Figure 3.2b).  In the cell body, it was also present as intracellular puncta, with 
no clear localization to the cell membrane (Figure 3.2d).  We chose to perform subsequent 
localization studies specifically in the cell body, as this wider structure would allow for any 
mobilization of EFF-1 to the membrane to be clearly identified.  
To test if perturbing RAB-5 activity led to EFF-1 localization at the membrane, we then co-
expressed RAB-5(DN).  In these animals, EFF-1::GFP formed a more continuous pattern along the 
axon (Figure 3.2c), and accumulated at the membrane of the PLM cell body (Figure 3.2d); this was 
commonly associated with membranous protrusions of EFF-1 (Figure 3.2d, arrowhead).  Line scan 
profiles through these protrusions clearly demonstrated that EFF-1 was present on the membrane of 
the cell body, a phenomenon that we never observed in control animals (Figure 3.2e).  To quantify 
EFF-1 localization, we measured the average intensity of GFP along the membrane of the cell body, 
normalized to the average intensity for the whole cell body (see Methods).  This revealed a 
significant increase in the relative amount of EFF-1::GFP at the membrane in the presence of 
RAB-5(DN) (Figure 3.2f).  These results indicate that loss of RAB-5 activity leads to EFF-1 
accumulation at the membrane of the cell body.    
As expected, enhancing RAB-5 activity, either through expression of RAB-5(CA) or over-
expression of wild-type RAB-5, had no effect on the relative amount of EFF-1::GFP at the cell 
membrane (Figure 3.2f).  This is consistent with the axotomy results indicating that increased RAB-
5 activity did not significantly alter EFF-1 function.  Taken together, these findings demonstrate 
that RAB-5 activity functions in endocytosis of EFF-1 molecules that have been mobilized to the 
membrane.  
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Figure 3.2.  RAB-5 controls EFF-1 localization to the plasma membrane.  (a) Schematic of the 
PLM neuron in the tail of the animal; dashed box indicates the region depicted in panels (b) and (c).  
(b, c) Representative maximum projection confocal images of the PLM neuron in eff-1(ok1021) 
animals expressing EFF-1::GFP and cytoplasmic mCherry in PLM.  An animal co-expressing 
RAB-5(DN) (c) is compared with a sibling lacking this transgene (b).  Dashed boxes indicate the 
regions magnified in panel (d).  Scale bars 5 µm.  (d) Magnification of the PLM cell bodies in panels 
(b) (left) and (c) (right), where EFF-1::GFP localizes to a membranous protrusion (arrowhead).  
Contrast settings have been adjusted to better visualize EFF-1 in the cell body instead of the axon.  
Scale bars 1 µm.  (e) Fluorescence profiles from line scans of the overlying cell bodies confirm 
membranous EFF-1::GFP localization in the presence of RAB-5(DN).  Results demonstrative of ≥10 
animals per group.  AU = arbitrary units.  (f) Quantification of the relative amount of EFF-1::GFP 
at the membrane of the cell body in eff-1(ok1021) animals co-expressing EFF-1::GFP with either 
RAB-5(DN), RAB-5(CA) or RAB-5(WT) (a low (5 ng/µl) and high (10 ng/µl) injection concentration 
is shown).  For each independent transgenic line, animals carrying a particular RAB-5 transgene 
(red) are compared with siblings lacking the transgene (black).  Each data point represents one 
animal.  Bars represent the mean of each group; P values from t-test: ****P<0.0001. 
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Plasma membrane accumulation of EFF-1 forms extracellular vesicles  
Remarkably, we observed that animals expressing RAB-5(DN) not only had protrusions of the 
transmembrane EFF-1::GFP from the PLM cell body, but also generated what appeared to be 
extracellular EFF-1::GFP-positive vesicles.  These extracellular vesicles, ranging in number from 2 
- 20 per neuron, were present around the PLM cell body and proximal axon, and were reproducible 
in multiple independent transgenic strains (Figure 3.3a).  Interestingly, previous work has shown 
the presence of EFF-1 vesicles in cultured media of baby hamster kidney cells transfected with 
EFF-121, and vesicles containing AFF-1, another C. elegans fusogen, have been described both in 
vitro from mammalian cells22, and in vivo from seam cells23 (see Discussion).  
 
Figure 3.3.  EFF-1 forms 
extracellular vesicles with 
perturbed RAB-5 activity.  
(a) Representative images 
of extracellular EFF-
1::GFP vesicles in animals 
from three independent 
transgenic lines expressing 
RAB-5(DN).  Scale bar 5 
µm.  (b) Single plane 
confocal image of the PLM 
cell body in an eff-1 
mutant expressing 
EFF-1::GFP, RAB-5(DN), 
and cytoplasmic and 
membrane-bound mCherry (MYR::mCherry) in PLM.  There is no mCherry signal present in the 
vesicles.  Image is demonstrative of 18 animals.  Scale bar 2 µm.  (c) Time lapse demonstrating 
budding of an EFF-1::GFP vesicle (arrowhead).  Each image represents the maximum projection 
of several slices to optimize visualization of the vesicle.  The asterisks at 14 and 16 min indicate 
non-specific GFP expression.  Scale bar 1 µm.  (d) Time lapse demonstrating an immobile vesicle 
(asterisk), a mobile vesicle (arrowhead) and a new membranous protrusion (line).  Scale bar 1 µm.  
(e) The proportion of mobile vs. immobile vesicles; based on 105 vesicles in 14 animals.  
 
To determine the composition of these vesicles, we generated strains that co-expressed a 
cytoplasmic marker (mCherry) and a membrane-bound marker (MYR::mCherry) in addition to 
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EFF-1::GFP and RAB-5(DN).  Vesicles observed in these animals contained no detectable mCherry 
signal (Figure 3.3b), indicating that membrane-bound forms of mCherry were excluded from the 
vesicles, and that they contain a highly reduced volume of cytoplasm (based on the resolution of 
confocal imaging).  This suggests that these vesicles may be selective in their composition, and 
perhaps contain mostly fusogen, similar to the EFF-1 vesicles reported in culture21. 
To characterize the dynamics of the vesicles, we undertook time lapse imaging of the PLM cell 
body.  Confocal imaging of the vesicles at 2 min intervals for up to 60 min revealed that they fall 
into two categories of mobility: ‘immobile’ vesicles, representing the majority of vesicles which 
exhibited no movement in this time period, and ‘mobile’ vesicles, which instead exhibited linear or 
disorganised, oscillatory movements around the cell body (Figure 3.3d,e).  This occurred at an 
average rate of 0.2 µm/s (n = 22).  We observed that these vesicles are present from the first and 
second larval stages.  At the fourth larval stage, budding of the vesicles from the cell body was a 
rare event but captured on one occasion (Figure 3.3c).  EFF-1 retained at the membrane also 
underwent dynamic changes, and the formation of de novo protrusions of EFF-1 from the cell body 
was captured within a period of minutes (Figure 3.3d). 
To determine whether the vesicle dynamics were altered following neuronal injury, we 
performed axotomies and visualized the axon and cell body at 3 hr and 6 hr post-axotomy.  
However, we observed no clear change in vesicle number or localization at these time points 
(Supplementary Figure 3.1).  Overall, we believe these vesicles are likely generated via 
accumulation of EFF-1 at the membrane, such that EFF-1 is ‘pinched off’ in the form of a vesicle.    
 
RAB-5 controls EFF-1 localization to intracellular compartments   
We next asked whether RAB-5 also controls EFF-1 localization to intracellular puncta.  Given that 
EFF-1 co-localizes with RAB-5 in other cell types1, we hypothesized that the EFF-1::GFP puncta in 
PLM neurons represent EFF-1 contained in early endosomes, and are formed through RAB-5-
mediated endocytosis and endosome fusion.  Changes in RAB-5 activity were therefore expected to 
alter the morphology of these puncta.   
We expressed the three different versions of RAB-5 described above and characterized the size 
of EFF-1::GFP puncta present in the PLM cell body.  We used the Squassh imaging tool (ImageJ)24 
to automatically select and measure these puncta.  We found that increasing RAB-5 activity with 
RAB-5(CA) caused accumulation of EFF-1 within enlarged intracellular puncta (Figure 3.4a).  This 
effect was observed to a smaller but significant extent with overexpression of RAB-5(WT) (Figure 
3.4b).  In contrast, there was no significant difference in the average size of puncta detected in 
RAB-5(DN) cell bodies (Figure 3.4c).  This result is consistent with the known role of RAB-5 in 
endosome fusion and the enlarged endosome phenotype generated by RAB-5 overactivity19,20. 
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Figure 3.4.  Increased RAB-5 activity causes EFF-1 accumulation in large intracellular puncta.  
(a, b, c) Representative maximum projection confocal images of the PLM cell body in eff-1(ok1021) 
animals expressing RAB-5(CA) (a), RAB-5(WT) (b) or RAB-5(DN) (c) compared with control 
animals lacking each respective RAB-5 transgene.  Displayed for each cell body is the overlay of 
the red (diffusible mCherry) and green (GFP-tagged EFF-1) channels (top row), the green channel 
(middle row) and the result of automatic puncta selection using Squassh (bottom row).  Scale bars 
1 µm.  (d) Quantification of the average EFF-1::GFP puncta size in independent transgenic lines 
expressing RAB-5(CA), RAB-5(WT) or RAB-5(DN).  Animals with the given RAB-5 transgene (red) 
are compared with siblings lacking the transgene (black).  A significant increase in average puncta 
size was found for three independent RAB-5(CA) lines, and for two RAB-5(WT) lines injected at 
different concentrations (5 ng/µl and 10 ng/µl).  Each data point represents one cell body from one 
animal.  Bars represent the mean of each group; P values from t-test: *P<0.05; **P<0.01, 
****P<0.0001.  AU = arbitrary units.  
 
To confirm that EFF-1 was accumulating in RAB-5-positive compartments, we performed co-
localization studies of EFF-1 with RAB-5 in the context of RAB-5 overexpression.  We co-
expressed BFP::RAB-5 with EFF-1::GFP in the mechanosensory neurons (Figure 3.5), which 
reproduced the enlarged EFF-1 puncta phenotype, leading to a significant increase in average EFF-
1 puncta size (Figure 3.5b).  In these enlarged puncta, EFF-1 co-localization with RAB-5 was on 
average 85% (range 67 - 98%; n = 12).  This strongly supports that overactivity of RAB-5 results in 
EFF-1 accumulation in enlarged early endosomes. 
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Figure 3.5.  EFF-1 accumulates in RAB-5-positive 
compartments.  (a) Representative maximum projection 
confocal image of the PLM cell body in an animal co-
expressing EFF-1::GFP and BFP::RAB-5; the overlay and 
individual green and blue channels (left column) are matched 
with the result of automatic puncta selection using Squassh 
(right column), demonstrating strong co-localization between 
the EFF-1::GFP and BFP::RAB-5 puncta.  Scale bar 1 µm.  
(b) Quantification of the average EFF-1::GFP puncta size in 
a transgenic strain carrying EFF-1::GFP and BFP::RAB-5. 
A significant increase in EFF-1::GFP puncta size occurred 
when BFP::RAB-5 was also present (indicated by a plus sign 
(+)).  The BFP::RAB-5 transgene was injected at the same 
concentration as the other RAB-5 transgenes.  Each data 
point represents one cell body from one animal.  Bars 
represent the mean of each group; P values from t-test: ****P<0.0001.  AU = arbitrary units.  
 
RAB-5 controls the amount of EFF-1 in the PLM neuron   
Our results indicate that altering RAB-5 activity causes EFF-1 mis-localization to specific 
subcellular compartments (either the membrane with decreased RAB-5 activity, or enlarged 
endosomes with increased RAB-5 activity).  We next asked whether this mis-localization affected 
the ability of the neuron to transport EFF-1 into pathways for recycling or degradation.  We 
hypothesized that such transport defects would result in a buildup of EFF-1::GFP in the neuron.  To 
test this, we measured the average EFF-1::GFP intensity in the PLM axon and cell body of animals 
co-expressing either RAB-5(DN), RAB-5(CA) or RAB-5(WT).  We also used an alternative 
approach to perturb RAB-5 activity using cell-specific RNAi25, whereby animals expressed rab-
5(sas) in the mechanosensory neurons for cell-specific silencing of rab-5.  We found that the 
average EFF-1::GFP intensity in both the axon and cell body was significantly greater in animals 
expressing either RAB-5(DN), RAB-5(CA) or rab-5(sas) (Supplementary Figures 3.2a-d,g,h).  This 
may represent defective recycling or degradation of EFF-1 due to altered RAB-5 activity.  
In contrast, the overexpression of RAB-5(WT) had no significant effect on EFF-1::GFP 
intensity (Supplementary Figures 3.2e,f).  This indicates that the RAB-5(WT) molecule may be 
modified by endogenous regulators, and hence regulated to minimise changes in EFF-1 levels.  It is 
therefore only unregulated alterations in RAB-5 activity (generated with expression of RAB-5(DN), 
RAB-5(CA) or rab-5(sas)) that disrupt EFF-1 protein levels.   
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Other endocytic molecules have no effect on EFF-1 regulation  
A number of molecules are able to function in endocytosis of cargo from the plasma membrane.  
We sought to determine whether other endocytic regulators might act in conjunction to RAB-5 for 
regulating neuronal EFF-1.  One important candidate for this role is DYN-1, the C. elegans 
ortholog of dynamin, as it has been demonstrated to act in this fashion alongside RAB-5 to regulate 
EFF-1 in the hypodermis1.  We tested whether loss of DYN-1 function, induced using the 
temperature sensitive allele dyn-1(ky51), influenced EFF-1::GFP localization in the PLM neurons.  
Surprisingly, we found no significant effect of DYN-1 on EFF-1::GFP puncta size, membrane 
localization or average intensity in the neuron (Supplementary Figures 3.3a,c,e).  
We also tested EHS-1, a clathrin adaptor involved in endocytosis that localizes to the plasma 
membrane.  However, loss-of-function ehs-1 mutant animals showed no significant change in the 
same measurements of EFF-1::GFP localization (Supplementary Figure 3.3b,d,f).  We believe this 
is consistent with studies of ehs-1 in other systems that indicate it can act redundantly with other 
clathrin adaptors26.  As such, identifying its potential role in this process requires further 
investigation.   
From early endosomes, the endocytic pathway allows for transport of cargo to downstream 
compartments, potentially for membrane recycling or degradation.  We thus wondered whether 
molecules localizing to these compartments also participated in EFF-1 regulation.  A number of 
RAB proteins presented good candidates; these included RAB-7, which functions in endosome-to-
lysosome trafficking, RAB-10, an endocytic recycling regulator that localizes to endosomes and 
Golgi, and RAB-11, which controls transport between recycling endosomes and the plasma 
membrane.  We perturbed the function of these rab genes in the PLM neurons, either through 
expression of dominant negative versions, or using loss-of-function alleles.  However, our results 
indicated that the function of these RAB molecules was not involved in EFF-1 localization in the 
PLM neurons.  Neither expression of dominant negative RAB-7 or RAB-11, nor the presence of the 
rab-10(dx2) loss-of-function allele, significantly altered our measurements of EFF-1::GFP intensity 
or localization (Supplementary Figure 3.4).  Overall, these results support the specificity of our 
findings with RAB-5, and suggest that this molecule is a key regulator of neuronal EFF-1. 
 
Discussion 
 
RAB-5 activity regulates the function of neuronal EFF-1  
Our axonal fusion data demonstrates that perturbing RAB-5 activity in the PLM neurons has a clear 
functional consequence.  In our previous study9, we demonstrated that overexpression of EFF-1 
cell-autonomously in the PLM neurons was sufficient to rescue the axonal fusion defect in psr-1 
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mutants.  This suggested that increased neuronal levels of EFF-1 could promote axonal fusion.  We 
have now seen that the presence of RAB-5(DN) phenocopies EFF-1 overexpression in rescuing the 
psr-1 axonal fusion defect, and is in turn associated with increased amounts of EFF-1 in the neuron 
and at the membrane.  Interestingly, the presence of RAB-5(CA) also increases overall levels of 
EFF-1 in the neuron, but did not influence axonal fusion rates, highlighting that accumulated EFF-1 
must be present on the membrane to function in fusion. 
We had anticipated that increased RAB-5 activity might instead cause a defect in axonal fusion 
by preventing EFF-1 mobilization to the membrane.  Rather, we found no significant effect.  It is 
possible that there was insufficient overactivity of RAB-5 in the strains tested, or that only a small 
number of EFF-1 molecules is required at the membrane for fusion, and sufficient amounts were 
present even in the presence of RAB-5(CA).  Alternatively, it is possible that a RAB-5-independent 
mechanism exists for the mobilization of EFF-1 to the membrane after injury.  Recruitment of EFF-
1 to fusion sites in larval hypodermal cells was shown to be mediated at least in part by the actin 
regulator VAB-10 (ref. 27), but other pathways may also exist.  Much has been characterized about 
the molecular cascades that are activated in regenerating axons28-30 and it is plausible that some of 
these molecules play a currently uncharacterized role in EFF-1 recruitment.   
 
RAB-5 activity determines EFF-1 localization and protein levels  
By visualizing EFF-1, we determined that changes in EFF-1 activity reflected underlying changes 
in its localization.  Our study confirms the previous EFF-1 localization pattern reported in the PLM 
axon9 and provides more detailed characterization of its localization in the PLM cell body.   
As described in the C. elegans hypodermis1, we found that reducing RAB-5 function led to 
membranous localization of EFF-1.  We note that perturbing endogenous rab-5 using cell-specific 
RNAi did not generate this membranous localization in our system (data not shown).  This may be 
due to a reduced effect size with this technique, and previous studies have indicated that RAB-5 
depletion must reach a threshold before changes in endosomal organization are seen31.  
We also observed an increase in EFF-1::GFP intensity when RAB-5 activity was altered.  It 
occurred both in the axon and cell body, indicating it likely represents protein accumulation rather 
than an axonal transport defect.  It occurred specifically in the presence of RAB-5 molecules with 
locked activity states, which were associated with abnormal accumulation of EFF-1 at either the 
membrane or in early endosomes.  There is good precedence for RAB-5 functioning in protein 
degradation and homeostasis.  In the C. elegans embryo, this molecule is required for both 
endocytosis and degradation of the C. elegans caveolin CAV-1 (ref. 32).  In HeLa cells, either 
increasing or decreasing RAB-5 activity (achieved indirectly using a regulator of RAB-5) was 
found to perturb endocytic trafficking and lead to cargo build-up in specific compartments33.  Our 
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results indicate that EFF-1 accumulation per se does not affect EFF-1 activity in axonal fusion, but 
we cannot exclude that it might have other consequences for the function of the neuron.  
Our analyses did not demonstrate that more EFF-1 was removed from the membrane with 
increased RAB-5 activity (Figure 3.2); if it was, it was not sufficient to prevent axonal fusion.  The 
accumulated EFF-1 seen with RAB-5(CA) is most likely due to build-up from transport defects 
associated with enlarged endosomes, as opposed to additional EFF-1 removal from the membrane.  
 
The significance of extracellular EFF-1::GFP vesicles   
Extracellular vesicles were observed incidentally in the earliest studies of EFF-1-mediated cell-cell 
fusion using electron microscopy34.  Vesicles that specifically contain fusogens have now been 
documented in vitro21,22, and more recently in vivo in C. elegans23, but their exact characteristics 
and functionality are yet to be elucidated.  
The absence of both membrane and cytoplasmic markers in the EFF-1::GFP vesicles suggests 
that the vesicles may exclude some membrane proteins, such as fluorophores, or contain insufficient 
amounts for visualization with confocal microscopy.  However, it appears unlikely that these 
vesicles contain purely EFF-1::GFP, as fusogen-containing vesicles in vitro have been shown to 
contain contaminant proteins21, as well as membrane proteins in some cases22.  We therefore 
postulate that these vesicles may be selective in their uptake of membrane proteins, and their 
content could differ from the original composition of the PLM plasma membrane.      
The mechanism through which the EFF-1::GFP vesicles are generated is currently a matter of 
speculation.  It remains to be determined whether they are passively extruded, or are instead 
actively secreted.  Given that they occur in the presence of increased intracellular and membranous 
EFF-1, it is plausible that they are created through excessive build-up of EFF-1 at the membrane.  
With its known function in membrane sculpting35, EFF-1 could potentially ‘pinch off’ a section of 
membrane.  Consistent with this, the vesicles localize in the vicinity of the PLM cell body; it may 
be that the higher volume-to-surface-area ratio in this part of the neuron allows for sufficient build-
up of EFF-1::GFP behind the membrane.  Accordingly, most protrusions, and the observed event of 
vesicle budding, originated from the cell body.  If there is instead molecular machinery for active 
secretion of these vesicles, one strong candidate is the ABC transporter CED-7, which is known to 
generate extracellular vesicles containing phosphatidylserine during apoptotic cell clearance36.  We 
have shown that the CED-7 functions in regeneration of the PLM neuron9 (see Chapter 2) as well as 
its degeneration37 (see Chapter 4), possibly through vesicle generation.  It is therefore possible that 
CED-7 is recruited in the neuron for the secretion of EFF-1 vesicles.  
Whether the EFF-1::GFP vesicles have fusogenic activity is unclear.  There is evidence that 
fusogen-containing vesicles can function in vitro, as well as in vivo.  In vitro, infection of cells with 
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fusogen-expressing pseudotyped viruses was associated with the presence of vesicles containing the 
fusogen22,38.  In the PVD neuron, extracellular vesicles of the fusogen AFF-1 were associated with 
regenerative fusion in PVD dendrites.  Interestingly, the regenerative state was associated with an 
increase in the number and mobility of the vesicles23.  However, in our study, there was no clear 
change in vesicle number or localization following axotomy.  In particular, there was no obvious 
migration of the vesicles towards the injury site or distal axonal fragment (data not shown), as 
might be expected if they were mediating the increased capacity for axonal fusion seen with RAB-
5(DN).  To be present at the site of fusion, significant distances would have to be traversed, much 
greater than the 10 µm suggested for delivery of the AFF-1 vesicles23.  It thus remains to be seen 
whether the EFF-1::GFP vesicles are able to participate in axonal fusion.  Potential approaches to 
addressing this include assessing the effect of ablating the vesicles, or attempting to generate them 
closer to the injury site by expressing RAB-5(DN) non-cell autonomously in the hypodermis. 
Finally, given that extracellular vesicles are known to deliver cargo in diverse systems39, 
fusogen-containing vesicles represent an attractive vehicle for imparting fusion competence to 
surrounding tissues, and potentially to mammalian neurons, as previously postulated23.  The 
evidence that these vesicles may be selective, and largely contain fusogen, suggests that they could 
be very efficient in delivering fusogenicity. 
 
EFF-1 in intracellular compartments  
Our co-localization experiments confirm that EFF-1 accumulates in RAB-5-positive compartments 
with RAB-5 overactivity.  Previous studies1 have documented co-localization of endogenous EFF-1 
with RAB-5 in hypodermal cells of 45 - 69%.  As our model visualizes overexpression of RAB-5, 
our results are not directly comparable and we are unable to conclude to what extent EFF-1 co-
localizes with wild-type RAB-5 levels in the neuron.  However, our findings are consistent with a 
role for RAB-5 in determining steady state EFF-1 localization to early endosomes.   
 
The role of associated endocytic regulators   
RAB proteins have well-established roles in intracellular trafficking, and we tested a suite of 
molecules other than RAB-5 that potentially regulate such transport of EFF-1 in PLM.  As reported 
for the hypodermis1, RAB-7, RAB-10 and RAB-11 did not influence EFF-1 localization.  
We also did not find a role for DYN-1, whereas this molecule has been demonstrated in the 
hypodermis to negatively regulate EFF-1 and cell-cell fusion1.  However, the literature on dynamin 
suggests it can have varying roles in fusion events in different systems, related to its multiple 
functions in endocytosis as well as actin cytoskeletal rearrangements.  In some mammalian cell-cell 
fusion, including in osteoclasts and myoblasts, dynamin activity appears to instead promote 
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fusion40.  Our result is in keeping with an alternative role for DYN-1 in the neuron, potentially in 
endocytic regulation of molecules other than EFF-1.  
 
Model of RAB-5 regulation of EFF-1 in neurons  
Our results are consistent with a model in which RAB-5 mediates endocytosis of EFF-1 from the 
PLM cell membrane, similar to that described in the hypodermis1.  In our model (Figure 3.6), 
EFF-1 is transiently inserted into the plasma membrane following synthesis.  Active RAB-5 is 
responsible for subsequent transport of this EFF-1 into early endosomes, where EFF-1 largely 
resides in the steady state.  Decreasing RAB-5 activity allows EFF-1 accumulation at the 
membrane, whereas overactivity of RAB-5 leads to accumulation in early endosomes.  
We also propose that, in neurons, RAB-5-mediated endocytosis occurs upstream of pathways 
for EFF-1 recycling/degradation.  Because altering RAB-5 activity sequesters EFF-1 in specific 
compartments, it prevents downstream trafficking and creates a build-up of EFF-1 in the neuron.  
 
Figure 3.6.  Model of RAB-5 regulation of 
EFF-1 in PLM.  In the wild-type scenario, 
EFF-1 (green) is transiently inserted into the 
membrane following synthesis.  Active RAB-5 
(purple) functions in removal of this EFF-1 into 
early endosomes.  This is in turn required for 
EFF-1 trafficking into downstream 
compartments for recycling/degradation.  When 
RAB-5 function is perturbed, EFF-1 is no longer 
removed from the membrane, and subsequent 
accumulation at the membrane results in 
membranous protrusions and budding of 
extracellular vesicles.  There is an additional 
failure of trafficking into recycling/degradation 
pathways.  With increased RAB-5 activity, 
EFF-1 instead accumulates in enlarged early 
endosomes.  This endosomal enlargement also 
leads to a defect in downstream trafficking of 
EFF-1 for recycling/degradation.   
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Methods 
 
Strains and genetics  
Standard techniques were used for C. elegans strain maintenance and genetic manipulations41.  All 
experiments were performed at 22 °C (room temperature) on L4 animals unless otherwise specified.  
The following mutations were used: rab-10(dx2) I, eff-1(ok1021) II, ehs-1(ok146) II, psr-1(ok714) 
IV, dyn-1(ky51) X.   The integrated transgenic strain QH3135 [zdIs5(Pmec-4::GFP) I] was used as a 
background strain for performing axotomies.  The transgenic strain QH4748 [eff-1(ok1021) II; 
vdEx662[Pmec-4::eff-1::gfp; Pmec-4::mCherry; Podr-1::DsRed]]9 was used as a background strain 
for all experiments involving EFF-1 confocal imaging.  To generate extrachromosomal arrays, 
microinjections were performed into the germline using standard methods.  The following 
transgenes were generated (concentrations used for the microinjection mix are indicated in brackets; 
all injection mixes had a total concentration made up to 100 ng/µl using empty pSM plasmid): 
vdEx1192/vdEx1193/vdEx1197[Pmec-3::rab-5(S33N) (5 ng/µl); Podr-1::gfp (60 ng/µl)], 
vdEx1450/vdEx1451/vdEx1452[Pmec-3::rab-5(Q78L) (5 ng/µl); Podr-1::gfp (60 ng/µl)], vdEx1194 
[Pmec-3::rab-5(WT) (5 ng/µl); Podr-1::gfp (60 ng/µl)], vdEx1237[Pmec-3::rab-5(WT) (10 ng/µl); 
Podr-1::gfp (60 ng/µl)], vdEx1051/vdEx1055/vdEx1084[Pmec-3s::rab-5(s) (5 ng/µl); Pmec-3::rab-
5(as) (5 ng/µl); Podr-1::gfp (60 ng/µl)], vdEx1301/vdEx1302/vdEx1303[Pmec-3::rab-7(T23N) (5 
ng/µl); Podr-1::gfp (60 ng/µl)], vdEx1375/vdEx1390/vdEx1443[Pmec-3::rab-11(S25N) (5 ng/µl); 
Podr-1::gfp (60 ng/µl)], vdEx1389[Pmec-3::bfp::tev-s::rab-5 (5 ng/µl); Pmyo-2::mCherry (2.5 
ng/µl)], vdEx1566[Pmec-4::myr::mCherry (5 ng/µl); Pmyo-2::mCherry (2.5 ng/µl)], vdEx1576 
[Pmec-4::myr::mCherry (15 ng/µl); Pmyo-2::mCherry (2.5 ng/µl)].  It is noted that a TEV-S signal 
exists between the BFP and RAB-5 sequences in vdEx1566; this signal allows for protein cleavage 
with addition of TEV protease and is unlikely to influence this study.   
 
Molecular Biology 
Standard molecular biology techniques were used42.  To generate the plasmid Pmec-3::rab-5(WT), 
the gene rab-5 was amplified from the pCL206 plasmid using 
5’-gcTCTAGAatggccgcccgaaacgcagg-3’ and 5’-gggaCCCGGGttatttacagcatgaaccc-3’.  These 
primers introduced Xba I and Xma I restriction sites respectively, which were used to clone the 
amplicon into the plasmid L1026 (Pmec-3, from Fire Vector Kit 1995).  The QuikChange II Site-
Directed Mutagenesis Kit (Agilent Technologies) was then used to generate rab-5(Q78L) and 
rab-5(S33N) variants of this plasmid, using primers 5’-aaatctgggatactgcaggaaaagaaagatatcattattgg-
3’, 5’- ccaatgaatgatatctttcttttcctgcagtatcccgattt-3’ and 5’-ctatcatttcaggcaaaaactctctcgtattgcgattc-3’, 
5’-gaatcgcaatacgagagagtttttgcctgaaatgatag-3’ respectively.    
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To generate Pmec-3s::rab-5(sas), a sense-antisense PCR fusion technique was used25.  rab-5 
was amplified from genomic C. elegans DNA using standard primers (5’-cgtgccttcaatctttttcg-3’ and 
5’-acaatgacgacgatcacaggc-3’).  Pmec-3s was amplified from the L3784 plasmid (Pmec-3::gfp, from 
Fire Vector Kit 1997) with a standard forward primer (5’-aggtacccggagtagttggc-3') and two different 
reverse primers with sequences complementary to the extremities of rab-5 at the 5’ ends (5’-
atgttgcatttttctttccagaatctataacttgatagcgata-3’ and 5’-cttcccaactaccatgtacaaaatctataacttgatagcgata-3’).  
The rab-5 and Pmec-3s reactions products were then fused using nested primers 5’-
ggcagtaatgaagacgtccat-3’ and 5’-gaagggttgatggtacatgaaa-3’ or 5’-ttctggaaagaaaaatgcaacat’-3’.  
Pmec-3::rab-7(T23N) and Pmec-3::rab-11(S25N) were generated using the QuikChange II 
Site-Directed Mutagenesis Kit on Pmec-3::rab-7 and Pmec-3::rab-11 plasmids respectively, with 
primers 5’-cgggcgttggaaagaattctttgatgaatcaatatg-3’, 5’-catattgattcatcaaagaattctttccaacgcccg-3’ and 
5’-gagactcaggcgtcggaaagaataatctcctgtctcgtttcac-3’, 5’-gtgaaacgagacaggagattattctttccgacgcctgagtctc-
3’ respectively.  The construction of Pmec-3::rab-7 and Pmec-3::rab-11 involved amplification of 
each gene from C. elegans genomic DNA with primers to introduce Xba I and Xma I restriction 
sites, followed by cloning into the L1026 plasmid downstream of Pmec-3.  
To generate Pmec-3::bfp::tev-s::rab-5, the bfp::tev-s::rab-5 insert was amplified from 
pOG172, a kind gift from Prof. Guangshuo Ou (Tsinghua University, Beijing).  Primers were used 
that introduced BamH I and Msc I restriction sites for cloning into L1026 downstream of Pmec-3.  
To generate the Pmec-4::myr::mCherry plasmid, myr::mCherry from the PNV::myr::mCherry 
plasmid was cloned into Pmec-4::GFP using Msc I and EcoR I restriction enzymes which remove 
the GFP sequence. 
 
Laser axotomy  
We performed UV laser axotomy of PLM in animals at the L4 larval stage as previously 
described8,9.  Animals were anaesthetized using 0.05% tetramizole hydrochloride on 4% agarose 
pads.  The axotomy was performed at approximately 50 µm from the cell body using a MicroPoint 
Laser System Basic Unit attached to a Zeiss Axio Imager A1.  At 48 hr post-axotomy, animals were 
analyzed on a Zeiss Axio Imager Z1 equipped with a Photometrics Cool Snap HQ2 camera with 
MetaMorph software for the presence of reconnection and fusion.  If it was unclear whether a distal 
fragment had been maintained, the animal was scored again at 72 hr post-axotomy. 
 
Confocal microscopy  
Localization studies of EFF-1 and RAB-5 were performed on a LSM 710 META confocal 
microscope, equipped with a GaAsP detector and Zen 2012 software.  L4 animals were mounted on 
3% agarose pads in 25 mM sodium azide.  Z-stacks were performed separately of the PLM cell 
	 85	
body and proximal axon.  For imaging of EFF-1::GFP and cytoplasmic mCherry, green 
fluorescence was visualized with a 488 nm laser (5% power for the axon, 2% power for the cell 
body; gain of 600 and 4x averaging for both) and red fluorescence was visualized with a 543 nm 
laser (1% power for the axon, 0.2% power for the cell body; gain of 500 and 4x averaging for both).  
For imaging of BFP::TEV-S::RAB-5, blue fluorescence was visualized with a 405 nm laser (0.5% 
power, gain of 500, 4x averaging).  For imaging of MYR::mCherry, red fluorescence was again 
visualized with a 543 nm laser (up to 10% power, gain of 500, 4x averaging).  
For imaging of EFF-1::GFP post-axotomy, animals were mounted for axotomies in tetramizole 
as described above.  They were then recovered in drops of M9 buffer onto seeded NGM plates for 
either 3 hr or 6 hr, after which they were mounted in sodium azide for confocal imaging.  
 
Vesicle time lapse  
For characterization of EFF-1::GFP vesicle dynamics, z-stacks of the PLM cell body were acquired 
at 30 s or 2 min intervals for a total of 6 - 60 min depending on the dynamics observed.  Vesicles 
were classified as immobile or mobile based on the presence of any movement in this timeframe.  
Mobile vesicles (22 out of 105) were measured for movement in the XY axis per frame by drawing 
a linear ROI from the center of the vesicle to the center at its subsequent location; the total distance 
was averaged over the time imaged to be expressed in µm/min.  
 
dyn-1 heat-shock  
For testing the temperature-sensitive allele dyn-1(ky51), heat-shocks were performed for either 30 
min or 2 hr.  L4 animals were placed on NGM plates in a 25 °C incubator.  Mutant and control 
animals were heat-shocked concurrently on separate plates, and mounted on the same slide for 
subsequent confocal imaging.  dyn-1(ky51) animals raised at 25 °C were found not to lay viable 
progeny, whereas eggs laid at 15 °C and then transferred to 25 °C developed to the L4 stage.  
However, these animals raised at 25 °C demonstrated non-specific increases in EFF-1::GFP 
intensity in both mutant and control groups (data not shown).  Heat-shocks greater than 2 hr were 
therefore considered inappropriate for this assay.  
 
Confocal image analysis  
Image analysis was performed using Fiji for Mac OS X.  To score for the presence of EFF-1::GFP 
on the membrane of the cell body, fluorescence profiles of line scans were obtained using the ‘Plot 
Profile’ tool in ImageJ.  EFF-1::GFP was scored as localizing to the membrane if the peak of green 
intensity (EFF-1::GFP) and the peak of red intensity (cytoplasmic mCherry) were not overlapping. 
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For EFF-1::GFP intensity calculations, average projections of z-stacks were analysed.  For the 
axon, a line scan was performed along the axon for the initial ~50 µm anterior to the cell body, and 
the mean intensity in the green and red channels was measured.  Background fluorescence was 
calculated using the same line scan moved to three different positions around the axon in the image; 
the mean background fluorescence from these three readings was subtracted from the average 
intensity value of the axon.   The ratio of the GFP intensity to the mCherry intensity was then 
calculated to control for differences in transgene expression between animals.  For intensity 
calculations of the cell body, a region of interest was drawn following the boundary of the cell 
body, and calculations were performed as for the axon. 
For measurements of EFF-1::GFP border localization, average projections of z-stacks were 
analysed.  A region of interest was drawn along the border of the PLM cell body.  The average GFP 
intensity was first measured along this line (border intensity); the average GFP intensity was then 
measured within the area of the region (cell body intensity).  The final measurement was expressed 
as a ratio of the average border intensity to cell body intensity.  Background subtraction was 
performed as described for intensity measurements.  
For quantifying EFF-1::GFP puncta size and number, maximum projection confocal images of 
z-stacks were analysed.  Puncta were identified automatically using the ImageJ plugin Squassh24.  
The following settings were used: background removal, rolling ball window size 10, regularization 
0.1, minimum object intensity 0.3, subpixel segmentation, automatic local intensity estimation, 
Poisson noise model, Gaussian psf approximation as for confocal microscopy.  The circularity of 
the resulting objects was calculated using the ‘Analyse Particles’ function on Fiji.  The following 
exclusion criteria were applied to all objects: circularity <0.7, object located in proximal axon or 
outside the neuron.  If none of the puncta selected in a cell body met these criteria, the cell body 
was discarded from analysis. 
For co-localization studies of EFF-1 and RAB-5, only enlarged puncta were analysed; these 
were defined as puncta >125 units, as puncta of this size were specific to RAB-5 overactivity and 
never observed in non-transgenic controls.  Squassh analysis was applied to both green and blue 
channels, providing co-localization values for the selected objects.  Identical settings (described 
above) were used for the two channels.  
 
Statistical testing   
Statistical analysis was performed using GraphPad Prism and Microsoft Excel.  Error of proportions 
was used to assess variation across a single population.  Two-way comparison was performed using 
either the t-test or t-test with Welch correction (the latter was performed if the standard deviations 
of two compared groups were significantly different).  
	 87	
Acknowledgments 
We thank Luke Hammond and Rumelo Amor for help with microscopy, as well as Rowan 
Tweedale and members of the Hilliard lab for helpful discussion and comments.  We also thank 
Guangshuo Ou for the pOG172 plasmid, Nick Valmas for the PNV myr::mCherry plasmid, and Elia 
Di Schiavi for advice regarding cell-specific RNAi.  This research was supported by the University 
of Queensland Research Scholarship to C.L and HFSPO Fellowship LT000762/2012 to R.G.S.  
Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure 
Programs (P40 OD010440).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 88	
SUPPLEMENTARY DATA 
  
Supplementary Figure 3.1.  EFF-1 localization pre- and post-axotomy with perturbed RAB-5 
activity.  Representative confocal images of the PLM cell body and axon in eff-1(ok1021) animals 
expressing EFF-1::GFP, mCherry and RAB-5(DN).  Three different animals are shown.  Pre-
axotomy, EFF-1 in the axon forms a continuous localization pattern, and can be visualized in areas 
on the membrane (box i, arrowhead marks a membranous protrusion).  Vesicles are visualized 
around the cell body (box ii, arrowheads mark individual vesicles).  At 3hr post-axotomy, the 
regenerating axon has formed a growth cone lined with EFF-1::GFP (box iii, asterisk indicates 
axotomy site; arrowhead indicates growth cone).  EFF-1::GFP vesicles are present in the same 
number and localization as prior to injury (box iv, arrowheads mark individual vesicles, asterisk 
indicates a membranous protrusion of EFF-1 that is out of focus).  At 6hr post-axotomy, EFF-
1::GFP can be seen forming membranous protrusions (box v) on a regenerating axon that has 
undergone fusion.  Asterisk indicates the axotomy site; arrowhead indicates the site of fusion.  A 
cell behind PLM non-specifically expresses GFP (indicated by cross).   
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Supplementary Figure 3.2.  Altered RAB-5 activity increases the EFF-1::GFP intensity in PLM.  
Quantification of the relative mean EFF-1::GFP intensity in the axon (left column) and cell body 
(right column) of eff-1(ok1021) animals co-expressing EFF-1::GFP with different RAB-5 
transgenes.  ‘Line’ refers to an independent transgenic line.  Each mean GFP measurement is 
expressed relative to the mean mCherry intensity in the same region (see Methods).  This intensity 
was significantly increased with expression of RAB-5(DN) (a, b), RAB-5(CA) (c, d), or rab-5(sas) 
(g, h).  No significant difference was found with expression of RAB-5(WT) (e, f).  Each point 
represents the mean for a single axon or cell body; bars represent the mean of each group; P 
values from t-test: *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.  AU = arbitrary units. 
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Supplementary Figure 3.3.  The endocytic molecules DYN-1 and EHS-1 have no effect on EFF-1 
localization in PLM.  Analyses of EFF-1::GFP localization in the presence of the temperature 
sensitive allele dyn-1(ky51) (a,c,e) or the loss-of-function allele ehs-1(ok146)  (b,d,f).  No 
significant difference was found in EFF-1::GFP intensity (top row), the average EFF-1::GFP 
puncta size (middle row) or amount of EFF-1 at the membrane (bottom row).  For testing of 
dyn-1(ky51), animals maintained at the permissive temperature (15 °C) are compared with those 
heat-shocked at the restrictive temperature (25 °C) for 30 min or 2 hr.  Each point represents the 
mean for a single cell body; bars represent the mean; P values from t-test.  AU = arbitrary units.  
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Supplementary Figure 3.4.  Other RAB molecules have no clear effect on EFF-1 localization in 
PLM.  Analyses of EFF-1::GFP localization in independent transgenic lines co-expressing RAB-
7(DN) (a,d,g), RAB-11(DN) (c,f,i), or rab-10(dx2) (b,e,h).  For each line tested, there was no 
significant difference found in the relative mean EFF-1::GFP intensity (top row), average EFF-
1::GFP puncta size (middle row) or amount of EFF-1 at the membrane (bottom row).  Animals with 
the altered rab gene of interest (red) are compared with siblings wild-type for that rab gene (black).  
Each point represents the mean for a single cell body; bars represent the mean of each group; P 
values from t-test.  AU = arbitrary units.  
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3.3 Discussion  
 
This study fulfils a key thesis aim of identifying a neuronal regulator of EFF-1, with RAB-5 
demonstrated to regulate EFF-1-mediated axonal repair.  The following discussion highlights some 
further insights that were made in light of additional data not included in the manuscript.  
Our study indicates that RAB-5 is capable of regulating EFF-1 in the neuron.  However, it did 
not ascertain whether RAB-5 regulates EFF-1 specifically during axonal regeneration (as postulated 
in Section 3.1).  One hypothesis is that axonal injury is associated with down-regulation of RAB-5 
activity, potentially achieved through a reduction in rab-5 gene expression, or the activity of RAB-
5-specific GTPase Activating Proteins (GAPs)43.  This down-regulation would in turn allow EFF-1 
accumulation at the membrane of the regenerating growth cone.  Testing this hypothesis would 
require further experiments that assess RAB-5 expression and activity during regeneration.  
However, a number of results make this hypothesis unlikely.  Firstly, we have performed axotomies 
on animals with up-regulated RAB-5 activity (expressing RAB-5(CA)) and hypothesized that this 
should sequester EFF-1, preventing its mobilization to the membrane after injury.  However, we 
found that EFF-1 was still visualized on the membrane of the regenerating axon (data not shown).  
This suggests that the mobilization of EFF-1 to the membrane following injury is RAB-5-
independent.  Secondly, we have observed that regenerating neurons only retain EFF-1 on the 
axonal membrane, not the membrane of the cell body9.  In contrast, the presence of RAB-5(DN) 
leads to membranous EFF-1 localization throughout the neuron.  This again suggests that a RAB-5-
independent mechanism leads to EFF-1 membranous localization following injury, and that this 
mechanism may be compartment-specific.  
An alternative hypothesis is that RAB-5 instead regulates EFF-1 in a constitutive manner, 
preventing membranous accumulation in the steady state.  However, our model does not indicate 
when EFF-1 is naturally expressed in PLM, as EFF-1::GFP is under the control of an ectopic 
promoter.  Hence, it is currently unknown if RAB-5 regulates endogenous EFF-1 in the neuron, or 
if it does so constitutively.  However, these questions could potentially be addressed using an EFF-
1::GFP knock-in model that tags the endogenous eff-1 locus; such a model has recently been 
described that allowed visualization of endogenous EFF-1 in the hypodermis27.  
Another interesting consideration is that the EFF-1 we observed on the membrane did not lead 
to uncontrolled fusion of PLM with surrounding cells.  We have previously shown that PLM can 
undergo ectopic fusion events with neighbouring neurons in the context of axonal regeneration (see 
Chapters 2 and 5), and that the frequency of this is increased with EFF-1 overexpression9.  In the 
hypodermis, reduced RAB-5 activity was associated with both EFF-1 membranous localization and 
excessive developmental fusion1.  However, we did not see a similar phenomenon occur in the PLM 
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neurons in the presence of RAB-5(DN) (data not shown), even though EFF-1 appeared to localize 
to the membrane.  One plausible explanation is that there was insufficient contact between 
neighbouring neurons for ectopic fusion to occur, as neurons are not known to exist in a tightly 
apposed configuration as seen in the hypodermis.  It is also possible that EFF-1 was not being 
expressed at the correct time in both neurons, meaning that RAB-5(DN) could not facilitate EFF-1-
mediated fusion.  
Another compelling explanation for the discrepancy is that activation of EFF-1 in neurons 
might require an additional, injury-specific trigger.  Ectopic fusion of PLM does not occur under 
normal conditions, but is observed in models of axonal injury.  This includes both laser axotomy 
and the unc-70 genetic model of axonal damage, in which a mutation in the membrane cytoskeleton 
generates spontaneous axonal breaks9,44 (see Chapter 5).  The requirement of an injury stimulus 
could represent an additional level of regulation for neuronal EFF-1; it could act cooperatively with 
localization dynamics to limit the activity of EFF-1 to the context of neuronal repair.  However, we 
have also performed experiments indicating that RAB-5(DN) does not enhance ectopic fusion of 
PLM even in the presence of the unc-70 mutation (Dr. R. Giordano-Santini, personal 
communication).  Therefore, there must be another underlying reason for why ectopic fusion is not 
enhanced with perturbed RAB-5.  For now, this reason remains unclear.  In the case of ectopically-
expressed EFF-1::GFP, it may be that this tagged EFF-1 is unable to form trimers and mediate 
fusion with untagged EFF-1 present in neighbouring cells.  
Finally, additional unpublished data from our lab provides strength to the conclusion that 
DYN-1 does not regulate EFF-1 in PLM (Dr. B. Neumann, personal communication).  As discussed 
in Section 3.2, our negative result for DYN-1 suggests that it might perform alternative endocytic 
functions in the neuron.  Consistent with this, axotomy results from our lab indicate that loss of 
dyn-1 function actually reduces the rate of axonal fusion in PLM (data not shown).  This is the 
opposite result of what would be expected if DYN-1 mediated endocytosis of EFF-1.  It may 
indicate that DYN-1 mediates endocytosis of other molecules involved in fusion, or has a role in 
other associated processes such as membrane dynamics.  
 
3.4 Statement of Contribution  
 
I designed the experiments and interpreted the data with Dr. R. Giordano-Santini and Associate 
Professor M. A. Hilliard.  I performed all experiments detailed in this chapter, and wrote the 
manuscript.  
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4.1 Introduction 
 
Axonal repair requires a specific balance between processes of regeneration and degeneration.  This 
balance appears to vary depending on the mode of regeneration attempted by the axon.  In 
mammalian systems, where regenerative regrowth attempts to extend the entire length beyond the 
site of damage to reach its original target, it is clear that the presence of the severed distal axon is 
inhibitory1,2.  Thus, degeneration is actually required for axonal repair in this instance.  In contrast, 
axonal fusion presumably requires minimal degeneration, with maintenance of the distal axon 
allowing its recognition and ‘rescue’ by the regrowing axon.  
One important question for understanding this balance is whether axonal regeneration and 
degeneration are mediated by distinct molecular pathways, or instead by an overlapping suite of 
molecules.  There is some evidence that the same molecules can regulate both processes in different 
species3.  A molecular characterization of both processes is crucial if we are to understand axonal 
repair in its entirety and instigate this repair in a clinical context.  
This chapter consists of a published manuscript (Section 4.2) detailing our studies of axonal 
degeneration in the C. elegans mechanosensory neurons, demonstrating involvement of several 
apoptotic clearance molecules.  It is followed by a discussion of additional, linked experiments 
(Section 4.3) that dissected whether this degeneration process is also influenced by EFF-1.  In the 
manuscript, published in Cell Reports, we characterized axonal degeneration following axotomy in 
the PLM neurons.  Remarkably, we discovered that many of the same apoptotic clearance 
molecules that promote regeneration in this axon (see Chapter 2) also mediate its degeneration and 
clearance.  As part of this project, we generated additional data (currently unpublished) suggesting 
that EFF-1 has a role in axonal degeneration as well.  The results suggest that these different 
activities of EFF-1 are potentially regulated through the production of alternative splicing variants.  
However, it raises interesting questions and forms a base for further investigation of a potential 
degenerative role for EFF-1.  
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4.2 Published manuscript 
 
The apoptotic engulfment machinery regulates axonal degeneration in C. elegans neurons 
 
Nichols, A. L. A.†, Meelkop, E.†, Linton, C.*, Giordano-Santini, R.*, Sullivan, R. K., Donato, A., 
Nolan, C., Hall, D. H., Xue, D., Neumann, B., & Hilliard, M. A. The apoptotic engulfment 
machinery regulates axonal degeneration in C. elegans neurons. Cell Rep. 14, 1673-1683 (2015).   
†*These authors contributed equally to this work  
 
Please note that this manuscript has been reformatted for inclusion in the thesis; references are 
included in a combined reference list at the end of the chapter.  For original format of the published 
manuscript, see the online version of the paper: http://dx.doi.org/10.1016/j.celrep.2016.01.050  
  
	 100	
ABSTRACT 
Axonal degeneration is a characteristic feature of neurodegenerative disease and nerve injury.  
Here, we characterize axonal degeneration in Caenorhabditis elegans neurons following laser-
induced axotomy.  We show that this process proceeds independently of the WLDS and Nmnat 
pathway and requires the axonal clearance machinery that includes the conserved transmembrane 
receptor CED-1/Draper, the adaptor protein CED-6, the guanine nucleotide exchange factor 
complex Crk/Mbc/dCed-12 (CED-2/CED-5/CED-12), and the small GTPase Rac1 (CED-10).  We 
demonstrate that CED-1 and CED-6 function non-cell autonomously in the surrounding 
hypodermis, which we show acts as the engulfing tissue for the severed axon.  Moreover, we 
establish a function in this process for CED-7, an ATP-binding cassette (ABC) transporter, and 
NRF-5, a lipid-binding protein, both associated with release of lipid-vesicles during apoptotic cell 
clearance.  Thus, our results reveal the existence of a WLDS/Nmnat-independent axonal 
degeneration pathway, conservation of the axonal clearance machinery, and a function for CED-7 
and NRF-5 in this process. 
 
Introduction 
The axon is a neuron’s longest neurite, requiring its structure to be actively maintained by support 
from the cell body through axonal transport, as well as from associated glial cells4.  Following 
trauma or transection, the axon undergoes a stereotypical degenerative process termed Wallerian 
degeneration.  This process consists of a latent phase followed by beading, thinning, fragmentation, 
and finally clearance of axonal debris by macrophages5,6.  Wallerian degeneration has been 
described across many vertebrate species as well as in Drosophila1,7.  The discovery of the 
Wallerian degeneration slow (WldS) mutation in mice, which drastically delays the onset of 
degeneration8, suggested that degeneration is the result of an active molecular pathway that can be 
manipulated.  Expression of the murine WldS gene is able to robustly and potently delay axonal 
degeneration in every species tested, including rat, zebrafish, and Drosophila1,9-11.  WldS encodes a 
chimeric protein consisting of the first 70 N-terminal amino acids from the ubiquitin fusion 
degradation protein 2a (UFD2a), a unique 18-amino-acid linker region, and the full in-frame 
sequence of nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1)12.  Further studies have 
shown that it is the Nmnat portion that confers neuroprotection in WldS animals, and that the 
endogenous Nmnat2 protein in mice and its Drosophila homolog dNmnat are crucial axon survival 
factors13,14.  Upstream of dNmnat, the highly conserved E3 ubiquitin ligase Highwire (RPM-1 in C. 
elegans) promotes axonal degeneration while also acting through a parallel pathway involving the 
dual leucine kinase Wallenda (DLK-1 in C. elegans)15.  In addition to its function in axonal 
degeneration in Drosophila, Wallenda/DLK-1 is also implicated in Wallerian degeneration in 
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mice16,17.  Furthermore, a forward genetic screen in severed olfactory receptor neurons of 
Drosophila identified dSarm (TIR-1 in C. elegans) as an extremely potent promoter of axonal 
degeneration, an effect that is conserved in mice18.  Axonal degeneration ultimately ends with 
clearance of the axonal debris, and glial cells have been shown to play a key role in this process in 
both vertebrates and Drosophila5,19,20.  Importantly, despite axonal degeneration being distinct from 
apoptosis18,21,22, the clearance of axonal debris shares molecular elements with the clearance of 
apoptotic cells.  In particular, the apoptotic molecules Draper and dCed-6 (CED-1 and CED-6 in C. 
elegans) are required for the activation and recruitment of glial cells to degenerating Drosophila 
axons7,23.  Furthermore, the guanine nucleotide exchange factor complex Crk/Mbc/dCed-12 and the 
small GTPase Rac1 (CED-2/CED-5/CED-12 and CED-10 in C. elegans) have been shown to 
function downstream of Draper and dCed-6 to promote the clearance of axonal debris23.  However, 
many details of this clearance process, as well as possible alternative pathways and the molecules 
that regulate this event, remain unknown. 
Although several studies have examined axonal degeneration in C. elegans in the context of 
neurodegenerative disease models and neuronal dysfunction24-27, no Wallerian degeneration (i.e., 
severed axon) paradigm has been investigated.  Here, we provide a detailed characterization of 
axonal degeneration in C. elegans neurons following laser-induced axotomy and show that it 
proceeds independently from the WldS/Nmnat pathway.  We identify a conserved function for the 
axonal clearance molecules CED-1 and CED-6, and the intracellular pathway that includes CED-2, 
CED-5, CED-12, and CED-10.  Importantly, we also reveal a function in this process for the ATP-
binding cassette (ABC) transporter CED-7 and the lipid-binding protein NRF-5 and identify the 
hypodermis as an engulfing tissue for the severed PLM axon fragments. 
 
Results  
Characterization of axonal degeneration in C. elegans  
The C. elegans mechanosensory neurons have been extensively studied as a model for both 
neurodegeneration and regeneration, and are among the best-characterized neurons in the nematode 
nervous system27-32.  We selected the posterior mechanosensory neurons (PLM left and right) in 
which to characterize axonal degeneration and visualized these neurons with the zdIs5(Pmec-
4::GFP) transgene (Figure 4.1A).  We then used laser-induced axotomy to selectively transect 
single PLM axons, allowing us to investigate the subsequent degeneration of the separated distal 
fragment.  In wild-type animals, we found that the axon degenerated in a stereotypical manner, with 
similarities to Wallerian degeneration in other species, including thinning, beading, fragmentation, 
and clearance of the separated distal fragment (Figure 4.1A).  However, unlike in other species, we 
did not observe a delay between the fragmentation and clearance phases of the degenerating axon,  
! %&'!
 
Figure 4.1.  Characterization of axonal degeneration in C. elegans neurons following laser-
induced axotomy.  (A) Representative images and schematics of progressive stages of axonal 
degeneration after axotomy in PLM neurons in different L4 animals expressing the zdIs5(Pmec-
4::GFP) transgene.  Arrowheads indicate location of axotomy, asterisks indicate the end of the 
regrowing axon, and arrow points to a distal fragment.  The PVM neuron, which also expresses 
GFP, is represented in gray.  Scale bar 50 !m.  Degeneration of the distal fragment classified as 
the Axonal Integrity Score with a value of 1 (completely cleared) to 5 (intact).  The panel on the 
right is a schematic representation of these phenotypes.  (B-G) Representative EM images of the 
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degenerating PLM axon on the axotomized side (B-D) compared to the intact PLM axon on the 
non-operated side (E-G).  The axon is intact upstream of the injury site (D), whereas in regions 
distal to the injury site it becomes severely reduced in diameter (C) or completely absent (B) (see 
also Supplementary Figures 4.1E-F).  On the contrary, in the unoperated contralateral side, PLM is 
intact along its entire length (E-G).  (H-J) Axonal degeneration at multiple time points post- 
axotomy of the PLM neurons at L1 (H) or L4 (I) stages.  The area of each circle represents the 
proportion of data points that fall into that category, n value indicated on top of each bubble graph.  
Each animal was imaged at only one time point.   (J) Pie graph representing the complete 
clearance (score of 1) after 24 hr in PLM and DD neurons in L1 and L4 animals. 
 
with these two processes apparently occurring simultaneously in different regions of the axon.  To 
determine whether the axonal degeneration phenotypes observed were indeed due to changes in 
axonal morphology, and not specific to the cytoplasmic GFP signal, we first analysed animals 
expressing a membrane-bound fluorophore (Pmec-4::MYR::mCherry) together with cytoplasmic 
GFP.  The degenerative phenotypes observed using the two different fluorophores were nearly 
identical (Supplementary Figure 4.1A).  Second, we obtained electron microscopy (EM) serial 
transverse sections of two unilaterally axotomized L4 (fourth larval stage) animals.  We found that 
the thinning observed with epifluorescence corresponded to a decreased diameter of the axon 
compared to that on the contralateral uninjured side, with a highly reduced number of the 
mechanosensory neuron-specific large diameter microtubules (Figures 4.1B-G, Supplementary 
Figures 4.1E,F).  Furthermore, we found that the PLM axon on the injured side was discontinuous, 
matching the observation of axonal breaks made with epifluorescence (Figures 4.1B-D, 
Supplementary Figures 4.1E,F).  Based on these classical morphological indicators of degeneration, 
we developed a five-point scale (Axonal Integrity Score) to score the degeneration of the distal 
fragment (Figure 4.1A), with 1 indicating complete clearance, and 5 indicating no signs of 
degeneration. 
It has previously been suggested that axonal degeneration in C. elegans is developmentally 
dependent33.  To investigate this further, we compared the degeneration in L1 (first larval stage) and 
L4 animals at different time points after axotomy.  In the majority of L1 animals, we found that the 
distal fragment was completely cleared by 24 hr post-axotomy (Figures 4.1H,J).  This was in stark 
contrast to the L4 animals, in which the distal fragment was still present - although visibly 
degenerated - as late as 10 days post-axotomy (Figures 4.1I,J).  We also performed axotomies at 
different time points after hatching and scored the degeneration 24 hr later, revealing that the rate of 
axonal degeneration was maximal within the first 10 hr after hatching, approximately corresponding 
to the duration of the L1 stage (Supplementary Figure 4.1B).  
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To determine whether the progression of degeneration and developmental stage-dependent 
differences were a general feature of the nervous system, we also performed axotomies on the 
GABAergic DD motor neurons (visualized with the ynIs37(Pflp-13::GFP) transgene).  Axonal 
degeneration proceeded rapidly in L1 animals, with complete clearance observed in the majority of 
animals 24 hr post-axotomy (Figure 4.1J and Supplementary Figure 4.1C).  However, we again 
observed a far more gradual rate of degeneration in L4 animals, with complete clearance not 
observed until as late as 72 hr post-axotomy (Figure 4.1J and Supplementary Figure 4.1D).  These 
results suggest that developmental stage-dependent differences in degeneration could be a general 
characteristic of C. elegans neurons, providing a platform to investigate axonal degeneration in this 
species. 
 
WLDS and Nmnats do not delay laser-induced axonal degeneration in C. elegans  
In both vertebrates and Drosophila, Wallerian degeneration has been shown to proceed through a 
highly conserved pathway that can be characterized by the protective effect of the WldS gene.  To 
determine whether this pathway is conserved in C. elegans, we generated transgenic strains that 
expressed the murine WldS gene in the six mechanosensory neurons.  Surprisingly, and contrary to 
what has been observed in other organisms, we did not find any delay in axonal degeneration in 
WldS strains at either the L1 (Figure 4.2A and Supplementary Figure 4.2A) or L4 stage 
(Supplementary Figure 4.2B).  Moreover, we found that this lack of protection was not a function of 
neuronal class, as WLDS did not delay axonal degeneration in either the AVM mechanosensory 
neuron (Supplementary Figure 4.2C) or the DD motor neurons of L4 animals (Supplementary 
Figure 4.2D).  However, WLDS did maintain function, as it protected against neurodegeneration 
caused by a dominant mutation in the degenerin channel MEC-4(d), similar to the overexpression of 
the C. elegans Nmnat2 (ref. 24) (Supplementary Figure 4.2E).  Moreover, unlike in other 
species7,34, overexpression of the C. elegans Nmnat genes (nmat-1 or nmat-2) in the six 
mechanosensory neurons could not delay axonal degeneration in L1 or L4 animals (Figure 4.2B and 
Supplementary Figures 2B,F,H).  These results reveal that neither overexpression of WLDS nor the 
presence of endogenous Nmnat proteins is able to delay laser-induced axonal degeneration in C. 
elegans. 
In the past decade, three genes have been identified as promoters of the Wallerian degeneration 
pathway in Drosophila and/or mice: Sarm1 (ref. 18), Wallenda/Dlk1 (ref. 16,17,35), and the E3 
ubiquitin ligase Highwire15.  We found that mutations in the C. elegans homologs of these genes, 
tir-1, dlk-1, and rpm-1, had no protective effect on axonal degeneration of PLM neurons (Figure 
4.2C and Supplementary Figure 4.3A).  Taken together, these results point to a possible divergence 
in C. elegans, such that the functions of key molecules identified in other species are not conserved 
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in the context of axonal degeneration following axotomy, suggesting the existence of redundant 
pathways and/or other still unidentified molecules. 
 
Figure 4.2.  Overexpression of Wlds or 
the endogenous Nmnat isoforms (nmat-
1 and 2) has no protective effect against 
axonal degeneration after laser-
axotomy in PLM neurons.  Axonal 
degeneration of representative 
transgenic strains expressing Pmec-
4::Wlds (A) at low (5 ng/!l), medium 
(10 ng/!l), or high (20 ng/!l) 
concentrations, 16 hr post-axotomy at 
the L1 stage.  Axonal degeneration of 
the PLM neuron in representative Pmec-
4::nmat-1 and Pmec-4::nmat-2 lines (B) 
at low (5 ng/!l) and high (20 ng/!l) 
concentrations 16 hr post-axotomy at 
the L1 stage.  The high concentration of 
Pmec-4::nmat-2 induced an increase in 
degeneration.  (C) Quantification of 
PLM axonal degeneration at the L1 
stage in rpm-1(ju41), dlk-1(ju476), tir-
1(tm3036) or tir-1(ok1052) animals 
compared to wild-type (WT) animals 16 
hr post-axotomy.  The area of each 
circle represents the proportion of data 
points that fall into that category, n value indicated on top of each bubble graph.  *P<0.05 as 
determined by either a Mann-Whitney test or a Kruskal- Wallis and Dunn’s test.  
 
A role for CED-7 and NRF-5 in regulating axonal degeneration/clearance 
As expected from studies in different species, we found no effect on axonal degeneration in mutants 
of genes of the canonical apoptosis pathway, ced-3 and ced-4 (Figure 4.3B and Supplementary 
Figure 4.3A), indicating that the axonal degeneration process in C. elegans, as in vertebrates, is not 
regulated by caspase function21.  However, in several species, clearance of severed axonal 
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fragments by glial cells has been shown to use some of the same molecular components necessary 
for the engulfment of apoptotic cells.  For example, the apoptotic engulfment genes Draper and 
dCed-6 are needed for axonal clearance in Drosophila and mice7,36.  Similarly, Crk/Mbc/dCed-12 
and Rac1 have also been shown to function in this process23.  To determine whether this molecular 
machinery is also employed in C. elegans, we examined animals carrying mutations in the 
orthologous genes.  We found that animals mutant for ced-6, ced-1, ced-12, or ced-10 all displayed 
a significantly decreased axonal degeneration phenotype following axotomy of PLM at the L1 stage 
(Figure 4.3A).  As CED-12 acts in a molecular complex that includes CED-5 (mammalian 
Dock180) and CED-2 (mammalian CrkII)37, we also tested animals carrying mutations in each of 
these genes and found that each mutant displayed a defective degenerative phenotype compared to 
wild-type animals (Figure 4.3A).  In other species, all of these apoptotic molecules function in glial 
cells, which are responsible for the clearance of the damaged axon, and thus their role is non-cell-
autonomous with respect to the damaged neuron.  However, the cells that can engulf the damaged 
axonal fragments in C. elegans have not previously been identified.  At the L1 stage, PLM is tightly 
associated with the hypodermis, and later becomes embedded in this tissue38.  We therefore 
hypothesized that the hypodermis might be responsible for engulfment of the distal fragment after 
axotomy.  To test this, we generated transgenic ced-6 mutant animals in which wild-type CED-6 
was tagged with mRFP and selectively expressed in the hypodermis using the dpy-7 promoter 
(Pdpy-7::mRFP::CED-6)39.  Strikingly, we found a strong rescue of the PLM defect (Figures 
4.4A,B), indicating that the hypodermis is a key tissue in this process.  In agreement with this 
conclusion, cell-autonomous expression of CED-6 (Pmec-4::mRFP::CED-6) failed to rescue the 
defect (Figure 4.4A).  Similarly, expression of wild-type CED-1 tagged with mRFP in the 
hypodermis (Pdpy-7::mRFP::CED-1) was able to strongly rescue the defects of ced-1 mutant 
animals (Figures 4.4C,D), confirming that CED-1 and CED-6 both act within the engulfing cells.  
These results are consistent with our EM imaging data of L4 animals (Figure 4.1B and 
Supplementary Figures 4.1E,F), where we found evidence of membrane whorls in the hypodermis 
in areas where the PLM axon was absent; these morphological changes in the hypodermis are 
strongly suggestive of a role of this tissue in the engulfment and clearance of the axon.  In 
summary, we find that the molecular elements responsible for the clearance of severed axon 
fragments are conserved across species and reveal that the hypodermal cells play a role in this 
process in C. elegans.  
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Figure 4.3.  Conserved 
components of the 
apoptotic cell clearance 
machinery mediate 
clearance of axonal debris 
in the PLM neurons of C. 
elegans.  (A) Mutations in 
the apoptotic cell clearance 
genes ced-6(n1813), ced-
1(e1735), ced-12(bz187), 
ced-10(n3246), ced-
5(n1812), ced-2(e1752), 
ced-7(n2094), ced-
7(n2690), and nrf-5(sa513) 
delay axonal degeneration in L1 animals.  (B) Mutations in the other apoptotic-related genes 
ced-3(n2452), ced-4(n1162), ttr-52(sm211), psr-1(ok714), ina-1(gn144), tat-1(tm3117), and 
scrm-1(tm805) have no effect on axonal degeneration following axotomy in L1 animals.  The area 
of each circle represents the proportion of data points that fall into that category, n value indicated 
on top of each bubble graph.  *P<0.05, **P<0.005, ***P<0.0005 as determined by a Kruskal- 
Wallis and Dunn’s or a Mann-Whitney test. 
 
During apoptosis, the CED-1 receptor present on an engulfing cell recognizes apoptotic cells 
through the exposure of phosphatidylserine (PS) on their membranes40.  This process is facilitated 
by the ABC transporter CED-7, which promotes the generation of extracellular PS-containing 
vesicles41.  To determine whether CED-7 contributes to the axonal degeneration phenotype, we 
analysed the PLM axon in ced-7 mutants after axotomy.  Interestingly, these animals presented a 
striking defect at the L1 stage, resembling that observed for the other apoptotic engulfment genes 
analysed (Figure 4.3A).  Given the possible role of PS in this process, we then tested whether 
similar phenotypes were also present in animals carrying mutations in nrf-5, which encodes a lipid-
binding protein that functions with CED-7 to mediate PS transfer from apoptotic cells to 
phagocytes42.  We found a significant defect in the PLM axonal degeneration phenotype following 
axotomy in nrf-5 mutant animals (Figure 4.3A).  On the contrary, we observed no such effect in 
animals lacking TTR-52 (a secreted transthyretin-like protein that acts as a bridging molecule 
between CED-1 and PS43), PSR-1 or INA-1 (both PS membrane receptors44,45) (Figure 4.3B), 
suggesting that these molecules either are not involved or have redundant roles in this process.   
! %&$!
 
Figure 4.4.  CED-1 and CED-6 function in the hypodermis.  (A) Cell-specific expression of Pmec-
4::mRFP::CED-6 indicates that the molecule does not act cell-autonomously in PLM neuron, 
whereas expression of Pdpy-7::mRFP::CED-6 in the hypodermis is sufficient to rescue the 
diminished degeneration and clearance in ced-6(n1813) mutants.  This strain is representative for 
three independent rescue strains (data not shown).  (B) Localization of Pdpy-7::mRFP::CED-6 in 
the hypodermis in an animal at the L1 stage, 16 hr after axotomy.  (C) Cell-specific expression of 
Pdpy-7::CED-1::mRFP is sufficient to rescue the diminished degeneration and clearance in ced-
1(e1735) mutants.  This strain is representative of three independent rescue strains (data not shown).  
(D) Localization of Pdpy-7::CED-1::mRFP in the hypodermis and seam cells in an animal at the L1 
stage, 16 hr after axotomy.  The area of each circle represents the proportion of data points that fall 
into that category, n value indicated on top of each bubble graph.  *P<0.05, **P<0.005, as 
determined by a Kruskal-Wallis and Dunn’s or a Mann-Whitney test.  Scale bars 20 !m.  
Arrowheads indicate the location of axotomy, brackets indicate regrowth, and asterisks mark the 
seam cells. 
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Axonal degeneration/clearance also appeared normal in mutants of genes encoding for known PS-
regulating molecules such as TAT-1 (an ATPase required for regulating PS asymmetry46) and 
SCRM-1 (a phospholipid scramblase required for PS exposure47) (Figure 4.3B).  Furthermore, using 
a mRFP-tagged version of AnnexinV (sAnxV::mRFP) that binds PS41, we could not detect PS on the 
axonal fragment in L1, and its overexpression did not affect the axonal degeneration phenotype 
(Supplementary Figure 4.3C), as would be expected if PS exposure functioned in this process.  Our 
data therefore suggest that PS might have, at most, only a minor role in axonal 
degeneration/clearance, or that CED-7 and NRF-5 could facilitate the transport of other lipids or 
molecules. 
 
Axonal degeneration/clearance is modulated by CED-7 and mitochondria 
The role of CED-7 appears to change with developmental stage, as compared with wild-type 
animals ced-7 mutants exhibited a delayed degenerative phenotype at the L1 stage (Figure 4.3A) 
but an increased rate at the L4 stage (Supplementary Figure 4.3B).  This developmental switch may 
be explained by a time-dependent role of CED-7 in regulating the secretion of lipids or other 
molecules.  For example, in the context of apoptotic clearance, CED-7 not only promotes the 
generation of PS-containing extracellular vesicles, but is also required to remove externalized PS 
from unengulfed apoptotic cells over time41.  This dual function of CED-7, with early production of 
lipid-containing vesicles promoting clearance and later removal of lipids from the degenerating 
axon preventing clearance, could explain its different effects at the L1 and L4 stages. 
We also tested a number of other factors that potentially alter the axonal degeneration 
phenotype.  Presynaptic loci are present on the PLM axon at the L4 stage but not at the L1 stage, as 
revealed by the absence of the synaptic vesicle-associated small guanosine triphosphatase RAB-3 
on the PLM synaptic branch in L1 animals (Supplementary Figures 4.4A,B).  To investigate 
whether the presence of synapses stabilized the axon, we severed both the PLM synaptic branch and 
the main PLM axon in L4 animals; however, we found no difference in the degenerative phenotype 
between axons deprived of their synaptic branch and those with an intact branch (Supplementary 
Figure 4.4C).  The PLM axon is positioned adjacent to both the hypodermis and the muscle during 
the L1 stage, becoming separated from the muscle by the embedding hypodermis in L4 animals48.  
To test for a possible positional effect of the axon, we carried out axotomies in L4 mec-1 mutant 
animals in which the hypodermis fails to establish this separation48.  Our results showed no 
significant difference in the degenerative phenotype between wild-type and mec-1 mutant animals 
(Supplementary Figure 4.4D), indicating that the location of the PLM axon with respect to the 
surrounding tissues is not responsible for the differences in the degeneration between L1 and L4 
stage animals. 
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A recent study has shown that the presence of mitochondria in C. elegans axons protects from 
degeneration following axotomy49.  To ascertain whether mitochondria might similarly modulate 
the rate of degeneration in PLM, we performed axotomies in animals carrying a mutation in the 
ric-7 gene that disrupts mitochondrial transport, resulting in the accumulation of mitochondria in 
neuronal cell bodies and a near complete absence in neurites49 (Figure 4.5A and Supplementary 
Figure 4.5).  We found that L4 ric-7 mutant animals displayed a very rapid axonal degenerative 
phenotype, with more than a third of axons completely cleared 24 hr post-axotomy (Figure 4.5B), a 
rate of degeneration comparable to that of L1 wild-type animals.  To determine whether this effect 
was specifically due to the lack of mitochondria in the PLM axon, we rescued the normal 
localization of mitochondria by tethering them to a kinesin protein (Pmec-4::UNC-
116::GFP::TOMM-7), thereby bypassing the requirement of RIC-7 for the transport of these 
organelles49.  We found a strong rescue of the axonal degeneration defect in ric-7 animals 
expressing this construct (Figure 4.5B), supporting a specific, cell-autonomous role for 
mitochondria in regulating the rate of axonal degeneration in PLM. 
 
Discussion 
Model organisms have been instrumental in our understanding of the molecular mechanisms behind 
axonal degeneration and the active Wallerian degeneration pathway50.  We have characterized 
axonal degeneration in C. elegans, investigated the molecules involved in this process, and 
examined whether the Wallerian degeneration pathway is functionally conserved in this species.  
We show that following laser-induced axotomy, C. elegans PLM mechanosensory and DD motor 
axons degenerate with morphological similarity to Wallerian degeneration, although there is no 
delay between fragmentation and clearance of the transected axon as in other organisms.  
Surprisingly, we also demonstrate that WldS expression does not delay axonal degeneration in 
different C. elegans neurons.  We show that this lack of effect is not due to a lack of function, as the 
same transgene can protect against necrotic neurodegeneration caused by mec-4(d).  In mammalian 
systems, WLDS has been shown to increase mitochondrial flux and calcium buffering capacities51, 
whereas the mec-4(d) mutation causes calcium channels to be constitutively open, leading to 
necrosis52,53.  Therefore, WLDS could protect against mec-4(d) neurodegeneration by enhancing the 
capacity of mitochondria to buffer the influx of calcium.  Also unexpectedly, but consistent with the 
inability of WLDS to protect against axonal degeneration, we found that the orthologs of 
dNmnat/Nmnat1, dsarm/Sarm1, Wallenda/Dlk1, and Highwire/Phr, which are involved in the 
conserved Wallerian degeneration program in Drosophila and vertebrates13-15,18,54,55 had no 
significant role in axonal degeneration following laser axotomy in C. elegans mechanosensory 
neurons.
! %%%!
Figure 4.5.  Mitochondria are largely 
absent from the PLM axon in ric-7 mutant 
animals and are important for delaying 
axonal degeneration.  (A) Mitochondria 
visualized through expression of TOMM-
20::mRFP at the L1-stage in wild-type (top 
panels) and ric-7(nu447) (bottom panels) 
animals, highlighting the lack of 
mitochondria within the axons of PLM in 
ric-7 mutants.  (B) PLM axons of L4 
ric-7(nu447) animals show a significant 
increase in degeneration and clearance 
compared to wild-type L4 animals after 24 
hr, closely resembling the degree of 
degeneration and clearance in wild-type L1 
animals.  This defect can be rescued with 
cell autonomous expression of UNC-
116::GFP::TOMM-7 to restore 
mitochondrial localization in the axon.  The 
area of each circle represents the proportion 
of data points that fall into that category, n 
value indicated on top of each bubble graph.  
*P<0.05, ***P<0.0005 as determined by a 
Kruskal-Wallis and Dunn’s or a Mann- 
Whitney test.  
 
In contrast, we found a conserved function in C. elegans for CED-1, CED-6, CED-2, CED-5, 
CED-12, and CED-10, all molecules that are known to be involved in axonal clearance in different 
species.  Their effects appear to be restricted to the L1 stage during which the rate of axonal 
degeneration/clearance is extremely fast, with no effect detected at the L4 stage where the PLM 
axonal degenerative phenotype proceeds very slowly.  Notably, tissue-specific rescue experiments 
with CED-1 and CED-6, and analysis of EM serial sections, demonstrated that the hypodermis is 
responsible for the clearance of the severed PLM axon.  During apoptosis, the normally internally 
localized PS is externalized to the outer leaflet and serves as an ‘‘eat me’’ signal for engulfing 
phagocytes.  The ABC transporter, CED-7, has previously been shown to promote the generation of 
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PS-containing extracellular vesicles41.  Interestingly, our data reveal a function for CED-7 in 
promoting axonal degeneration/clearance in L1 animals, whereas it appears to switch to a 
suppressive mode in L4 animals (Supplementary Figure 4.3B).  This resembles the function of 
CED-7 in apoptotic clearance.  In apoptosis, CED-7 has two functions, the first involving early 
production of lipid-containing vesicles that promote clearance, and the second involving later 
removal of lipids from the apoptotic cell.  In axonal degeneration, CED-7 may be acting early in L1 
to promote the secretion of lipids from the PLM axon, which function as ‘‘eat me’’ signals leading 
to clearance.  Conversely, in the L4 stage, during which degeneration proceeds over a longer 
timeline, the main function of CED-7 may switch to removal of lipids, thereby preventing 
clearance.  Therefore, loss of CED-7 at the L4 stage leads to an accumulation of lipids on the axon, 
causing increased clearance.  How exactly CED-7 can switch between these two modes and how 
this is regulated are currently unknown.  A possible involvement of lipids is supported by our 
results with NRF-5, a lipid-binding protein that functions with CED-7 to mediate PS transfer from 
apoptotic cells to phagocytes, which also affects the axonal degenerative phenotype.  However, our 
results from mutants in the tat-1, scrm-1, ttr-52, psr-1, and ina-1 genes, in which the axonal 
degenerative phenotype is not altered, could indicate either that CED-7 also has a function that is 
independent of PS, or that PS is produced and recognized by other molecules in the context of 
degeneration.  Overall, our results suggest conservation of the molecular machinery involved in 
axonal clearance and raise the possibility that CED-7 and NRF-5 have an important role in this 
process in species other than nematodes. 
In C. elegans, a severed axon can present a new growth cone at the end of the proximal 
fragment within 6 hr of surgery33, and this regrowing axon can reconnect to its separated distal 
fragment to restore the original axon tract, in a process known as axonal fusion27,31,33,56.  
Remarkably, we have shown that some of the same molecules involved in axonal degeneration, 
such as CED-7, NRF-5, and CED-6, also regulate axonal fusion in L4 animals31.  This suggests 
that, in a number of C. elegans neurons, axotomy triggers a tug-of-war between the axonal repair 
event occurring by way of axonal fusion and degeneration/clearance of the distal axon fragment 
mediated by the surrounding hypodermis57.  For example, the nuclear receptor FAX-1 has been 
shown to simultaneously increase axonal regeneration and decrease degeneration in C. elegans 
AVK interneurons58.  In contrast, the presence of the distal fragment is inhibitory for regeneration 
and neuroplasticity in vertebrates1.  Delaying axonal degeneration through WldS expression has 
been shown to substantially delay the locomotory recovery of mice following partial spinal cord 
lesions from 6 to 16 days2.  This may explain why vertebrates have evolved to rapidly clear the 
inhibitory axonal fragments through an active degeneration pathway.  The evolutionary pressure 
dictating why vertebrates have reduced regeneration in the presence of distal fragments, as well as 
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in the CNS, is still a point of speculation.  However, although it is presumably advantageous for 
mammals to actively promote axonal degeneration in order to undergo regeneration, there seems to 
be no such benefit for C. elegans.  Even so, the need and mechanisms to clear axons once they have 
degenerated appear widely conserved. 
 
Methods   
Strains  
Animals were maintained at room temperature (~22 °C) on nematode growth medium (NGM) 
plates seeded with Escherichia coli OP50 according to standard methods.  The following strains 
were obtained from the Caenorhabditis Genetic Center (CGC): RB1085 [tir-1(ok1052)], CB3203 
[ced-1(e1735)], MT8347 [ced-3(n2452)], MT2547 [ced-4(n1162)], MT4433 [ced-6(n1813)], 
MT9258 [ced-7(n2690)], VC537 [psr-1(ok714)], NG144 [ina-1(gm144)], CB3257 [ced-2(e1752)], 
MT4434 [ced-5(n1812)], ZB547 [ced-12(bz187)], MT9958 [ced-10(n3246)], CB1066 [mec-
1(e1066)], JT513 [nrf-5(sa513)], CZ1251 [rpm-1(ju41)], CZ5730 [dlk-1(ju476)], KP2048 [ric-
7(nu447)], NY2037 [ynIs37(Pflp-13::GFP)], and the National Bioresource Project (NBRP): 
FX0805 [scrm-1(tm805)], FX3036 [tir-1(tm3036)], and FX3117 [tat-1(tm3117)]. 
The following transgenes were generated by microinjection: vdEx289/vdEx290/vdEx291 [Pmec-
4::WldS (5 ng/µl); Podr-1::DsRed (30 ng/µl)], vdEx295/vdEx296/vdEx297 [Pmec-4::WldS (10 
ng/µl); Podr-1::DsRed (30 ng/µl)], vdEx298/vdEx299 [Pmec-4::WldS (20 ng/µl); Podr-1::DsRed 
(30 ng/µl)], vdEx429/vdEx430/vdEx431 [Pflp-13::WldS (5 ng/µl); Podr-1::DsRed (30 ng/µl)], 
vdEx717/vdEx718/vdEx720 [Pflp-13::WldS (10 ng/µl); Podr-1::DsRed (30 ng/µl)], 
vdEx722/vdEx723/vdEx724 [Pflp-13::WldS (2 ng/µl); Podr-1::DsRed (30 ng/µl)], vdEx294 [Pmec-
4::WldS::mCherry (5 ng/µl); Podr-1::DsRed (30 ng/µl)], vdEx422 [Pmec-4::nmat-1 (5 ng/µl); 
Podr-1::DsRed (30 ng/µl)]; vdEx424 [Pmec-4::nmat-1 (20 ng/µl); Podr-1::DsRed (30 ng/µl)], 
vdEx426/vdEx427/vdEx428 [Pmec-4::nmat-2 (5 ng/µl); Podr-1::DsRed (30 ng/µl)], 
vdEx437/vdEx438/vdEx439 [Pmec-4::nmat-2 (10 ng/µl); Podr-1::DsRed (3 ng/µl)], vdEx502 
[Pmec-4::nmat-2 (20ng/µl); Podr-1::DsRed (30 ng/µl)], vdEx1058 [Pdpy-7::ced-1::mRFP 
(1ng/µl); Podr-1::DsRed (30 ng/µl)], vdEx1025/vdEx1027 [Pdpy-7::ced-1::mRFP (5 ng/µl); Podr-
1::DsRed (30 ng/µl)], vdEx895 [Pmec-4::mRFP::ced-6 (5 ng/µl); Podr-1::DsRed (30 ng/µl)], 
vdEx1059 [Pdpy-7::mRFP::ced-6 (1 ng/µl); Podr-1::DsRed (30 ng/µl)], vdEx239 [Pmec-
4::mCherry::rab-3 (0.5 ng/µl); Podr-1::DsRed (3 ng/µl)], vdIs13[Pmec-4:: 
tomm-20::mRFP (0.5 ng/µl); Punc-22::GFP (25 ng/µl)], vdEx919[Pmec-4:: 
myr::mCherry (5 ng/µl); Podr-1::DsRed (60 ng/µl)]; vdEx1124[Pmec-4::unc-116 
::GFP::tomm-7 (10 ng/µl); Podr-1::DsRed (60 ng/µl)]. smIs65[Phsp::sAnxV::mRFP] 
 was used for the Annexin experiments.   
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Molecular Biology  
Molecular biology was performed using standard techniques59.  All primers were sourced from 
GeneWorks.  WldS was amplified from the WldS plasmid (a gift from Michael Coleman, Babraham 
Institute, University of Cambridge) and cloned into pSM plasmids containing either Pmec-4 (Pmec-
4::WldS), Pmec-4::mCherry (Pmec-4::mCherry::WldS), or Pflp-13 (Pflp-13::WldS) using 
5’-TCAGTGGGATCCATGGAGGAGCTGAGCGCTG-3’ paired with either 
5’-TACGGAATTCTCACAGAGTGGAATGGTTGTGC-3’ (for cloning into the Pmec-4 plasmid 
using BamH I and EcoR I sites) or 5’-TCAGTGGGATCCGCCAGAGTGGAATGGTTGTGCT-3’ 
(for cloning into the Pmec-4::mCherry plasmid using BamHI).  Genomic sequences of nmat-1 and 
nmat-2 were each cloned into pSM plasmids containing the mec-4 promoter using the 
5’-TCAGTGGCTAGCCTATGGGGACCGAAAAAGTTG-3’ and 
5’-TCAGTGACCGGTGCTCATTCGTAGAGTCTATGAT-3’ or the 
5’-TCAGTGGCTAGCACGATGAAACGAGTCGCTCT-3’ and 
5’-GGGGGACCGGTATTAAATTTTCTGATACAGATTATTCT-3’ primers, respectively, which 
include Nhe I and Age I sites and genomic DNA from mixed-stage animals as a template (whole-
animal lysates performed as previously described60.  The dpy-7 promoter39 was amplified from 
genomic C. elegans DNA using 5’-AAAAAAGGATCCTTATCTGGAACAAAATGTAAG-3’ and 
5’-CGACGCCTGCCTTGAAACACTAC-3’ which include BamH I and Hind III sites for insertion 
into the pSM plasmid.  pSM plasmids carrying Pmec-4::ced-1::mRFP and Pmec-4::mRFP::ced-6 
were used to replace the mec-4 promoter with the dpy-7 promoter.  The Pmec-4::UNC-
116::GFP::TOMM-7 plasmid was built as follows: UNC-116:: 
GFP::TOMM-7 was amplified from the pRR125 plasmid (a gift from Erik Jorgensen, University of 
Utah) using primers 5’-CGCGGATCCCAAAAAAGCAGGCTGCATGG-3’ and 
5’-ATTGGGCCCGCCAAGCGAGGACAATTCTC-3’ and cloned into Pmec-4 pSM using BamH I 
and Apa I restriction sites.  To build Pmec-4::MYR::mCherry, the insert MYR::mCherry (from the 
plasmid pNV myr::mCherry) was cloned into pSM Pmec-4::GFP using Msc I and EcoR I 
restriction sites (replacing GFP with MYR::mCherry). 
 
Microscopy 
Fluorescence microscopy was performed using an upright Zeiss AxioImager Z1 equipped with 
epifluorescence, differential interference contrast (DIC), and a Cool SNAP HQ2 camera 
(Photometrics) or an AxioCam MRm camera (Carl Zeiss).  Images were acquired and processed 
using either Metamorph or AxioVision Release 4.8 software.  Additional processing was completed 
using ImageJ 64.  Worms were anesthetized with 0.01% - 0.05% tetramisole on 4% agar pads. 
Mitochondria were visualized using the vdIs13(Pmec-4::tomm-20::mRFP; Punc-122::GFP) 
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transgene and a LSM710 META confocal microscope, equipped with GaAsP detectors and Zen 
2012 software.  Green cytoplasmic fluorescence was visualized with a 488 nm laser (0.15% power, 
with a gain of 650 and 83 averaging), and red fluorescence was visualized with a 561 nm laser 
(1.5% power, with a gain of 600 and 83).  Animals were analysed at L1 and L4 stages as indicated. 
 
Laser Axotomy 
A MicroPoint 337 UV laser mounted onto an upright Zeiss AxioImager A1 equipped for 
fluorescence and DIC microscopy was used to perform individual axon transections.  Animals were 
operated at the L1 (6 hr after hatching) or L4 stage, while anesthetized with 0.01% - 0.05% 
tetramisole on 4% agar pads unless otherwise specified.  The surgery was performed on the axon of 
the PLM neuron approximately 50 µm anterior to the cell body in the case of L4 animals and 
approximately 10 µm anterior to the cell body in L1 animals.  In the case of the DD motor neurons, 
axotomies were performed approximately halfway across the commissure for DD3 and DD5, and 
cell bodies were ablated post-axotomy to prevent regeneration that would complicate visualization 
of the distal fragments.  Animals were recovered on NGM plates seeded with E. coli and observed 
at the single time point indicated.  For the Annexin experiments, L1 animals receiving the heat-
shock (wild-type and Phsp::sAnxV) were placed at 30 °C for 30 min, 4 hr prior to axotomy. 
 
Electron Microscopy 
72 hr post-axotomy of PLM in L4 animals, fluorescence imaging was used to determine the axonal 
degeneration phenotype of the PLM distal axonal fragment.  Fixation of single animals was 
achieved by transection of the animal in the middle of the anterior half of the body in buffered 
aldehydes, followed by incubation in osmium tetroxide, uranyl acetate, and positioning in groups in 
agar cubes prior to embedding in Epon resin61.  Serial thin sections were collected onto plastic-
coated slot grids (Pioloform) from multiple animals at once and post-stained with uranyl acetate.  
Digital Transmission EM images were collected using iTEM software on an Olympus Morada 
camera mounted on a Philips CM10 electron microscope. 
 
Data Analysis 
Degeneration data were gathered by qualitative measurements.  Degeneration of each axotomized 
PLM was classified on a scale of 1 (complete clearance of the distal fragment) to 5 (no 
degeneration) (Figure 4.1A).  Data were analysed using the Mann-Whitney test for single 
comparisons and a Kruskal-Wallis and Dunn’s post hoc test for multiple comparisons.  In the case 
of the mec-4(d) phenotypic data, proportions were compared by calculating z-ratios for the 
significances of the differences between the independent proportions. 
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Above: Supplementary Figure 4.1.  Additional characterization of axonal degeneration in C. 
elegans neurons following laser-induced axotomy, related to Figure 4.1.  (A) Axotomies of 
neurons expressing a membrane-bound fluorophore (Pmec-4::MYR::mCherry) together with 
cytoplasmic GFP show highly correlated levels of degeneration at both the L1 and L4 stages 
(scored at 16 and 72 hr, respectively).  For each axon, degeneration was first scored using 
MYR::mCherry (myrCh), followed by GFP, thereby generating two scores for each axon.  (B) 
Axotomies of the PLM neuron where performed at increasing time points after hatching, and 
degeneration was scored 24 hr post-axotomy.  Axonal degeneration at multiple time points post-
axotomy of the DD3 and DD5 motor neurons at the L1 (C) or L4 (D) stages.  Each animal was 
imaged at only one time point.  The area of each circle represents the proportion of data points that 
fall into that category; n value indicated on top of each bubble graph.  Significance was tested for 
by a Kruskal-Wallis and Dunn’s post-test or a Mann-Whitney test.  (E, F) Representative images of 
EM serial transverse sections of two unilaterally axotomized L4 animals.  For each animal, the 
fluorescence image shows the axotomized PLM neuron 72 hr post-axotomy, immediately before 
fixation for EM imaging.  Arrowheads point to the location of the axotomy, asterisks indicate the 
regrowing axon, the arrow in (E) points to a distal separated fragment, and the bracket in (E) 
indicates a break in the axon.  For each transverse section presented here, an electron micrograph 
of the operated neuron is presented in the top panel (operated right PLM axon, axon highlighted in 
red), and an electron micrograph of the healthy contralateral neuron is presented in the bottom 
panel (unoperated left PLM axon, axon highlighted in green).  Note the reduced diameter and 
number of microtubules of the degenerating axon (thinning), compared to the healthy axon on the 
contralateral side (E, F).  The axon is completely absent in sections corresponding to an axonal 
break in animal (E). 
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Above: Supplementary Figure 4.2.  Overexpression of WldS or the endogenous Nmnat genes has 
no protective effect against axonal degeneration after axotomy, related to Figure 4.2.  Axonal 
degeneration of PLM axons quantified (A) 16 hr post-axotomy in L1 animals or (B) 72 hr post-
axotomy in L4 animals.  Animals expressed Pmec- 4::WldS at low (5 ng/µl), medium (10 ng/µl), or 
high (20 ng/µl) concentrations.  (C) Axonal degeneration of the AVM neuron 72 hr post-axotomy at 
the L4 stage in animals expressing the Pmec-4::WldS transgene at low (5 ng/µl), medium (10 
ng/µl), or high (20 ng/µl) concentrations.  (D) Quantification of axonal degeneration 48 hr after 
axotomy in DD3 and DD5 motor neurons in animals carrying the Pflp- 13::WldS transgene at low 
(5 ng/µl), medium (10 ng/µl), or high (20 ng/µl) concentrations.  (E) WLDS significantly protects 
against mec-4(d) induced neurodegeneration of AVM; n ≥ 100.  (F) Quantification of axonal 
degeneration in PLM neurons 72 hr post-axotomy in L4 in animals carrying the Pmec-4::nmat-1 
transgene at low (5 ng/µl), or high (20 ng/µl) concentrations.  (G) Quantification of axonal 
degeneration in PLM neurons 24 hr after axotomy in L1 at low (5 ng/µl) and medium (10 ng/µl) 
concentrations, or (H) 72 hr post-axotomy in L4 at low (5 ng/µl) and medium (10 ng/µl) 
concentrations of the Pmec-4::nmat-2 transgene.  The area of each circle represents the proportion 
of data points that fall into that category; n value indicated on top of each bubble graph.  *P<0.05, 
**P<0.005 as determined by a Kruskal-Wallis and Dunn’s or a Mann-Whitney test, or a Z test for 
proportions (E). 
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Supplementary Figure 4.3.  Conserved genes associated with axonal degeneration in other 
species do not have a similar role in C. elegans, related to Figure 4.3.  (A) Mutations in dlk- 
1(ju476), tir-1(tm3036), tir-1(ok1052), ced-2(e1752), ttr-52(sm211), psr-1(ok714), tat-1(tm3117), 
ced-3(n2452), and ced-4(n1162) do not protect against axonal degeneration 72 hr post-axotomy at 
the L4 stage.  (B) Quantification of axonal degeneration 72 hr post-axotomy at the L4 stage in 
animals carrying mutations in ced-6(n1813), ced-1(e1735), ced-7(n2094), or ced-7(n2690).  (C) 
Quantification of axonal degeneration following exposure to an mRFP-tagged version of Annexin 
V, driven by a heat-shock promoter.  The area of each circle represents the proportion of data 
points that fall into that category; n value indicated on top of each bubble graph.  *P<0.05, 
***P<0.0005 as measured by a Kruskal-Wallis and Dunn’s test comparing groups to wild-type 
(WT) or a Tukey’s multiple comparisons test to compare between mutants. 
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Supplementary Figure 4.4.  During development, axonal degeneration of PLM occurs 
independently of the presence of the synaptic branch, related to Figure 4.5.  (A) The synaptic 
branch develops after the extension of the PLM axon and is absent in 79% (n = 19) of L1 animals 
but only 5% (n = 20) of L4 animals.  (B) The lack of PLM presynaptic loci at the L1 stage is 
supported by the absence of accumulation of the synaptic vesicle associated small guanosine 
triphosphatase RAB-3 tagged with mCherry on the PLM branch.  The arrowhead indicates the 
presynaptic locus with RAB-3 localization on the left PLM neuron; the arrow points to the locus of 
the right PLM.  (C) Severing the synaptic branch after axotomy does not change the average 
degeneration score after 24 hr in L4 animals.  (D) Degeneration of PLM in L4 wild-type (WT) and 
mec-1(e1066) mutant animals, 72 hr after axotomy.  The area of each circle represents the 
proportion of data points that fall into that category; n value indicated on top of each bubble graph.  
Significance was tested using the Mann-Whitney test. 
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Supplementary Figure 4.5.  Mitochondria are largely absent from the PLM axon in ric-7 mutant 
animals, related to Figure 4.5.  TOMM-20::mRFP was used to fluorescently label mitochondria in 
wild-type (left panels) and ric-7(nu447) (right panels) animals at the L4-stage.  Note the lack of 
mitochondria within the PLM axon of ric-7 mutants.  Arrowheads in the overlay images point to 
each mitochondrion. 
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4.3 Additional results: the potential role of EFF-1 in axonal degeneration  
 
Introduction 
Having established that several apoptotic clearance molecules participate in both regeneration and 
degeneration of the PLM axon, we wondered if the fusogen EFF-1 also functions in both processes.  
EFF-1 has already been shown to mediate diverse forms of neurite sculpting following injury.  In 
the PVD neuron, it is required for the retraction and pruning of dendritic branches to control their 
remodeling during regeneration62.  This study did not report changes in PVD neurite degeneration 
with loss of eff-1, but whether EFF-1 contributes to Wallerian degeneration in other neurons, 
including PLM, has not been investigated.  
One potential mechanism for diversity in EFF-1 function is through the production of isoforms 
that perform distinct functions.  As previously discussed (see Chapter 1), the eff-1 locus encodes a 
number of alternatively spliced isoforms, including A, B, and C (Figure 4.6).  Isoforms A and B are 
transmembrane molecules and have been shown to be capable of mediating cell-cell fusion63.  
Isoform A has been visualized on cell surfaces63,64 and we have found that it functions in axonal 
fusion (Figure 2.5).   In contrast, isoform C lacks a transmembrane domain and has been found 
intracellularly and in secreted cell media63.  Its function has not yet been established. 
 
 
Figure 4.6.  Schematic of three EFF-1 alternative splicing variants.  Image courtesy of Dr. R. 
Giordano-Santini.  
 
Results 
EFF-1 regulates axonal degeneration in a dose-dependent manner 
To determine if eff-1 plays a role in axonal degeneration in PLM, we performed axotomies on eff-1 
null mutants at the first larval stage (L1).  Notably, we found a significant reduction in the rate of 
degeneration in these eff-1 mutants compared to wild-type animals (Figure 4.7).  To determine if 
EFF-1 functions cell-autonomously in this context, we selectively expressed wild-type eff-1 
genomic DNA in the mechanosensory neurons (Pmec-4::EFF-1::GFP) of eff-1 mutant animals.  
! %'*!
We found that the rate of axonal degeneration was completely rescued in PLM, indicating a cell-
autonomous function of EFF-1 (Figure 4.7).   
 
 
Figure 4.7. EFF-1 isoform C acts in a cell-autonomous manner in axonal degeneration.  
Diminished axonal degeneration in eff-1(ok1021) mutants can be rescued by cell-specific 
expression of Pmec-4::EFF-1(gDNA)::GFP and Pmec-4::EFF-1C in PLM, but not by expression of 
isoforms A or B, indicating a cell-autonomous role for EFF-1 isoform C.  The area of each circle 
represents the proportion of data points that fall into that category.  n values listed above each 
group.  **P<0.005, ***P<0.0005 as determined by a Mann-Whitney test.   
 
EFF-1 regulates axonal degeneration via a specific isoform 
We next dissected the role in axonal degeneration of the three EFF-1 isoforms A, B and C.  To 
determine which isoforms function in axonal degeneration, we tested the capacity of the individual 
isoforms to rescue the axonal degeneration defect of eff-1 mutants.  Intriguingly, we found that 
isoform C, but not isoforms A or B, was able to rescue the axonal degeneration phenotype of PLM, 
indicating a role for this specific isoform in the axonal degeneration process (Figure 4.7).  To 
investigate if isoform C functions in a dose-dependent manner, we over-expressed it in a wild-type 
background and found that this caused an increase in the rate of degeneration in fourth larval stage 
(L4) animals (Figure 4.8).  This dose-dependent effect was phenocopied by overexpression of the 
genomic eff-1 DNA (Figure 4.8).  Taken together, these results suggest a novel role for EFF-1, and 
specifically a role for isoform C, in regulating axonal degeneration in a cell-autonomous and dose-
dependent manner.  
Finally, we also performed preliminary studies of EFF-1 localization during axonal 
degeneration.  We first characterized EFF-1A localization in L1 animals, as this strain was available 
from our studies of regeneration (see Chapter 2).  We observed that, while GFP-tagged isoform A 
was present in the distal axonal fragment following axotomy, there were no clear changes in its 
localization during degeneration (Figure 4.9).  The next step will be to characterize the localization 
of EFF-1C during axonal degeneration, as this isoform appears to function in this process.    
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Figure 4.8.  EFF-1 acts in a dose-dependent manner during 
axonal degeneration.  The EFF-1 effect is dose-dependent, as 
overexpression of EFF-1(gDNA) and EFF-1C in PLM is able 
to increase degeneration in L4 animals.  The area of each 
circle represents the proportion of data points that fall into 
that category.  n value listed above each group.  **P<0.005, 
***P<0.0005 as determined by a Mann-Whitney test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9.  EFF-1A localization in the degenerating PLM axon.  Localization of EFF-1A::GFP 
and cytoplasmic mCherry in an uncut L1 axon (top panel) and a cut L1 axon (lower panel).  White
boxes indicate regions magnified in the bottom right corner of each panel.  Scale bars 20 µm. 
 
Unfortunately, the validity of these results was brought into question due to a possible effect of the 
genetic background of the strains.  We found that eff-1(ok1021) animals were not always defective 
for degeneration following genetic outcross.  More specifically, we found that outcrossing this 
mutation twice with the mechanosensory marker strain was sufficient to remove the degeneration 
defect.  In addition, rescue of the degeneration defect with EFF-1C was achieved only when EFF-
1C was introduced through a genetic cross, as opposed to direct injection of the EFF-1C DNA.  
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This suggests that the defect may be related to a separate mutation in the background of the strain.  
In addition to this, overexpression of isoform A also appeared to increase the rate of degeneration in 
L4 animals (data not shown), suggesting either that it is also capable of mediating degeneration, or 
that the effect we observed is non-specific.  
 
Methods 
Strains  
Animals were maintained at room temperature (~22 °C) according to standard methods.  The strain 
VC777 [eff-1(ok1021)/mIn1[mIs14 dpy-10(e128)]] was obtained from the Caenorhabditis Genetic 
Center (CGC).  Transgenes used were: vdEx851[Pmec-4::eff-1 (5 ng/µl); Podr-1::dsRED (60 
ng/µl)], vdEx662[Pmec-4::EFF-1::GFP (5 ng/µl); Podr-1::dsRED (60 ng/µl)], vdEx957[Pmec-
4::eff-1A (1 ng/µl); Podr-1::dsRED (60 ng/µl)], vdEx961[Pmec-4::eff-1B (2.5 ng/µl); Podr-
1::dsRED (60 ng/µl)], vdEx1144[Pmec-4::eff-1C (2.5 ng/µl); Punc-122::RFP (15 ng/µl)], 
vdEx1141[Pmec-4::eff-1C (0.5 ng/µl); Punc-122::RFP (15 ng/µl)].  
 
Molecular Biology  
Standard molecular biology techniques were used.  All primers were sourced from GeneWorks Pty 
Ltd (Hindmarsh, Adelaide).  Construction of the Pmec-4::eff-1 and Pmec-4::eff-1::gfp plasmids 
was as outlined previously31.  To build Pmec-4::eff-1A plasmid, a fragment containing the eff-1A 
isoform cDNA was amplified by PCR from plasmid pCP179 (a gift from Shai Shaham, The 
Rockefeller University, New York), using primers 5’-GATCCCCGGGATGGAACCGC-3’ and 5’- 
CTAGCTAGCTCAAATGTACTGGCTACTGC-3’.  These primers introduced Xma I and Nhe I 
cutting sites, and were used to clone the amplicon into a pSM plasmid containing Pmec-4.  A 
fragment containing the last ~170 bp of eff-1 isoform B cDNA sequence was then amplified from 
yk1017c10 clone (a gift from Yuji Kohara, National Institute of Genetics, Mishima, Japan), using 
primers 5’-CTGCAGAACCAGCTCATTGGATCAAAGG-3’ and 5’-
ACGCGTCGACTACTTCTTGCACCATCTTCG-3’, which introduced Bst XI and Sal I restriction 
sites.  These sites were used to clone this fragment into Pmec-4::eff-1A plasmid, replacing the last 
~350 bp of isoform A sequence, to create Pmec-4::eff-1B.  To build Pmec-4::eff-1C, a fragment 
containing the full length of eff-1C cDNA was amplified from yk857d09 clone (also a gift from Yuji 
Kohara, National Institute of Genetics, Mishima, Japan), using primers 
5’-CGCGGATCCATGGAACCGCCGTTTGAGTG-3’ and 
5’- ACGCGTCGACCTAGATACAACTGGCATGAAC-3’.  These primers introduced BamH I and 
Sal I restriction sites, which were used to clone the cDNA into a pSM plasmid containing Pmec-4. 
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Microscopy, laser axotomy and data analysis   
EFF-1 was visualized using the vdEx662[Pmec-4::EFF-1::GFP; Pmec-4::mCherry] transgene on a 
LSM 710 META confocal microscope, equipped with GaAsP detectors and Zen 2012 
software.  Microscopy settings were as described previously for this transgene (Section 2.2); laser 
axotomy and data analysis were performed as previously described (Section 4.2).  
 
4.4 Discussion  
 
It is curious that processes of fragmentation and clearance occur concurrently in C. elegans 
neurons, but as distinct steps in mammalian neurons.  This is perhaps related to the differences in 
their intrinsic mechanisms for regeneration of the axon.  In mammalian axons, extensive 
fragmentation of the distal fragment is likely incompatible with axonal fusion.  Rather, a process of 
thinning and beading, combined with eventual clearance, as seen in C. elegans, is better suited to 
allowing a regrowing axon to find and rescue the distal axon.  
In this C. elegans system, it is intriguing that the same molecules mediate both axonal 
regeneration and degeneration in one neuron.  There is significant overlap between the pathways, 
with CED-1 and CED-6, as well as CED-7 and NRF-5, participating in both axonal fusion and 
axonal degeneration.  This might reflect differences in the tissue specificity of molecules for each 
process, or differences in larval stage specificity (e.g. for CED-7).  Another very elegant possibility 
is that axonal regeneration and degeneration are mediated by two different eff-1 isoforms: EFF-1A 
mediating fusion, and EFF-1C mediating degeneration.  We have shown that EFF-1A mediates 
regenerative axonal fusion (Chapter 2), and during this process displays a dynamic localization 
pattern.  In contrast, we found that EFF-1A did not rescue axonal degeneration, and that, 
correspondingly, there were no changes in its localization in the distal axon.  This is consistent with 
the dynamic localization of EFF-1 relating to its function.   
The role of eff-1 in axonal degeneration is currently unconfirmed, but we have devised an 
approach to definitively resolve the issues with our eff-1 results.  This will involve testing 
alternative eff-1 loss-of-function alleles, as the inconsistent degeneration phenotype of the 
eff-1(ok1021) allele suggests a contributing factor in the background of the original strain.  We also 
plan to re-test the eff-1(ok1021) allele using a different marker for visualizing the mechanosensory 
neurons, as the background of the original marker strain may also be associated with the 
inconsistency.  However, some of our current results still provide support for a role of eff-1 in 
axonal degeneration.  In particular, we found that EFF-1 overexpression enhanced axonal 
degeneration in a wild-type background, which indicates that EFF-1 activity can function in 
degeneration of the axon.  
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It will also be important to determine whether EFF-1 mediates axonal degeneration in a purely 
cell-autonomous manner.  Evidence is emerging of non-cell-autonomous roles for C. elegans 
fusogens; this was first demonstrated for the AFF-1 fusogen in the context of PVD dendrite 
regeneration62, and more recently for EFF-1 in the context of PVD dendrite development65.  While 
our current results suggest that cell-autonomous expression of EFF-1C may be sufficient, or even 
necessary, to mediate axonal degeneration, we have not excluded a non-cell-autonomous function 
for this molecule.  Interestingly, given that EFF-1C is a secreted molecule, it is conceivable that 
expression from multiple different cell types may be sufficient.  Examining this in detail will be 
important for further characterizing EFF-1 function in axonal degeneration.  
If this role of eff-1 is confirmed, ours would be the first study to implicate a fusogen-encoding 
gene specifically in axonal degeneration.  Fusogens are proving to have varied roles in neurons, and 
this complexity may be even greater if different isoforms are involved.  In the PVD neuron, EFF-1 
mediates dendritic branch ‘fusion’ during development66, but also mediates branch ‘fission’ and 
performs this role more prominently in the setting of injury62.  Given that fission and fusion are 
merely alternative forms of membrane merging67, it is conceivable that one fusogen can perform 
both actions.  It is possible that, if EFF-1 mediates axonal degeneration, it does so through fission 
events in the distal fragment.  However, given that we have implicated the isoform C in axonal 
degeneration, this becomes less likely, as EFF-1C lacks a transmembrane domain.  This molecule 
could instead act as a secreted extracellular cue, and in the case of axonal degeneration, serve as an 
‘eat me’ signal for the engulfing tissue to clear the axonal fragment.  This is a particularly 
compelling possibility because we have also identified that EFF-1 is acting genetically downstream 
of CED-7 for axonal degeneration (data not shown).  CED-7 is an ATP-binding Cassette (ABC) 
transporter which functions in secretion of lipid-vesicles41 (see Section 4.2); these could potentially 
contain EFF-1C. If eff-1 is definitively found to function in axonal degeneration, it would be 
important to characterize the exact roles of the different EFF-1 isoforms, including the mechanisms 
through which they mediates axonal remodeling, and how their production is controlled.  Neurite 
repair is clearly a complex process, and processes of fission and fusion might both be involved in 
the optimal recovery of neuronal morphology and function.  
 
4.5 Statement of Personal Contribution  
 
I designed and carried out a number of experiments included in the published manuscript.  These 
included confirming our degeneration scoring using a myristoylated membrane signal, and rescuing 
axonal degeneration in ric-7 mutant animals using kinesin-tethered mitochondria.  I also devised a 
plausible hypothesis as to why CED-7 has a larval-stage-dependent role in axonal degeneration 
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(Section 4.2 Discussion).  
In addition, I personally contributed to the majority of experiments involving eff-1.  These 
included testing individual EFF-1 isoforms for rescue of axonal degeneration in eff-1 mutants, 
testing EFF-1 overexpression to examine a dose-dependent effect of EFF-1, and the studies of EFF-
1::GFP localization in the degenerating axon.  I was also involved in testing the cell autonomy of 
eff-1 in axonal degeneration, testing the function of different alleles of eff-1 (data not shown) and 
conducting experiments to test the genetic interaction between eff-1 and ced-7 (data not shown). 
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Chapter 5: EFF-1-mediated cell-cell fusion  
- an alternative mechanism of repair?  
  
(Published review) 
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5.1 Introduction 
 
Cell-cell fusion occurs commonly in nature, and refers to the process whereby cells fuse their 
membranes to create a syncytium with cytoplasmic continuity.  It is known that this merging of 
plasma membranes requires the presence of a fusogen.  In the case of C. elegans, which undergoes 
many cell-cell fusion events as part of its development, most of this fusion is EFF-1-mediated1.  
Much of the characterization of EFF-1 has hence been conducted in C. elegans models of cell-cell 
fusion, both in vitro as well as in vivo (see Chapter 1).    
Cell-cell fusion is of particular relevance to the PLM neurons, as our lab has demonstrated that 
PLM may undergo cell-cell fusion with other neurons2,3.  These fusion events were observed in the 
setting of axonal injury, either through laser axotomy2 or a genetic model of axonal damage3.  Of 
note in the context of this thesis is that the rate of these fusion events is enhanced with EFF-1 
overexpression3.  
Cell-cell fusion involving neurons, or neuronal cell-cell fusion, is an emerging area of research.  
It is a somewhat unexpected phenomenon, given that neurons are classically considered to be 
individual units connected by chemical or electrical synapses.  However, it is becoming clear that 
neurons do undergo fusion with other cells in a wide range of contexts.  
This chapter contains the manuscript of an invited review that was published in Seminars in 
Cell and Molecular Biology (Section 5.2).  In this review, we explored the existing literature on 
neuronal cell-cell fusion, occurring both in C. elegans as well as other species.  We placed 
regenerative axonal fusion in this broader context, dissecting what is currently known regarding the 
mechanisms of neuronal cell-cell fusion, and its biological consequences.  
Of particular relevance to this thesis is the overarching role of EFF-1, and the evidence for cell-
cell fusion as a potential mechanism for repair.  One of the more intriguing possibilities at this stage 
is that neuronal cell-cell fusion might represent an alternative mechanism for axonal repair 
following injury, although the functional outcomes remain to be defined.  Insight pertaining to this 
thesis is discussed in the subsequent section of the chapter (Section 5.3) as well as a statement of 
personal contribution (Section 5.4).  
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5.2 Published review  
 
Cell-cell fusion in the nervous system: alternative mechanisms of development, injury and 
repair  
 
Giordano-Santini, R., Linton, C. & Hilliard, M. A. Cell-cell fusion in the nervous system: 
alternative mechanisms of development, injury and repair. Semin. Cell Dev. Biol. 60, 146-154 
(2016).  
 
Please note that this manuscript has been reformatted for inclusion in the thesis; references are 
included in a combined reference list at the end of the chapter.  For original format of the published 
manuscript, see the online version of the paper: http://dx.doi.org/10.1016/j.semcdb.2016.06.019    
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ABSTRACT  
Over a century ago, the seminal work of Ramón y Cajal revealed that the nervous system is made of 
individual units, the neurons, which are related to each other by contiguity rather than continuity.  
This view overturned the idea that the nervous system was a reticulum of fibers, a rete diffusa 
nervosa, as proposed and defined by Camillo Golgi.  Although the neuron theory has been widely 
confirmed in every model system studied and constitutes the basis of modern neuroscience, 
evidence accumulated over the years suggests that neurons, similar to other types of cells, have the 
potential to fuse their membranes and undergo cell-cell fusion under certain conditions.  This 
concept adds a substantial layer to our view of the nervous system and how it functions.  Here, we 
bring together past and more recent discoveries on multiple aspects of neuronal fusion, discussing 
how this cellular event is generated, and what consequences it has for our understanding of nervous 
system development, disease, injury, and repair. 
 
1. Introduction 
The neuron theory proposed by Ramón y Cajal, according to which neurons exist as individual 
cells, has been the foundation of modern neuroscience and has paved the way for our current 
understanding of how the nervous system develops and functions.  Neurons are highly polarized 
cells that extend two functionally and morphologically different compartments from the soma: 
dendrites and an axon.  Dendrites are specialized to receive and process electrochemical inputs, 
whereas the axon transmits the electrochemical messages to other neurons or a target tissue via 
chemical or electrical synapses.  Although a number of other tissues normally develop through cell-
cell fusion, thereby generating multinucleate syncytia (placenta, muscle, osteoclasts, macrophages), 
this cellular mechanism was thought to be absent from the nervous system.  However, several 
reports suggest that neurons, similar to other cells, have the capacity to fuse their plasma 
membranes, and that these events occur under both physiological and pathological conditions.  This 
raises a number of intriguing questions.  Is it possible that the true extent of neuronal fusion across 
species has been overlooked due to the complexity of the nervous system?  What consequences do 
these cellular events have for the identity and function of the neurons involved, and for the circuits 
they form?  Could neuronal fusion be part of the etiology underlying certain neurological diseases?  
What is the molecular machinery that governs neuronal fusion?  This review aims to present the 
current evidence in the field, and highlight the potential impact of recent advances on our 
understanding of the nervous system. 
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2. Neuronal self-fusion 
One of the simplest examples of the capacity of neurons to fuse their membranes is observed during 
neuronal self-fusion.  This term defines the ability of a neuron to fuse sections of its own neuronal 
processes (dendrites or axon), in order to remodel them during development or repair them 
following injury (Figure 5.1 and Table 5.1). 
 
2.1. Dendrite fusion to remodel a developing dendritic arbor 
The PVDs (left and right) are a bilateral pair of mechanosensory neurons in C. elegans, each of 
which extends anteriorly and posteriorly directed dendrites, and a ventrally directed axon.  Each 
dendrite extends several multibranched units (named menorahs based on their shape) both ventrally 
and dorsally, covering almost the full body of the animal (Figure 5.1A).  
 
 
Figure 5.1.  Different forms of neuronal self-fusion.  (A) C. elegans mechanosensory PVD 
neurons and their branched, stereotypical dendritic arbors.  Dendritic fusion maintains the angle of 
neurites at branching points and avoids overlapping branches.  (B) Self-contact elimination as a 
form of shaping dendrites.  (C) Axonal self-fusion after injury.  The separated proximal and distal 
axonal fragments fuse during axonal regeneration. 
 
This highly branched and stereotypical dendritic arbor has made PVD one of the best-characterized 
neurons in terms of dendrite development and repair4-10.  Using this cell as a model system, Oren-
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Suissa and colleagues10 have described a new mechanism for dendritic arbor development involving 
membrane fusion.  They have elegantly shown that, during development, the PVD dendritic arbor is 
pruned and shaped through branch retraction and, most interestingly, through loop formation by 
neurite self-fusion.  Both these processes were shown to be mediated by the nematode-specific 
fusogen Epithelial Fusion Failure-1 (EFF-1), a bona fide fusogen previously shown to mediate cell-
cell fusion during development in other C. elegans tissues1.  The authors proposed that assembly of 
EFF-1 complexes in cis causes membrane curvature and retraction, whereas interactions between 
EFF-1 molecules in trans across closely apposed membranes causes dendrite fusion.  EFF-1 sculpts 
these neurons in a dose-dependent manner to maintain the angle of neurites at branching points and 
avoid overlapping branches.  This process could be compared to the self-contact elimination 
process described decades ago for the development of neuronal growth cones in vitro11.  A similar 
self-contact elimination by membrane self-fusion has recently been characterized in epithelial 
cells12 and in the vascular endothelial cells of zebrafish embryos13, raising the possibility that it 
might be a common mechanism to shape cellular processes (Figure 5.1B).  These findings show that 
some neurons express a functional fusogen, and that dendrites are capable of membrane fusion. 
 
2.2. Axonal fusion to repair an injured axon 
Another example of neuronal self-fusion is the process of axonal fusion observed during axonal 
regeneration.  In this case, following transection of the axon, the proximal axonal fragment that is 
still attached to the cell body regrows toward and fuses with its own separated axonal fragment 
(Figure 5.1C), re-establishing membrane and cytoplasmic continuity and therefore the original 
axonal tract.  This process has been recognized for more than 50 years, and has been described in 
the motor neurons of crayfish14, sensory neurons of the leech15,16, giant axons of the earthworm17, 
dissociated Aplysia sensory neurons in vitro18 and, more recently, in the mechanosensory neurons of 
the nematode C. elegans2,19.  In these studies, cytoplasmic continuity after rejoining of the two 
separated fragments was confirmed by electron microcopy2, 15,17,19, by injection of high molecular 
weight dyes (such as horseradish peroxidase) into the soma16, or by expressing genetically encoded 
photoconvertible fluorophores such as Kaede2, which were able to diffuse through the fusion site, 
from the soma to the distal axonal fragment.  In some models, neuronal function has also been 
shown to recover fully at the electrophysiological14,15,17,18  and behavioral levels14,17.  However, 
although the process of neuronal self-fusion during axonal regeneration has been well characterized 
at the morphological level, it was not until recent studies in C. elegans that the molecular mediators 
of this fusion process were identified3,19.  In the C. elegans mechanosensory neurons, membrane 
fusion of the rejoining axonal fragments is mediated by the nematode fusogen EFF-1 (ref. 3,19).  In 
this process, EFF-1 is the final effector of a pathway involving changes in membrane lipid 
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composition, which mediates the recognition of the separated distal fragment by the regrowing 
proximal fragment.  In particular, these studies revealed that, following axonal transection, the lipid 
phosphatidylserine (PS) becomes exposed on the outer leaflet of the plasma membrane of the distal 
axonal fragment.  Exposed PS itself, or PS bound by specific secreted ligands (such as the 
transthyretin TTR-52 or the lipid-binding protein NRF-5), is detected by transmembrane receptors 
present on the regrowing fragment (such as the PS receptor PSR-1, and the TTR-52-binding 
receptor CED-1), thereby mediating recognition between the two separated axonal fragments prior 
to specific membrane fusion3.  
It is not known whether the role of these molecules in mediating axonal self-fusion during 
regeneration is conserved among species, but it is likely that similar molecular pathways are 
involved in other organisms, given that membrane fusion is an active process that requires 
specialized molecular players.  PS exposure and recognition by cell surface receptors is a common 
mechanism for many cell-cell fusion events, and has been implicated in the fusion of myoblasts20,21, 
syncytiotrophoblast cells in the placenta22, and macrophages23,24 , as well as in the fusion that 
mediates the entry of some viruses into host cells25,26.  Finally, it is likely that species-specific 
fusogens act as the last effectors in the mediation of membrane fusion.  Taken together, these 
findings demonstrate that neurons of different classes and from different invertebrate species likely 
express functional fusogens and can fuse their membranes as a mechanism of repair.  
 
3. Neuronal cell-cell fusion and its implications  
It is also possible for neurons to undergo fusion with other neurons or with other cell types, a 
phenomenon that we will refer to as neuronal cell-cell fusion.  A select number of studies have 
shown that neuronal cell-cell fusion may occur spontaneously.  For example, the giant axons of the 
squid are generated by complete fusion of multiple neurons (third order giant fibers) and the 
syncytial axon is enclosed in a single sheath cell27.  In vertebrates, some studies using electron 
microscopy and brightfield microscopy have reported the formation of neuronal syncytia in vitro 
and in vivo28-32; unfortunately, however, these results were not quantified, making it difficult to 
determine their general relevance.  Overall, the vast majority of neuronal cell-cell fusion events in 
different species have been described in the context of specific conditions or insults, which include 
viral infection, axonal injury, or the presence of stem or precursor cells (Figure 5.2 and Table 5.1). 
 
3.1. Viral-induced neuronal cell-cell fusion  
It is well established that some viruses cause the formation of syncytia in infected tissues as a 
means of propagation and spreading.  This ability to mediate cell-cell fusion of infected cells was 
used in early experiments as a technique to study gene expression and nuclear reprogramming in 
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different cell types, including neurons.  Using inactivated Sendai virus (one of the Para-influenza I 
group of Myxoviruses)33, neurons were fused for the first time with undifferentiated green monkey 
kidney fibroblasts in vitro to form heterokarya34,35.  Recent evidence shows that viral-mediated cell-
cell fusion also occurs in vivo in the nervous system, with infected neurons forming viable syncytia 
(with either other neurons or different cell types).  Currently, the mechanisms of viral-mediated 
neuronal cell-cell fusion, and the effects of these fusion events on the function of the nervous 
system, are just beginning to be elucidated. 
 
 
Figure 5.2.  Factors leading to neuronal cell-cell fusion and its consequences. 
 
A number of neuroinvasive viruses from the Herpesviridae family have been shown to induce 
neuronal cell-cell fusion in vitro and in vivo.  Pseudorabies virus (PrV) was first shown to induce 
fusion between pre-and post-synaptic membranes of neurons in infected rat sympathetic and 
sensory ganglia, as evidenced by the observation of fusion pores at the electron microscopy level36.  
Later studies confirmed that PrV infection was able to induce fusion between infected sympathetic 
neurons in vitro, based on the diffusion of high molecular weight dyes from the soma of an injected 
neuron to neighboring neurons37.  More recently, neuronal cell-cell fusion caused by PrV infection 
has been observed in vivo in the autonomic ganglia of infected mice38.  Similarly, varicella-zoster 
virus (VZV) has been shown to induce fusion between neurons and satellite cells in human dorsal 
root ganglia (DRG) xenographs in mice.  Half of the neuron-satellite cell complexes analyzed 
showed signs of cell-cell fusion, which is consistent with the ability of VZV to induce cell-cell 
fusion in skin lesions39.  VZV can also induce fusion of DRG neurons with other non-neuronal cells 
that are in contact with the DRG axons, and potentially generates syncytia containing neurons and 
keratinocytes40.  Finally, herpes simplex virus type 1 (HSV1) is capable of fusing DRG neurons 
with non-neuronal cells40, although unlike VZV, it has not been found to mediate fusion with 
satellite cells41.  Another example of viral-mediated neuronal cell-cell fusion comes from an 
experimental setting designed to label dividing cells in the mouse brain.  Replication-incompetent 
murine retrovirus type-C, from the Retroviridae family, was found to induce fusion between 
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neurons and microglia in the mouse neocortex42.  Taken together, these lines of evidence show that 
some viral infections can generate viable neuronal syncytia or heterokarya, presenting a paradigm 
to study neuronal cell-cell fusion and, most importantly, the consequences of this fusion in terms of 
nervous system function. 
In order to understand the mechanisms of cell-cell fusion between infected neurons, McCarthy 
and colleagues investigated the temporal and spatial formation of the fusion pores between neurons 
in vitro37.  Using a combination of dyes with different molecular weights, they found that PrV 
infection first induced the formation of small pores, which allowed the diffusion of only low 
molecular weight dyes between neurons, followed by the formation of larger fusion pores later in 
the course of infection, as evidenced by the diffusion of high molecular weight dyes.  As infection 
progressed, signs of membrane fusion became apparent at the level of the soma, with 
multinucleated syncytia clearly visible. 
Interestingly, viral-induced cell-cell fusion might occur in a specific compartment of the 
neuron. McCarthy and colleagues observed that in vitro PrV-infected neurons underwent fusion at 
the level of the soma, whereas PrV infection in vivo led to neuronal fusion at the axonal level 
(unmyelinated axons).  Indeed, a PrV strain defective for the anterograde transport of virions and 
viral proteins into the axon was not able to induce the formation of neuronal syncytia38.  VZV-
induced fusion observed between DRG neurons and infecting cells occurred at either the axon or 
the soma40.  In contrast, HSV1 was able to induce the fusion of DRG neurons with cells contacting 
the axon, but not with satellite cells, which are in contact with the soma.  It has been proposed that 
the HSV1 virion, similar to PrV, may require transport into the axon to be functional, and therefore 
might only mediate fusion in this compartment40.  Lastly, during fusion of neurons and microglia in 
murine C-type retrovirus-infected mouse brains, Ackman and colleagues observed a consistent 
location of fusion between the apical dendrites of neurons and the processes of the associated 
microglia42.  This, together with the absence of other cell-cell fusion partners, pointed to a unique 
interaction between microglia and neurons that is favorable to membrane fusion.  Taken together, 
these results indicate that viruses are able to hijack a neuron and make it transition into a fusion-
competent cell, possibly in a spatially controlled manner to target particular neuronal compartments 
(Figure 5.3).  Although the molecular mechanisms of this transition are still to be identified, a likely 
prediction is that infected neurons are forced to express fusogens on their membranes.  Some 
evidence does suggest that fusion is mediated by the same viral membrane fusion machinery that 
mediates the entry of the virus into the host cell.  A mutated version of PrV lacking a functional 
viral fusion glycoprotein B (gB) (necessary for cell infection by the virus and its propagation to 
other cells), is unable to mediate the formation of neuronal syncytia following infection37,38.43. 
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An important question that arises from these discoveries is what are the physiological and 
behavioral consequences of the formation of neuronal syncytia?  Remarkably, it has been shown 
that PrV-induced syncytia in cultured neurons have altered electrophysiological activity, as fused 
neurons display synchronous electrical activity, as well as elevated rates of spontaneous action 
potential firing37.  Similar results have been found in vivo, with neurons in the ganglia of PrV-
infected mice showing a synchronous and cyclical calcium pattern38.  This spontaneous and 
synchronous cyclic activity had already been reported decades ago in neuronal tissues infected by 
PrV virus36,44,45.  Abnormal electrical activity is hypothesized to be the cause of the characteristic 
symptoms caused by alpha-herpesviruses i.e. numbness and tingling, and the sensations of itching 
and pain.  At the cellular level, the formation of neuronal syncytia was also shown to affect 
mitochondrial dynamics in vitro43.  After PrV infection, the formation of syncytia was followed by 
an increase in the intracellular calcium level, which in turn disrupted the association of the 
mitochondrion membrane anchored-Miro1 with Kinesin-1 through its calcium binding sites; this 
resulted in disruption of recruitment of mitochondria to Kinesin-1 and, as a consequence, altered 
mitochondrial transport.  It is important to note that such impairment of mitochondrial dynamics 
could lead to neuronal degeneration. 
Overall, viral-induced neuronal syncytia are viable, but their formation alters the normal 
electrophysiological properties of the neurons, which in turn results in an altered !behavioral" 
output.  Moreover, cell-cell fusion also alters cellular processes required for maintaining neuronal 
homeostasis.  
 
 
Figure 5.3.  Different neuronal compartments can engage in cell-cell fusion. 
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3.2. Ectopic neuronal cell-cell fusion during axonal regeneration 
Fusion between individual neurons has also been reported to occur during axonal repair after injury, 
first in the leech several decades ago16 and more recently in C. elegans2,3.  Although the fusion 
between the regrowing proximal fragment and its own distal fragment is generally specific, it has 
been reported that when two or more fasciculating axons are simultaneously transected, the 
regrowing proximal axonal fragment of one neuron can fuse with the proximal or distal axonal 
fragment of the nearby injured neuron2,16.  In C. elegans, this event has been well characterized in 
two pairs of tightly associated neurons: PLM-PLN and ALM-ALN2.  The axons of PLM and PLN 
extend from their respective cell bodies on the posterolateral side of the animal, and run in close 
association under the epidermis toward the midbody.  Similarly, the axons of ALM and ALN run in 
close association on the anterolateral side under the epidermis, toward the head of the animal.  
When both axons in each pair were transected, the transfer of fluorophore from one cell to the other 
revealed fusion between PLM and PLN in ~10% of cases, and between ALM and ALN in 13% of 
cases2.  Remarkably, PLM-PLN neuronal fusion has also been observed in a different model of 
axonal injury, induced by the lack of the cytoskeletal component UNC-70/β-Spectrin that causes 
axonal fragility3, 46.  Importantly, it has been demonstrated that PLM-PLN fusion depends on the 
same molecular machinery that mediates self-fusion between the PLM proximal and distal axonal 
fragments, requiring the fusogen EFF-1 (ref. 3).  It remains unclear whether this type of cell-cell 
fusion occurs by accident, or if it plays a physiological role.  It is also unknown whether it has 
consequences in terms of the identity and function of the neurons involved.  However, the very low 
frequency at which such fusion is observed makes it tempting to speculate that a specific molecular 
mechanism favors specific self-fusion repair and prevents cell-cell fusion. 
 
3.3. Cell-cell fusion with glia and between glial cells 
As briefly mentioned above, cell-cell fusion events involving neurons may occur with a glial 
partner.  VZV infection causes fusion between neurons and the support cells of the DRG39, and 
replication-incompetent C-type retrovirus injected in the mouse neocortex causes very specific 
fusion between neurons and microglia42.  Fusion has also been shown to occur between microglia 
and neuronal stem cells47.  However, one of the clearest examples of developmentally regulated 
glial fusion occurs in the major sensory organs of C. elegans, the amphids, which are located on the 
left and right sides of the nematode’s head.  Two support cells, the amphid sheath (AMsh) and 
socket (AMso) cells, provide the structural support and a channel for the sensory cilia of 12 neurons 
that are exposed to the environment and detect external stimuli.  In harsh environmental conditions, 
such as the absence of food, high temperature, or high population density, C. elegans enter a 
diapause stage (Dauer stage), which is characterized by a dramatic remodeling of body structures, 
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including the amphids48,49.  Cell-cell fusion occurs between the left and right glial AMsh cells, and 
this event is required for the correct morphological and functional changes to the ciliated receptive 
endings of the chemosensory neurons.  This AMsh glial fusion event is mediated by the second 
known bona fide C. elegans fusogen, Anchor cell Fusion Failure-1 (AFF-1)48.  These examples 
reveal that not only neurons but also glial cells can engage in cell-cell fusion events. 
 
3.4. Cell-cell fusion between neurons and stem cells 
In the past decade, it has become clear that cell-cell fusion is a key mechanism through which stem 
or progenitor cells of one tissue give rise to differentiated cells of another tissue.  In 2002, Ying and 
colleagues demonstrated that progenitor cells of the central nervous system were able to fuse with 
embryonic stem cells, giving rise to pluripotent hybrid cells50.  Other milestone discoveries revealed 
that bone marrow cells were able to fuse spontaneously with neuronal progenitors in vitro51, and 
that following bone marrow transplantation, bone marrow-derived cells fused with Purkinje neurons 
in vivo, forming binucleated heterokarya51-53.  This phenomenon has been demonstrated in both 
humans and mice, and can also occur between cells of different species54.  Interestingly, these 
binucleated heterokarya retain the Purkinje neuron cell fate, as the nucleus of the stem cell (usually 
round with condensed chromatin) acquires a Purkinje neuron-like nucleus shape (with dispersed 
chromatin), and also expresses some Purkinje neuron-specific genes51,55,56.  Most importantly, these 
heterokarya have been shown to act as electrically active Purkinje neurons57, suggesting that in this 
case fusion is not detrimental to the neuron. 
A series of important subsequent studies further characterized the formation of these 
heterokarya and their possible physiological role (reviewed in ref. 58).  The frequency of 
heterokaryon formation in both humans and rodents is very low, and ranges between ~0.1% and 
0.4% of the total Purkinje neuron population51-54,59.  However, several studies indicate that this rate 
of fusion increases (10 to 100 fold) with damage60-62, inflammation56,61,63, neurodegenerative 
disease54,56,59,64 or chemically induced degeneration65.  Although some authors defend the 
hypothesis that fusion is almost exclusively a consequence of damage and irradiation61, others 
report that fusion is not caused by the irradiation and transplantation procedure itself, as blood 
chimerism obtained by surgically joining two mice (parabionts) also leads to the formation of 
heterokarya between the hematopoietic cells of one mouse and the Purkinje neurons of the other 
mouse56.  Most importantly, other studies have revealed that neuronal fusion might also occur 
during normal development and during aging in non-manipulated mice60,65.  An increase in fusion 
rate with aging has also been found in irradiated models53,60, supporting the idea that aging 
somehow favors the acquisition of fusion competence by neurons.  The contribution of 
hematopoietic cells to Purkinje neurons can occur in physiological conditions; however, these cells 
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were found to be mononucleated, suggesting that fusion might be a transient event or that another 
mechanism is in place63. 
Despite considerable evidence of heterokaryon formation accumulated during the past decade, 
it is still unclear if this process plays a specific physiological role.  As noted above, the heterokarya 
remain functional Purkinje neurons, and a study by Bae and colleagues found that the degeneration 
of Purkinje neurons in a mouse model of Niemann-Pick disease type C1 (a disease that affects the 
function of the cerebellum leading to impaired motor function) was alleviated after transplantation 
of bone marrow-derived mesenchymal stem cells64.  Similar results were obtained in a mouse model 
of cerebellar ataxia, although the exact role of cell fusion in this functional recovery was not clear66.  
Overall, it has been hypothesized that the fusion of progenitor or stem cells with damaged neurons 
provides a healthy nucleus that is able to rescue these highly complex neurons that would otherwise 
be impossible to replace.  This is similar to the regenerative role of cell-cell fusion and 
heterokaryon formation first described in skeletal muscle67 and liver68,69 (for a review see ref. 70).  
Fusion in the nervous system has also been observed outside the cerebellum, with reports that bone 
marrow-derived stem cells can fuse with cortical neurons55 and spinal motor neurons71 following 
transplantation.  Fusion has also been described between embryonic stem cell-derived neuronal 
stem cells and microglia in vitro, and between neuronal stem cells and mature pyramidal neurons in 
the neocortex of mouse and rats in vivo47.  
Another important study has revealed that injured retinal neurons can undergo fusion with 
transplanted hematopoietic stem and progenitor cells72.  Remarkably, following activation of the 
Wnt/beta-catenin signaling pathway, these hybrids are programmed to a precursor stage, proliferate 
and develop into differentiated neurons, providing partial regeneration of the damaged retina and 
functional rescue.  However, lack of activation of the Wnt/beta-catenin signaling pathway leads to 
apoptosis of the newly formed heterokarya72.  
It is important to note that some neuronal types seem to be refractory to fusion, even under the 
same conditions in which Purkinje neurons form heterokarya61,73.  This raises the possibility that 
some neurons may be more prone to fusion than others.  It also suggests that there might be an 
inherent resistance to cell-cell fusion, and that neuronal fusion is potentially harmful in some 
contexts.  Consistent with this, fusion of bone marrow-derived cells with DRG neurons has been 
implicated in the pathogenesis of diabetic neuropathy.  In a mouse model of diabetes, cells thought 
to arise from these fusion events following bone marrow transplantation displayed abnormal 
calcium homeostasis and accelerated apoptosis74. 
In summary, the presence of progenitor cells or stem cells is able to facilitate neuronal fusion 
under certain circumstances, an effect that can be enhanced by different types of neuronal insults as 
well as aging.  However, the cellular and molecular mechanisms underpinning these fusion events 
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are still unknown.  For example, it is not known whether a specific fusogen becomes expressed on 
the surface of progenitor cells or neurons, making them more prone to fusion, or if specific neuronal 
types have a particular proteolipidic membrane composition that makes them fusion competent.  
Moreover, it is still controversial whether these cell-cell fusion events are beneficial or detrimental 
to the neurons involved.  Answers to these questions might allow us to control this biological 
process and potentially expand it for beneficial medical purposes, a concept already under 
consideration.58,75,76. 
 
4. Membrane nanotubes between neurons and between neurons and glia 
In 2004, a seminal study revealed the existence of specific nanotubular membrane structures that 
formed de novo between neuroendocrine cells, thereby allowing the transfer of vesicles, molecules, 
and organelles, and providing a new route for long-distance cell-to cell-communication77.  These 
peculiar structures, named tunneling nanotubes or TNTs, have a diameter of 50 - 200 µm and a 
length of several cell diameters78.  In addition to their role in HIV-1 transmission in T-cells79, an 
important study has shown that TNTs represent an efficient route for spreading of prions between 
neurons in the central nervous system, as well as between immune cells and neurons80.  
Importantly, TNTs formed between neurons and distant astrocytes have also been shown to 
facilitate electrical coupling and calcium signaling81.  Thus, TNTs represent a de facto neuron-
neuron or neuron-glia membrane fusion event, albeit they are mostly temporary, they transport only 
selected cargo, and they do not form true syncytia.  It is still unclear, and of the utmost interest, 
what molecular elements regulate the formation of TNTs, how the recognition proceeds between 
the cells involved, and most importantly what fusogenic elements facilitate the actual fusion of the 
two distinct membranes and what limits it to a transient process. 
 
5. Expression of fusogens in the nervous system in health and disease 
Most of the studies on neuronal or glial cell-cell fusion report these events at the cellular level, 
studying the circumstances and consequences of fusion; however, only a few have explored the 
underlying molecular mechanisms.  Membrane fusion is an active process and therefore requires 
specific protein and lipid effectors.  Viral-induced neuronal cell-cell fusion is likely to be mediated 
by the viral fusogens expressed by infected neurons37,38,43.  Studies on neuronal fusion in C. elegans 
have identified the nematode fusogen EFF-1 as the main effector of self-fusion during PVD 
dendrite development10 and axonal regeneration of PLM neurons3,19.  EFF-1 is also responsible for 
PLM-PLN cell-cell fusion following axonal injury3, and the second nematode fusogen AFF-1 has 
been identified as the main effector of AMsh glial cell-cell fusion48.  Interestingly, when EFF-1 and 
AFF-1 were first discovered in C. elegans, both fusogens appeared to be expressed in neurons and 
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glia8,82.  However, this was a puzzling discovery, given that at the time, these cells were not known 
to engage in fusion events.  Only recently has it been shown that these fusogens are active in 
neurons and glia, providing evidence that the C. elegans nervous system has the molecular 
machinery necessary for membrane fusion.  With this in mind, could the expression pattern of 
fusogens in vertebrates be used to predict if these neurons are also fusion competent?  In humans, 
two highly fusogenic proteins of retroviral origin have been identified: Syncytin-1 (encoded by the 
HERV-W envelope gene located in chromosome 7q21.2)83,84 and Syncytin-2 (encoded by the 
HERV-FRD envelope gene located in chromosome 6p24.1)85.  Both fusogens are almost 
exclusively expressed in the placenta, and Syncytin-1 and its receptors (the neutral amino acid 
transporter or type D mammalian retrovirus receptor ASCT 2 and the related protein ASCT 1) are 
responsible for mediating the fusion events involved in the formation of the syncytiotrophoblast, the 
syncytial outer layer of the placenta.  Interestingly, although expression of these fusogens has not 
been detected in the nervous system of healthy patients, expression of Syncytin-1 has been found to 
be upregulated in the brain of patients with multiple sclerosis86,87, and envelope genes of the 
HERV-W family have been found in the cerebrospinal fluid of patients with schizophrenia and 
bipolar disorder88-90 (for a review on this topic see ref. 91).  How the expression of fusogens might 
contribute to the etiology of neurological disorders is just beginning to be explored.  In multiple 
sclerosis, the expression of Syncytin-1 in astrocytes and microglia mediates neurotoxicity by 
triggering a robust inflammatory response that is toxic to oligodendrocytes and leads to 
demyelination, which explains at least in part the deleterious effect of this fusogen86.  Whether cell-
cell fusion events also contribute to this pathology has not yet been tested, but it is tempting to 
hypothesize that the expression of Syncytin-1 in the nervous system could lead to cell-cell fusion.  
Finally, in mice, Syncytin-A and Syncytin-B proteins have been identified as functional fusogens 
that are also involved in the formation of the syncytiotrophoblast layer of the placenta92.  These 
genes are essentially expressed in this tissue; however, Syncytin-A transcript expression is also 
detected in the brain above background levels92.  Ultimately, there is evidence that fusogens are 
expressed in the nervous systems of multiple species; whether this expression occurs in health or 
disease, it supports the idea that neurons and glia may acquire fusion competence under certain 
circumstances, and suggests that unknown self-fusion or cell-cell fusion events remain to be 
discovered. 
 
6. Conclusion 
The concept that neurons can form syncytia or heterokarya is still relatively novel, and the evidence 
of neuronal fusion discussed here represents the tip of the iceberg.  A range of studies addressing 
different questions in biology (viral infection, tissue regeneration, neuronal development, and more 
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recently the discovery of nanotubes) has converged on the concept of neuronal fusion; however, 
much remains to be explored in this fascinating field.  Are all classes of neurons fusion competent?  
Under which circumstances do neurons fuse?  What are the ultimate consequences of neuronal 
fusion?  
There are a number of factors unique to the nervous system that make in vivo studies of cell-
cell fusion difficult or impossible to conduct.  Firstly, the sheer complexity of the central nervous 
system, in terms of cellular number, architecture and density, makes observations of neuronal 
fusion technically challenging.  Secondly, neuronal fusion can occur not only at the level of the 
soma, but also at the level of axons or dendrites, and cellular connections in such a spatially 
restricted area may be impossible to discern with the resolution of current imaging techniques.  
Finally, identifying cell-cell fusion in neurons may be further confounded by the fact that such 
fusion can be transient and result in mono-nucleated diploid cells63.  There are clearly challenges to 
address, and progress is most likely to be achieved through a combination of different experimental 
paradigms in diverse model systems. 
We have begun to elucidate some of the molecular mechanisms that mediate neuronal fusion, 
starting with the EFF-1-containing pathways for neuronal self-fusion and cell-cell fusion in C. 
elegans.  The molecules that mediate neuronal fusion in vertebrates, and the role for as-yet-
undiscovered fusogens in these systems, are currently unknown.  It also remains to be determined 
whether membrane-exposed PS, an essential requirement for neuronal self-fusion during 
regeneration, has a common role in neuronal fusion. 
Another important step will be to determine how the molecular machinery for neuronal fusion 
is regulated.  The current evidence suggests that the circumstances of neuronal fusion are highly 
specific.  Although very little is known about the physiological advantage or possible detrimental 
effect of neuronal cell-cell fusion, it is clear that it can have consequences for the neuron at both the 
subcellular and electrophysiological levels.  Exactly how the balance is established between 
healthy, developmental self-fusion, and protection from ectopic cell-cell fusion, is still to be 
determined.  One hypothesis is that it involves subcellular regulation of cell-specific fusogens, with 
changes in expression and localization of these molecules occurring in response to specific stimuli 
or insults. 
The finding that neurons can form syncytia or heterokarya might be seen as a challenge to 
Ramón y Cajal’s neuron theory.  Conversely, our current understanding of neuronal fusion may 
instead strengthen this theory, as neurons appear to fuse only under very specific circumstances, 
and it is likely that mechanisms exist to prevent uncontrolled cell-cell fusion, thereby maintaining 
neurons (for the most part) as individual units. 
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5.3 Discussion  
 
As we have seen, there is evidence for and against the idea that neuronal cell-cell fusion serves to 
regenerate nervous tissue.  Perhaps the strongest evidence is that these fusion events occur mostly 
in the setting of neuronal injury, or are enhanced by such injury (see Section 5.2).  This makes it 
tempting to suggest that they represent an active attempt at neuronal repair.  Alternatively, the 
injury stimulus may simply be leading to break down of mechanisms inhibiting cell-cell fusion, or 
the fusion is an unintended by-product of the regenerative response.  
It is interesting to consider this in the context of PLM-PLN cell-cell fusion.  Does this fusion 
represent incorrect targeting of the PLM self-fusion strategy, or could it provide a beneficial 
outcome for the neuron?  Ideally, one would determine which functional outcomes occur with 
PLM-PLN fusion.  If PLM fuses with the severed PLN fragment, is this fragment now recruited for 
mechanosensory function?  If PLM fuses to the PLN cell body or proximal axon, does PLN acquire 
the identity of a mechanosensory neuron?  Unfortunately, dissecting this experimentally has proven 
to be difficult, as the PLM process appears to have a mixed axonal and dendritic identity, whereby 
the distal fragment alone can mediate some behavioural response to light touch (unpublished data, 
not shown).  Hence, we are yet to confirm the function of the PLM neuron following ectopic fusion 
with PLN. 
It would also be interesting to determine if PLN utilises the same suite of apoptotic molecules 
for distal fragment recognition (see Chapter 2).  We have shown that PLN can undergo axonal 
fusion similarly to PLM2.  If PS is also displayed on the surface of its severed distal fragment, this 
might explain the occurrence of ectopic fusion with PLM.  Alternatively, if it mediates axonal 
fusion through a different signalling system, this could explain the relatively low rate of these 
ectopic fusion events.  
If neuronal cell-cell fusion events are indeed incidental, and counterproductive to attempts at 
repair, it is then important to consider what mechanisms are in place to prevent them.  Much is 
known about the inhibition of ectopic fusion during the precise development of the C. elegans 
hypodermis, achieved through different levels of EFF-1 regulation (see Chapter 1), but whether this 
regulation applies to neurons is unknown.  What we do know is that PLM is capable of expressing 
EFF-1, and if this fusogen is being expressed constitutively, its activity is largely inhibited until 
axonal injury occurs (see Section 3.3).  Interestingly, we identified RAB-5 as a neuronal regulator 
of EFF-1 that could perform constitutive inhibition of EFF-1 activity (see Chapter 3).  However, we 
did not observed increased PLM cell-cell fusion when RAB-5 was perturbed, suggesting that other, 
unidentified mechanisms exist to prevent this ectopic fusion.  Following injury, such mechanisms 
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must be precisely overridden to allow for specific regenerative fusion, while avoiding widespread 
ectopic fusion with surrounding cells.   
Overall, our own work with EFF-1-mediated cell-cell fusion in PLM has not yet indicated that 
these events contribute to repair or functional recovery in this neuron.  However, in other contexts, 
it will be interesting to see whether this fusion proves to be a viable option for neuronal repair in 
different models of injury.  It raises compelling questions about subsequent changes in neuronal 
identity and function, as discussed here and in Section 5.2. 
 
5.4 Statement of contribution  
 
I wrote some sections of the above review and edited the full manuscript.  I designed the figures, 
and also performed a search of the relevant literature to ensure that all applicable studies were 
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6.1 Introduction 
 
This final chapter summarises the key findings of the thesis and emphasizes its specific contribution 
to the field of axonal regeneration.  It discusses how these findings may influence future research in 
EFF-1-mediated neuronal repair, and highlights remaining questions to be addressed in the future.  
 
6.2 Conclusions  
 
This thesis has investigated axonal fusion as a means of neuronal repair in C. elegans neurons.  
Specifically, its aim was to characterize the function and regulation of EFF-1, a molecule that had 
been strongly linked to axonal fusion.  The work detailed in this thesis has clearly fulfilled this aim, 
making significant contributions to our understanding of EFF-1 function in neurons.   
In the first results chapter (Chapter 2), we confirmed that EFF-1 functions cell-autonomously in 
PLM for axonal fusion, and undergoes dynamic changes in its subcellular localization following 
injury, whereby it is mobilized to the membrane of the newly formed growth cone.  We also placed 
EFF-1 downstream in a pathway of conserved apoptotic clearance molecules that promote axonal 
fusion.  This study was remarkable as the first to characterize how a fusogen mediates neurite 
repair.  Importantly, its findings indicated that EFF-1 is precisely regulated in neurons.  The model 
we established of EFF-1 localization in PLM provided a strong experimental platform for 
interrogating candidate neuronal regulators of EFF-1, and assessing their role in controlling both 
EFF-1 localization and function. 
In the subsequent study (Chapter 3), we identified that the GTPase RAB-5 is a regulator of 
neuronal EFF-1.  Crucially, we demonstrated that changes in RAB-5 activity could alter EFF-1 
subcellular localization, and that this was associated with changes in EFF-1 activity.  We proposed 
a model in which RAB-5 activity is required for transport of EFF-1 from the membrane to early 
endosomal compartments, negatively regulating EFF-1 activity.  Our results are consistent with a 
function for RAB-5 in constitutive control of EFF-1; it is also possible that it functions upstream of 
EFF-1 during axonal fusion, acting in parallel with the apoptotic pathway.  Although we did not 
confirm that RAB-5 regulates endogenous EFF-1, or that it plays a role during neuronal repair, 
these questions could be addressed by visualizing endogenous EFF-1, and investigating rab-5 
expression following axonal injury (see Chapter 3).   
In this study, we also characterized the ability of PLM to produce EFF-1 in extracellular 
vesicles, a phenomenon that to our knowledge has never been described.  Fusogen-containing 
vesicles have obvious potential for delivering fusogenicity to neighbouring cells (Chapter 3) and 
may be of clinical interest.  It raises exciting questions regarding how EFF-1 vesicles could 
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participate in neuronal repair, either cell-autonomously or non-cell-autonomously.  Future work 
could aim to determine exactly how these vesicles are generated, and whether they are functional.   
To complete our characterization of EFF-1 in neuronal repair, we also investigated the 
molecular responses activated in the severed axonal fragment following injury (Chapter 4).  We 
found that, in C. elegans, this severed axon undergoes a process of Wallerian degeneration similar 
to vertebrate systems.  Intriguingly, this degeneration is mediated by some of the same apoptotic 
molecules that promote regenerative fusion of the axon.  We interpret this as evidence that 
processes of regeneration and degeneration are closely coordinated to achieve repair via axonal 
fusion.  This coordination may also extend to EFF-1, as we presented evidence that EFF-1 also 
mediates distal fragment degeneration in addition to its role in fusing the axonal fragments.  
Excitingly, these dual functions could be achieved through the production of different EFF-1 
isoforms, with isoform A mediating axonal fusion, and isoform C mediating axonal degeneration.  
These dual functions could relate to the predicted structures of these isoforms, with isoform A 
containing a transmembrane domain, and isoform C likely to encode a secreted molecule that 
potentially acts as an ‘eat me’ signal for the degenerating axon.  Further experiments, which 
interrogate the potential role of background mutations, will be needed to address the limitations of 
our preliminary data.  However, if the role of EFF-1 in axonal degeneration is confirmed, it 
demonstrates significant complexity in the function of EFF-1 in this neuron.    
Finally, we explored the ability of EFF-1 to ectopically fuse the PLM neuron to surrounding 
neurons.  We reviewed this activity of EFF-1 in the context of neuronal cell-cell fusion (Chapter 5).  
It is clear that EFF-1 function in neurons must be exquisitely regulated following injury, allowing 
specific fusion to the severed fragment while simultaneously preventing ectopic fusion. The 
consequences of ectopic fusion of PLM neurons, and ectopic fusion between other C. elegans 
neurons, are currently uncharacterized, but represent an active area of research.   
The studies presented in this thesis have been the first to characterize EFF-1 function in 
neuronal repair; this is a context in which EFF-1 has significant therapeutic potential.  Axonal 
fusion presents an efficient alternative to the classic regeneration model, and has inspired novel 
approaches to the treatment of nerve injury in vertebrates.  Surgical ‘end-to-end’ reconnection of 
transected mammalian nerve fibers has been described in vivo, promoted by PEG and other 
polymers, with promising outcomes in terms of functional recovery (Chapter 1).  One could 
speculate that EFF-1 would be a promising substitute for inducing fusion at these injury sites, 
provided we build upon the understanding of its function and regulation presented in this thesis.  
Related to this, it is exciting that the C. elegans field has recently developed paradigms for 
dissecting the functional outcomes of axonal fusion events (Chapter 1).      
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To summarise, we have confirmed that EFF-1 acts as the key molecular effector of axonal 
fusion in the PLM neuron.  It functions by directly mediating fusion of the two axonal fragments, 
and might also have a more complex role involving degeneration of the distal axonal fragment.  
Regarding EFF-1 regulation, we determined that this fusogen has a dynamic pattern of subcellular 
localization in the PLM neuron following injury.  We identified a neuronal regulator of EFF-1 that 
is capable of controlling this localization pattern and EFF-1 activity.  We also placed EFF-1 activity 
in the context of a novel neuronal repair pathway consisting of molecules in the apoptotic clearance 
machinery.  These findings provide a foundation for ongoing characterization of axonal fusion, and 
for translational approaches using EFF-1 in the treatment of patients with nerve injuries.    
